<!DOCTYPE html> <html class="pb-page js" data-request-id=ebf762ff-6d9e-4367-964c-8f8d7062042d style=--header-height:120px lang=en><!--
 Page saved with SingleFile 
 url: https://journals.sagepub.com/doi/10.1345/aph.1R501?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed 
 saved date: Sun Nov 27 2022 10:57:18 GMT-0500 (Eastern Standard Time)
--><head data-pb-dropzone=head><meta charset=utf-8><style>:root{--sf-img-22: url("data:image/png;base64,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")}.qc-cmp2-persistent-link{cursor:pointer;position:fixed;background-color:#368BD6;padding:5px 15px;color:#FFF;display:flex;text-decoration:none;align-items:center;max-height:30px;z-index:2147483640;bottom:0;right:0;border-top-left-radius:3px;border-top-right-radius:3px}.qc-cmp2-persistent-link:focus{outline:-webkit-focus-ring-color auto 1px}.qc-cmp2-persistent-link img{width:16px;height:17px;margin-right:5px}:root{--litepicker-container-months-color-bg:#fff;--litepicker-container-months-box-shadow-color:#ddd;--litepicker-footer-color-bg:#fafafa;--litepicker-footer-box-shadow-color:#ddd;--litepicker-tooltip-color-bg:#fff;--litepicker-month-header-color:#333;--litepicker-button-prev-month-color:#9e9e9e;--litepicker-button-next-month-color:#9e9e9e;--litepicker-button-prev-month-color-hover:#2196f3;--litepicker-button-next-month-color-hover:#2196f3;--litepicker-month-width:calc(var(--litepicker-day-width)*7);--litepicker-month-weekday-color:#9e9e9e;--litepicker-month-week-number-color:#9e9e9e;--litepicker-day-width:38px;--litepicker-day-color:#333;--litepicker-day-color-hover:#2196f3;--litepicker-is-today-color:#f44336;--litepicker-is-in-range-color:#bbdefb;--litepicker-is-locked-color:#9e9e9e;--litepicker-is-start-color:#fff;--litepicker-is-start-color-bg:#2196f3;--litepicker-is-end-color:#fff;--litepicker-is-end-color-bg:#2196f3;--litepicker-button-cancel-color:#fff;--litepicker-button-cancel-color-bg:#9e9e9e;--litepicker-button-apply-color:#fff;--litepicker-button-apply-color-bg:#2196f3;--litepicker-button-reset-color:#909090;--litepicker-button-reset-color-hover:#2196f3;--litepicker-highlighted-day-color:#333;--litepicker-highlighted-day-color-bg:#ffeb3b}:root{--litepicker-mobilefriendly-backdrop-color-bg:#000}@keyframes lp-bounce-target-next{from{transform:translateX(100px) scale(0.5)}to{transform:translateX(0px) scale(1)}}@keyframes lp-bounce-target-prev{from{transform:translateX(-100px) scale(0.5)}to{transform:translateX(0px) scale(1)}}</style><meta name=pbContext content=";page:string:Article/Chapter View;issue:issue:10.1177/AOPD_47_3;ctype:string:Journal Content;article:article:10.1345/aph.1R501;journal:journal:aopd;website:website:sage;wgroup:string:Publication Websites;pageGroup:string:Publication Pages;subPage:string:Full Text;requestedJournal:journal:aopd">
<link rel=schema.DC href=http://purl.org/DC/elements/1.0/><meta name=citation_journal_title content="Annals of Pharmacotherapy"><meta name=dc.Title content="Phentermine/Topiramate for the Treatment of Obesity"><meta name=dc.Creator content="Steven M  Smith"><meta name=dc.Creator content="Melissa  Meyer"><meta name=dc.Creator content="Katy E  Trinkley"><meta name=dc.Description content="OBJECTIVETo review the pharmacology, efficacy, and safety of phentermine/topiramate (PHEN/TPM) in the management of obese patients.DATA SOURCESMEDLINE (1966-July 2012) was searched using the terms ..."><meta name=Description content="OBJECTIVETo review the pharmacology, efficacy, and safety of phentermine/topiramate (PHEN/TPM) in the management of obese patients.DATA SOURCESMEDLINE (1966-July 2012) was searched using the terms ..."><meta name=dc.Description content="OBJETIVORevisar la farmacología, eficacia y seguridad de fentermina/topiramato (PHEN/TPM) en el manejo de pacientes obesos.FUENTES DE DATOSSe realizó una revisión de la literatura mediante el siste..." lang=es><meta name=Description content="OBJETIVORevisar la farmacología, eficacia y seguridad de fentermina/topiramato (PHEN/TPM) en el manejo de pacientes obesos.FUENTES DE DATOSSe realizó una revisión de la literatura mediante el siste..." lang=es><meta name=dc.Description content="OBJECTIFRevoir la pharmacologie, l'efficacité et l'innocuité du phentermine/topiramate (PHEN/TPM) dans le traitement de l'obésité.SOURCE DES DONNÉESLa banque de données MEDLINE (1966 à juillet 2012..." lang=fr><meta name=Description content="OBJECTIFRevoir la pharmacologie, l'efficacité et l'innocuité du phentermine/topiramate (PHEN/TPM) dans le traitement de l'obésité.SOURCE DES DONNÉESLa banque de données MEDLINE (1966 à juillet 2012..." lang=fr><meta name=dc.Publisher content="SAGE PublicationsSage CA: Los Angeles, CA"><meta name=dc.Date scheme=WTN8601 content=2016-12-21><meta name=dc.Type content=research-article><meta name=dc.Format content=text/HTML><meta name=dc.Identifier scheme=doi content=10.1345/aph.1R501><meta name=dc.Identifier scheme=publisher-id content=10.1345_aph.1R501><meta name=dc.Source content=http://dx.doi.org/10.1345/aph.1R501><meta name=dc.Language content=en><meta name=dc.Coverage content="Sage CA: Los Angeles, CA"><meta name=dc.Rights content="© 2013 Annals of Pharmacotherapy">
<link rel=meta type=application/atom+xml href=https://doi.org/10.1345%2Faph.1R501>
<link rel=meta type=application/rdf+json href=https://doi.org/10.1345%2Faph.1R501>
<link rel=meta type=application/unixref+xml href=https://doi.org/10.1345%2Faph.1R501>
<style>/*! @name @brightcove/videojs-pip @version 1.1.5 @license UNLICENSED */</style>
<meta name=twitter:card content=summary_large_image>
<meta property=og:locale content=en_US>
<meta name=format-detection content="telephone=no">
<meta name=robots content=noarchive>
<meta property=og:title content="Phentermine/Topiramate for the Treatment of Obesity - Steven M Smith, Melissa Meyer, Katy E Trinkley, 2013">
<meta property=og:type content=article>
<meta property=og:url content="https://journals.sagepub.com/doi/10.1345/aph.1R501?url_ver=Z39.88-2003&amp;rfr_id=ori%3Arid%3Acrossref.org&amp;rfr_dat=cr_pub++0pubmed">
<meta property=og:image:width content=600>
<meta property=og:image:height content=314>
<meta name=twitter:image content=https://journals.sagepub.com/pb-assets/cover-alt/aop-cover-social-1565280396867.jpg>
<meta property=og:image content=https://journals.sagepub.com/pb-assets/cover-alt/aop-cover-social-1565280396867.jpg>
<meta property=og:site_name content="SAGE Journals">
<meta property=og:description content="OBJECTIVE To review the pharmacology, efficacy, and safety of phentermine/topiramate (PHEN/TPM) in the management of obese patients. DATA SOURCES MEDLINE (1966-...">
<meta property=article:author content="Steven M Smith, Melissa Meyer, Katy E Trinkley">
<meta property="article:published_time - datetime" content="December 21, 2016">
<title>Phentermine/Topiramate for the Treatment of Obesity - Steven M Smith, Melissa Meyer, Katy E Trinkley, 2013</title>
<style>/*!font-weight: bold;*//*!padding: 10px 10px;*/.popup{position:fixed;width:100%;height:100%;top:0;left:0;z-index:110000;background-color:rgba(255,255,255,.95)}@-webkit-keyframes load8{0%{-webkit-transform:rotate(0deg);transform:rotate(0deg)}100%{-webkit-transform:rotate(360deg);transform:rotate(360deg)}}@keyframes load8{0%{-webkit-transform:rotate(0deg);transform:rotate(0deg)}100%{-webkit-transform:rotate(360deg);transform:rotate(360deg)}}.icon-close:before{content:url(data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTQiIGhlaWdodD0iMTQiIHZpZXdCb3g9IjAgMCAxMCAxMCIgZmlsbD0ibm9uZSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj4KPHBhdGggZD0iTTkuNjY2MzQgMS4yNzYzNEw4LjcyMzAxIDAuMzMzMDA4TDQuOTk5NjcgNC4wNTYzNEwxLjI3NjM0IDAuMzMzMDA4TDAuMzMzMDA4IDEuMjc2MzRMNC4wNTYzNCA0Ljk5OTY3TDAuMzMzMDA4IDguNzIzMDFMMS4yNzYzNCA5LjY2NjM0TDQuOTk5NjcgNS45NDMwMUw4LjcyMzAxIDkuNjY2MzRMOS42NjYzNCA4LjcyMzAxTDUuOTQzMDEgNC45OTk2N0w5LjY2NjM0IDEuMjc2MzRaIiBmaWxsPSJibGFjayIvPgo8L3N2Zz4K)}@-moz-keyframes pulse{0%{opacity:0}100%{opacity:1}}@-webkit-keyframes pulse{0%{opacity:0}100%{opacity:1}}@-o-keyframes pulse{0%{opacity:0}100%{opacity:1}}@-ms-keyframes pulse{0%{opacity:0}100%{opacity:1}}@keyframes pulse{0%{opacity:0}100%{opacity:1}}:root{--journal-color:#14797b;--secondary-color:#14797b}.pull-right{float:right}@media (max-width:531px){.hidden-xs{display:none!important}}@media (min-width:532px) and (max-width:767px){.hidden-sm{display:none!important}}@media (min-width:768px) and (max-width:1023px){.hidden-md{display:none!important}}@keyframes shift-up-content{0%{top:-1.25rem}to{top:-2.5rem}}@keyframes trans-zoom-in{0%{transform:scale(.8)}to{transform:scale(1)}}@keyframes trans-fade{0%{opacity:.3}to{opacity:1}}@keyframes trans-pop{50%{transform:scale(1.3)}}@keyframes trans-wobble{16%{transform:skew(-12deg)}32%{transform:skew(10deg)}50%{transform:skew(-6deg)}66%{transform:skew(4deg)}82%{transform:skew(-2deg)}to{transform:skew(0)}}@keyframes trans-forward{0%,to{transform:translateX(0)}50%{transform:translateX(.25rem)}}@keyframes trans-backward{0%,to{transform:translateX(0)}50%{transform:translateX(-.25rem)}}@keyframes trans-float{0%,to{transform:translateY(0)}50%{transform:translateY(-.25rem)}}@keyframes trans-sink{0%,to{transform:translateY(0)}50%{transform:translateY(.25rem)}}@keyframes trans-pulse{0%,to{transform:scale(1)}50%{transform:scale(.9)}}@keyframes trans-pulse-shadow{0%{box-shadow:0 0 0 0 rgba(20,121,123,.4)}70%{box-shadow:0 0 0 .625rem transparent}to{box-shadow:0 0 0 0 transparent}}@keyframes trans-rotate{to{transform:rotate(1turn)}}@keyframes trans-shine-before{to{transform:translateX(18.75rem) skewX(-15deg);opacity:.6;transition:.7s}}@keyframes trans-shine-after{to{transform:translateX(18.75rem) skewX(-15deg);opacity:1;transition:.7s}}/*!* URL: http://ianlunn.co.uk*/@keyframes show-icon-popup{to{margin-left:1rem}}.hvr-grow{display:inline-block}.hvr-grow:active,.hvr-grow:focus,.hvr-grow:hover{transform:scale(1.2)}@keyframes dropdown-fade-left{0%{opacity:0;transform:translateX(-10%)}to{opacity:1;transform:translateX(0)}}@keyframes dropdown-grow{0%{opacity:0;transform:scaleY(.5)}to{opacity:1;transform:scale(1)}}@font-face{font-family:icomoon;src:url(data:font/woff;base64,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)format("woff");font-weight:400;font-style:normal}.icon-plus:before,.icon-plus_n:before{content:""}.icon-shopping_cart:before{content:""}.icon-share:before{content:""}.icon-lock_open:before{content:""}.icon-close:before,.icon-close_thin:before{content:""}.icon-arrow_down:before,.icon-section_arrow_d:before{content:""}.icon-arrow_up:before,.icon-section_arrow_u:before{content:""}.icon-open_in_new:before{content:""}.icon-person_outline:before{content:""}.icon-search:before{content:""}.icon-download:before{content:""}.icon-arrow-long-left:before,.icon-arrow-stroke-left:before{content:""}.icon-arrow-long-right:before,.icon-arrow-stroke-right:before{content:""}.icon-cite:before{content:""}body{word-wrap:break-word;min-height:100vh;overflow-x:hidden}.content{padding-bottom:.9375rem}.full-width{width:100%}.sr-only,.sr-only-focusable{position:absolute;width:.0625rem;height:.0625rem;padding:0;overflow:hidden;clip:rect(0,0,0,0);white-space:nowrap;border:0}.sr-only-focusable:active,.sr-only-focusable:focus{position:static;width:auto;height:auto;overflow:visible;clip:auto;white-space:normal;position:absolute!important;background:#f7f7f7!important;color:#888!important;border:.0625rem solid #888!important;padding:1rem!important;box-shadow:0 0 .125rem .25rem hsla(0,0%,53.3%,.2);border-radius:.1875rem;z-index:99999!important;font-weight:700!important;font-size:16px!important;font-size:1rem!important;text-shadow:none!important;text-decoration:underline!important;text-transform:none!important}.sr-only-focusable:hover{opacity:.9}.ux-modal-container .modal a:not(.btn):not(.dropdown-item),a{color:inherit;cursor:pointer}.ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),.ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),a:focus,a:hover{color:inherit;text-decoration:none}.ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),a:focus{text-decoration:underline}img{max-width:100%}.input-group{margin-bottom:.9375rem}.input-group label{font-size:.75rem;font-weight:500;display:block;margin-bottom:.625rem;color:#333}input[type=password],input[type=search],input[type=text]{font-family:Open Sans,sans-serif;width:100%;color:#333;border:.0625rem solid #ccc;background-color:#fff;outline:0;transition:all .15s ease-in-out}.ms-ctn:focus,input[type=email]:focus,input[type=password]:focus,input[type=search]:focus,input[type=tel]:focus,input[type=text]:focus,select:focus,textarea:focus{box-shadow:0 0 0 .1875rem rgba(0,0,0,.1)}input[type=password],input[type=text]{border-radius:2px}::-webkit-input-placeholder{color:#63666a;letter-spacing:1px;letter-spacing:.0625rem}::-moz-placeholder{color:#63666a;letter-spacing:1px;letter-spacing:.0625rem}:-moz-placeholder{color:#63666a;letter-spacing:1px;letter-spacing:.0625rem}[type=checkbox]{margin-right:.625rem;margin-bottom:.625rem}.checkbox--primary input:checked~span:before,input[type=checkbox]:checked:before{content:"";color:#fff;border-color:#14797b;background:#14797b}.checkbox--primary span:before,.radio--primary span:before,input[type=checkbox]:before{content:"";width:14px;width:.875rem;min-width:14px;min-width:.875rem;height:14px;height:.875rem;min-height:14px;min-height:.875rem;border-radius:.125rem;margin-right:.625rem;display:flex;justify-content:center;align-items:center;font-size:14px;font-size:.875rem;font-weight:700;border:.0625rem solid #000;transition:all .25s ease-in-out;font-family:icomoon!important;background-color:#000;background-color:transparent}.rlist{list-style:none;padding:0;margin:0}.rlist--inline{list-style:none;padding:0;margin:0}.rlist--inline>li{display:inline-flex}.rlist--inline.separator>li:not(:last-of-type){border-right:.0625rem solid #d9d9d9;padding-right:.5rem;margin-right:.5rem}i[class*=icon-]{transition:transform .5s}.icon-close_thin,a i[class*=icon-]:before{display:inline-block}.modal .icon-close_thin:focus,.modal .icon-close_thin:hover,.popup .icon-close_thin:focus,.popup .icon-close_thin:hover{transform:rotateY(180deg)}@-webkit-keyframes fadeOut{0%{opacity:1}to{opacity:0}}@keyframes fadeOut{0%{opacity:1}to{opacity:0}}/*!jQuery UI - v1.12.1 - 2018-04-24
* http://jqueryui.com
* Includes: sortable.css, core.css, datepicker.css, slider.css, theme.css
* To view and modify this theme, visit http://jqueryui.com/themeroller/?scope=&folderName=base&cornerRadiusShadow=8px&offsetLeftShadow=0px&offsetTopShadow=0px&thicknessShadow=5px&opacityShadow=30&bgImgOpacityShadow=0&bgTextureShadow=flat&bgColorShadow=666666&opacityOverlay=30&bgImgOpacityOverlay=0&bgTextureOverlay=flat&bgColorOverlay=aaaaaa&iconColorError=cc0000&fcError=5f3f3f&borderColorError=f1a899&bgTextureError=flat&bgColorError=fddfdf&iconColorHighlight=777620&fcHighlight=777620&borderColorHighlight=dad55e&bgTextureHighlight=flat&bgColorHighlight=fffa90&iconColorActive=ffffff&fcActive=ffffff&borderColorActive=003eff&bgTextureActive=flat&bgColorActive=007fff&iconColorHover=555555&fcHover=2b2b2b&borderColorHover=cccccc&bgTextureHover=flat&bgColorHover=ededed&iconColorDefault=777777&fcDefault=454545&borderColorDefault=c5c5c5&bgTextureDefault=flat&bgColorDefault=f6f6f6&iconColorContent=444444&fcContent=333333&borderColorContent=dddddd&bgTextureContent=flat&bgColorContent=ffffff&iconColorHeader=444444&fcHeader=333333&borderColorHeader=dddddd&bgTextureHeader=flat&bgColorHeader=e9e9e9&cornerRadius=3px&fwDefault=normal&fsDefault=1em&ffDefault=Arial%2CHelvetica%2Csans-serif
* Copyright jQuery Foundation and other contributors; Licensed MIT*/@media (max-width:1023px){.main-nav{display:none}}.main-nav .ux-modal-container .modal a:not(.btn):not(.dropdown-item),.main-nav a,.ux-modal-container .modal .main-nav a:not(.btn):not(.dropdown-item){display:block;font-size:12px;font-size:.75rem;font-weight:600;padding:.75rem .5625rem;text-transform:uppercase}.main-nav .drawer__nav .menu-item:hover{color:#333}.dropdown.hover>a,.dropdown:focus>a,.dropdown:hover>a,.ux-modal-container .modal .dropdown.hover>a:not(.btn):not(.dropdown-item),.ux-modal-container .modal .dropdown:focus>a:not(.btn):not(.dropdown-item),.ux-modal-container .modal .dropdown:hover>a:not(.btn):not(.dropdown-item){color:#333}.menubar>.menu-parent{transform:perspective(.0625rem) translateZ(0);vertical-align:middle;position:relative;overflow:inherit;z-index:1}.menubar>.menu-item:before,.menubar>.menu-parent:before{content:"";position:absolute;z-index:-1;left:51%;right:51%;bottom:0;background:#14797b;height:3px;height:.1875rem;transition:left .3s ease-out,right .3s ease-out}.menubar>.menu-item:active:before,.menubar>.menu-item:focus:before,.menubar>.menu-item:hover:before,.menubar>.menu-parent:active:before,.menubar>.menu-parent:focus:before,.menubar>.menu-parent:hover:before{left:0;right:0}.menubar>.menu-item:before,.menubar>.menu-parent:before{background:#333}[data-db-parent-of]:not(.sticko):not(.sticko__md):not(.js--not-parent):not(.fixed-element){position:relative}[data-db-target-of]{position:absolute;text-align:left;z-index:9}.dropBlock__link{position:relative}.tab__content .tab__pane{padding-top:.625rem}.tab__content .tab__pane.active{display:block}.tab__nav li{display:inline-block}.tab__nav span{line-height:2}.tab__nav a{display:block;border-bottom:.0625rem solid #d9d9d9}.tab--flex .tab__nav{display:flex}.tab--flex .tab__nav:after,.tab--flex .tab__nav:before{display:table;clear:both;content:" "}.tab--flex .tab__nav li{text-align:center}@media (max-width:1023px){.accordion-tabbed__control i{display:none}}table{width:100%}table tr{font-weight:600}table td:not([align]),table th:not([align]){text-align:left}table th{color:#000}.close{float:right;font-weight:700;line-height:1;color:#000;text-shadow:0 .0625rem 0#f7f7f7;padding:0;cursor:pointer;background:0 0;border:0;-webkit-appearance:none;-moz-appearance:none;appearance:none}.close:focus,.close:hover{color:#000;text-decoration:none;background-color:transparent}.ux-modal-container .modal{overflow:hidden;position:fixed;top:0;right:0;bottom:0;left:0;z-index:1050;-webkit-overflow-scrolling:touch}@media (max-width:531px){.ux-modal-container .modal{overflow-y:auto}}.ux-modal-container .modal__body{position:relative}.ux-modal-container .modal__dialog{overflow:auto;position:relative;background:#fff;padding:1.0625rem 1.875rem 1.875rem}@media (min-width:768px){.ux-modal-container .modal__dialog{border-radius:.625rem;width:26.875rem;margin:1.875rem auto;max-height:95%}}@media (max-width:531px){.ux-modal-container .modal__dialog{height:100%}}.ux-modal-container .modal a,.ux-modal-container .modal a:not(.btn):not(.dropdown-item){transition:all .15s linear;transition-property:color,outline,text-shadow,-webkit-text-decoration;transition-property:color,text-decoration,outline,text-shadow;transition-property:color,text-decoration,outline,text-shadow,-webkit-text-decoration;color:#888;text-decoration:none}.ux-modal-container .modal a:active,.ux-modal-container .modal a:active:not(.btn):not(.dropdown-item),.ux-modal-container .modal a:focus,.ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),.ux-modal-container .modal a:hover,.ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item){color:#555;text-decoration:underline}.ux-modal-container .modal a.focus,.ux-modal-container .modal a.focus:not(.btn):not(.dropdown-item),.ux-modal-container .modal a:focus,.ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item){outline:none;outline-offset:2px;outline-offset:.125rem;-webkit-text-decoration-style:double;text-decoration-style:double;-webkit-text-decoration-color:rgba(85,85,85,.4);text-decoration-color:rgba(85,85,85,.4)}div.holder:hover,figure:hover{cursor:pointer}figcaption{cursor:default}.header{z-index:10;display:flex;flex-direction:column;width:100%;color:#333;padding:0 1.5rem;transform:translate(0)}@media (max-width:767px){.header{padding:0 1rem}}.header--first-row{display:flex;justify-content:space-between;transition:all .2s cubic-bezier(.6,.01,.16,1.01)}@media (max-width:767px){.header--first-row{height:3.5rem}}@media (max-width:1023px){.header--first-row{border:none}}.header--second-row{display:flex;justify-content:space-between}@media (max-width:1023px){.header--second-row{height:0}}.header--first-col{display:flex;flex:1}@media (max-width:531px){.header--first-col{flex:6}}.header--second-col{display:flex;align-items:center;justify-content:flex-end}@media (max-width:531px){.header--second-col{flex:2}}.header__logo{display:flex;align-items:center}@media (max-width:767px){.header__logo img{max-height:90%;width:70%}}.header .institution{margin-right:2.25rem;color:#333;font-size:.75rem}.header .institution .ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),.header .institution .ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),.header .institution a:focus,.header .institution a:hover,.ux-modal-container .modal .header .institution a:focus:not(.btn):not(.dropdown-item),.ux-modal-container .modal .header .institution a:hover:not(.btn):not(.dropdown-item){color:#14797b}@media (max-width:1023px){.header .institution{display:none}}.header .institution img{padding-right:.625rem}@media (max-width:1279px) and (min-width:1024px){.header .institution img{display:none}}.header__quick-menu{text-align:right}@media (max-width:1279px){.header__quick-menu .cart-wrapper{margin-right:1.5rem}}@media (max-width:1023px){.header__quick-menu .cart-wrapper{padding:0 .75rem;margin:0;border-left:.0625rem solid hsla(0,0%,100%,.4)}}@media (max-width:531px){.header__quick-menu .cart-wrapper{padding:0 .625rem}}.header__quick-menu .cart-wrapper .cartLabel{padding:0}.header__quick-menu ul{display:flex;justify-content:flex-end}.header__quick-menu a{display:flex;align-items:center}.header__quick-menu a i{font-size:1.5rem;margin:0}@media (max-width:531px){.header__quick-menu li i{font-size:1.25rem}}@media (max-width:1279px){.header__quick-menu .sign-in{display:none}}.header .cart-wrapper:focus .icon-account_circle,.header .cart-wrapper:focus .icon-shopping_cart,.header .cart-wrapper:hover .icon-account_circle,.header .cart-wrapper:hover .icon-shopping_cart,.header .show-login:focus .icon-account_circle,.header .show-login:focus .icon-shopping_cart,.header .show-login:hover .icon-account_circle,.header .show-login:hover .icon-shopping_cart{display:inline-block;animation:trans-pop .5s 1}.tab__nav a{text-decoration:none}.tab__nav .active a{border-bottom-color:#14797b}@media (min-width:768px) and (max-width:1023px){.tab__nav .active a{font-weight:400}}.tab__nav li .ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),.tab__nav li a:hover,.ux-modal-container .modal .tab__nav li a:hover:not(.btn):not(.dropdown-item){color:#333}.tab--flex .tab__nav{box-shadow:inset 0-.0625rem 0-.0625rem #d9d9d9;border-bottom:.0625rem solid #ccc}@media (min-width:768px) and (max-width:1023px){.tab--flex .tab__nav a{font-weight:400}}@media (max-width:767px){.tab--flex .tab__nav a{padding:.5rem 0}}.tab--flex .tab__nav li{margin-bottom:0;text-transform:uppercase;font-size:1.125rem;font-weight:400;color:#888;transform:perspective(.0625rem) translateZ(0);vertical-align:middle;position:relative}.tab--flex .tab__nav li:before,.tab--generic .tab__nav li:before{content:"";position:absolute;z-index:-1;left:0;right:0;bottom:0;height:6px;height:.375rem;transform:translateY(.375rem);transition:transform .3s ease-out}.tab--flex .tab__nav li.active:before,.tab--generic .tab__nav li.active:before{transform:translateY(0)}.tab--flex .tab__nav li:before,.tab--generic .tab__nav li:before{background:#14797b}.tab .dropBlock>a{background:#fff;color:#000;font-size:.75rem;font-weight:500;display:flex}.tab .dropBlock i{font-size:.875rem;color:#000;margin-top:.1875rem;margin-left:.625rem}[data-db-target-of] li a{color:#888;transition:all .2s cubic-bezier(.6,.01,.16,1.01);width:100%}.ux-modal-container .modal [data-db-target-of] li a:focus:not(.btn):not(.dropdown-item),[data-db-target-of] li .likeLink:focus,[data-db-target-of] li .ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),[data-db-target-of] li a:focus{color:#eb8992}[data-db-target-for] i{margin-right:.75rem}[data-db-target-for] i:last-child{margin-right:0;margin-left:.75rem}.dropBlock__holder:not(.quick-search__dropBlock){background-color:#fff;padding:.625rem 0;width:100%}.dropBlock__holder:not(.quick-search__dropBlock) li{padding:.3125rem}.dropBlock [data-db-target-for]~.dropBlock__holder{visibility:hidden;opacity:0;transition:.6s ease 0s}td{font-weight:500}.icon-lock_open{color:#008744}.accordion-tabbed__control{width:100%;cursor:pointer}.accordion-tabbed__control:after{padding-left:.625rem}.login-popup{background:rgba(0,0,0,.8);align-items:center;justify-content:center;overflow:hidden}.login-popup .content{background:#fff;padding:1.25rem 3.375rem 3.375rem;position:relative;min-width:40.625rem}@media (max-width:767px){.login-popup .content{min-width:0;padding:2.5rem .75rem 3.375rem}}.login-popup .close{position:absolute;top:1.25rem;right:1.25rem;color:#000;box-shadow:none;text-shadow:none;opacity:1}.login-popup .tab--flex .tab__nav a{padding:.5rem}.login-popup .tab__nav li{flex:none;min-width:6.875rem}@media (min-width:768px){.login-popup .tab__nav li{margin-right:2.5rem}}.login-form,.login-popup{font-weight:500}.login-form label{color:#333}@media (max-width:767px){.login-form .login{width:100%}}.popup.hidden{visibility:hidden;display:block!important}.popup.hidden .content{transform:scale(.7);opacity:0;transition:all .3s}.popup.hidden{display:flex!important}.ux-modal-container .modal{visibility:hidden;display:block!important}.ux-modal-container .modal .modal__dialog{transform:scale(.7);opacity:0;transition:all .3s}.ux-modal-container .modal__dialog{border-radius:0}.close{opacity:1;font-size:1rem}.cartLabel{text-align:center;position:relative}.generic-menu,.main-nav{width:100%}.drawer__nav{width:100%;display:flex;justify-content:space-between}.quick-search{display:flex;align-items:center}.quick-search .input-group{margin:0}.quick-search .tab,.quick-search .tab .quick-search__searchbox{display:flex}@media (max-width:1023px){.quick-search .tab .quick-search__searchbox{width:100%}}.quick-search .tab__content{width:100%}@media (max-width:767px){.quick-search .tab{display:block}}.quick-search__form{display:flex}.quick-search__advanced-link{line-height:.9375rem;margin-left:1rem;text-decoration:underline}.quick-search__advanced-link:focus,.quick-search__advanced-link:hover{color:#14797b;text-decoration:underline}.quick-search__button{width:3.125rem}.quick-search .tab__pane{margin:0}.quick-search .dropBlock__link{border-radius:2px 0 0 2px}@media (max-width:1023px){.quick-search .dropBlock__link{border:.0625rem solid #ccc}}@media (max-width:1023px){.quick-search--all{margin:0}}@media (max-width:767px){.quick-search--all{padding:1.25rem .9375rem}}.quick-search--all .quick-search__searchbox{width:100%}.quick-search--all .quick-search__advanced-link{padding-top:.625rem}@media (max-width:1023px){.quick-search--all .quick-search__advanced-link{padding-top:0;width:6.25rem}}@media (max-width:767px){.quick-search--all .quick-search__advanced-link{margin-top:.625rem;float:right;width:auto}}article{position:relative}article .accordion-tabbed{color:inherit;font-weight:500}article .accordion-tabbed__control{text-decoration:none;color:inherit}@keyframes spinning{0%{transform:rotate(0deg)}to{transform:rotate(1turn)}}.user-login-bar .dropBlock__holder{min-width:10rem;box-shadow:0 .25rem 1.25rem rgba(0,0,0,.2)}.user-login-bar .dropBlock__holder ul{list-style:none;display:block}.user-login-bar .dropBlock__holder:before{content:" ";width:0;height:0;position:absolute;border:.625rem solid transparent;border-bottom-color:#fff;top:-17px;top:-1.0625rem;left:calc(50% - .625rem)}.content-navigation a{text-decoration:underline;font-size:.75rem}.content-navigation .ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),.content-navigation .ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),.content-navigation a:focus,.content-navigation a:hover,.ux-modal-container .modal .content-navigation a:focus:not(.btn):not(.dropdown-item),.ux-modal-container .modal .content-navigation a:hover:not(.btn):not(.dropdown-item){filter:brightness(120%)}@font-face{font-family:Open Sans;font-weight:400;font-style:normal;src:local("Open Sans Regular"),local("OpenSans-Regular"),url(data:text/plain;base64,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)format("woff2")}@font-face{font-family:Open Sans;font-weight:400;font-style:italic;src:local("Open Sans Italic"),local("OpenSans-Italic"),url(data:text/plain;base64,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)format("woff2")}@font-face{font-family:Open Sans;font-weight:600;font-style:normal;src:local("Open Sans SemiBold"),local("OpenSans-SemiBold"),url(data:text/plain;base64,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)format("woff2")}@font-face{font-family:Open Sans;font-weight:700;font-style:normal;src:local("Open Sans Bold"),local("OpenSans-Bold"),url(data:text/plain;base64,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)format("woff2")}[class*=" icon-"],[class^=icon-]{font-family:icomoon!important;font-style:normal;font-weight:400;font-variant:normal;text-transform:none;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.icon-download .path1:before{content:"";color:#dd3142}.icon-download .path2:before{content:"";margin-left:-1em;color:#fff}.icon-download .path3:before{content:"";margin-left:-1em;color:#fff}.icon-arrow_d:before,.icon-arrow_down:before{content:""}.icon-arrow_up:before,.icon-section_arrow_u:before{content:""}.icon-close:before,.icon-close_thin:before{content:""}.icon-person_outline:before{content:""}.icon-lock-open:before,.icon-lock_open:before{content:""}.icon-search:before{content:""}.icon-shopping_cart:before{content:""}.icon-cite:before{content:"";color:#dd3142}.icon-info-alt:before,.icon-info:before{content:"";color:#dd3142}.icon-metrics-alt:before,.icon-metrics:before{content:"";color:#dd3142}.icon-share-alt:before,.icon-share:before{content:"";color:#dd3142}.icon-tables-alt:before,.icon-tables:before{content:"";color:#dd3142}.icon-contents:before{content:""}*,:after,:before{box-sizing:border-box}html{font-family:sans-serif;line-height:1.15;-webkit-text-size-adjust:100%;-webkit-tap-highlight-color:transparent}article,aside,figcaption,figure,footer,header,main,nav,section{display:block}body{font-weight:400;line-height:1.5;text-align:left;background-color:#fff}[tabindex="-1"]:focus:not(:focus-visible){outline:0!important}p{margin-top:0;margin-bottom:1rem}ul{margin-bottom:1rem}ul{margin-top:0}ul ul{margin-bottom:0}b,strong{font-weight:bolder}sub,sup{position:relative;font-size:75%;line-height:0;vertical-align:baseline}sub{bottom:-.25em}sup{top:-.5em}.ux-modal-container .modal a:not(.btn):not(.dropdown-item),a{color:#888;text-decoration:none;background-color:transparent}.ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),a:hover{color:#555;text-decoration:underline}.ux-modal-container .modal a:not([href]):not([class]):hover:not(.btn):not(.dropdown-item),.ux-modal-container .modal a:not([href]):not([class]):not(.btn):not(.dropdown-item),a:not([href]):not([class]),a:not([href]):not([class]):hover{color:inherit;text-decoration:none}img{border-style:none}img,svg{vertical-align:middle}svg{overflow:hidden}table{border-collapse:collapse}th{text-align:-webkit-match-parent}label{display:inline-block}button{border-radius:0}button:focus:not(:focus-visible){outline:0}button,input{margin:0;font-family:inherit;font-size:inherit;line-height:inherit}button{overflow:visible}button{text-transform:none}[role=button]{cursor:pointer}[type=button],[type=submit],button{-webkit-appearance:button}[type=button]:not(:disabled),[type=reset]:not(:disabled),[type=submit]:not(:disabled),button:not(:disabled){cursor:pointer}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{padding:0;border-style:none}input[type=checkbox]{box-sizing:border-box;padding:0}[type=search]{outline-offset:-2px;-webkit-appearance:none}[type=search]::-webkit-search-decoration{-webkit-appearance:none}::-webkit-file-upload-button{font:inherit;-webkit-appearance:button}:root{--blue:#3e75cf;--indigo:#6610f2;--purple:#6f42c1;--pink:#ff0160;--red:red;--orange:#fd7e14;--yellow:#ffc107;--green:#66b96b;--teal:#20c997;--cyan:#17a2b8;--white:#fff;--gray:#707070;--gray-dark:#333;--primary:#dd3142;--secondary:#14797b;--success:#008744;--info:#5f8ab9;--warning:#bfac79;--danger:#b0132d;--light:#f7f7f7;--dark:#888;--supplementary:#587fd4;--lighter:#fff;--dark-secondary:#333;--darker:#000;--dim:#d9d9d9;--breakpoint-xs:0;--breakpoint-sm:532px;--breakpoint-md:768px;--breakpoint-lg:1024px;--breakpoint-xl:1280px;--breakpoint-xxl:1920px;--font-family-sans-serif:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,"Helvetica Neue",Arial,"Noto Sans","Liberation Sans",sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol","Noto Color Emoji";--font-family-monospace:SFMono-Regular,Menlo,Monaco,Consolas,"Liberation Mono","Courier New",monospace}/*!* Bootstrap Grid v4.6.2 (https://getbootstrap.com/)
* Copyright 2011-2022 The Bootstrap Authors
* Copyright 2011-2022 Twitter, Inc.
* Licensed under MIT (https://github.com/twbs/bootstrap/blob/main/LICENSE)*/html{box-sizing:border-box;-ms-overflow-style:scrollbar}*,:after,:before{box-sizing:inherit}.container{width:100%;padding-right:24px;padding-left:24px;margin-right:auto;margin-left:auto}@media (min-width:532px){.container{max-width:100%}}@media (min-width:768px){.container{max-width:100%}}@media (min-width:1024px){.container{max-width:1024px}}@media (min-width:1280px){.container{max-width:1280px}}.row{display:flex;flex-wrap:wrap;margin-right:-24px;margin-left:-24px}.col,.col-12{position:relative;width:100%;padding-right:24px;padding-left:24px}.col{flex-basis:0;flex-grow:1;max-width:100%}.col-12{flex:0 0 100%;max-width:100%}@media (min-width:532px){.col-sm-4{flex:0 0 33.33333%;max-width:33.33333%}}@media (min-width:1024px){.col-lg-6{flex:0 0 50%;max-width:50%}}.d-none{display:none!important}.d-flex{display:flex!important}@media (min-width:532px){.d-sm-block{display:block!important}}@media (min-width:1024px){.d-lg-block{display:block!important}}.flex-column{flex-direction:column!important}.justify-content-center{justify-content:center!important}.align-items-center{align-items:center!important}.m-0{margin:0!important}.mt-2{margin-top:.5rem!important}.mb-2{margin-bottom:.5rem!important}.p-0{padding:0!important}.btn{font-family:Open Sans,sans-serif;font-weight:600;color:#888;text-align:center;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;user-select:none;background-color:transparent;border:.0625rem solid transparent;font-size:.875rem;line-height:1.57}.billingBtn .payPallBtn:hover,.btn:hover,.jcf-file .jcf-upload-button:hover,.jcf-file .main-nav.menu--res ul .mddb-navigation a.jcf-upload-button:hover,.main-nav.menu--res ul .mddb-navigation .jcf-file a.jcf-upload-button:hover,.main-nav.menu--res ul .mddb-navigation a.btn:hover,.moreFromButton.smallButton .ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),.moreFromButton.smallButton a:hover,.ux-modal-container .modal .moreFromButton.smallButton a:hover:not(.btn):not(.dropdown-item){color:#888;text-decoration:none}.billingBtn .focus.payPallBtn,.billingBtn .payPallBtn:focus,.btn.focus,.btn:focus,.jcf-file .focus.jcf-upload-button,.jcf-file .jcf-upload-button:focus,.main-nav.menu--res ul .mddb-navigation a.btn:focus,.main-nav.menu--res ul .mddb-navigation a.focus.btn,.moreFromButton.smallButton .ux-modal-container .modal a.focus:not(.btn):not(.dropdown-item),.moreFromButton.smallButton .ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),.moreFromButton.smallButton a.focus,.moreFromButton.smallButton a:focus,.ux-modal-container .modal .moreFromButton.smallButton a.focus:not(.btn):not(.dropdown-item),.ux-modal-container .modal .moreFromButton.smallButton a:focus:not(.btn):not(.dropdown-item){outline:0;box-shadow:0 0 0 .2rem #00309f}.billingBtn .disabled.payPallBtn,.billingBtn .payPallBtn:disabled,.btn.disabled,.btn:disabled,.jcf-file .disabled.jcf-upload-button,.jcf-file .jcf-upload-button:disabled,.main-nav.menu--res ul .mddb-navigation a.btn:disabled,.main-nav.menu--res ul .mddb-navigation a.disabled.btn,.moreFromButton.smallButton .ux-modal-container .modal a.disabled:not(.btn):not(.dropdown-item),.moreFromButton.smallButton .ux-modal-container .modal a:disabled:not(.btn):not(.dropdown-item),.moreFromButton.smallButton a.disabled,.moreFromButton.smallButton a:disabled,.ux-modal-container .modal .moreFromButton.smallButton a.disabled:not(.btn):not(.dropdown-item),.ux-modal-container .modal .moreFromButton.smallButton a:disabled:not(.btn):not(.dropdown-item){opacity:.4}.billingBtn .payPallBtn:not(:disabled):not(.disabled),.btn:not(:disabled):not(.disabled),.jcf-file .jcf-upload-button:not(:disabled):not(.disabled),.main-nav.menu--res ul .mddb-navigation a.btn:not(:disabled):not(.disabled),.moreFromButton.smallButton a:not(:disabled):not(.disabled){cursor:pointer}.btn-primary{color:#fff;background-color:#dd3142;border-color:#dd3142}.btn-primary.focus,.btn-primary:focus,.btn-primary:hover{color:#fff;background-color:#c72131;border-color:#bc1f2f}.btn-primary.focus,.btn-primary:focus{box-shadow:0 0 0 .1875rem rgba(226,80,94,.5)}.btn-primary.disabled,.btn-primary:disabled{color:#fff;background-color:#dd3142;border-color:#dd3142}.btn-primary:not(:disabled):not(.disabled).active,.btn-primary:not(:disabled):not(.disabled):active,.show>.btn-primary.dropdown-toggle{color:#fff;background-color:#bc1f2f;border-color:#b11d2c}.btn-primary:not(:disabled):not(.disabled).active:focus,.btn-primary:not(:disabled):not(.disabled):active:focus,.show>.btn-primary.dropdown-toggle:focus{box-shadow:0 0 0 .1875rem rgba(226,80,94,.5)}.btn-secondary{color:#fff;background-color:#14797b;border-color:#14797b}.btn-secondary:hover,.main-nav.menu--res ul .mddb-navigation a.btn-secondary:hover,.moreFromButton.smallButton .ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),.moreFromButton.smallButton a:hover,.ux-modal-container .modal .moreFromButton.smallButton a:hover:not(.btn):not(.dropdown-item){color:#fff;background-color:#0f595a;border-color:#0d4e4f}.btn-secondary.focus,.btn-secondary:focus,.main-nav.menu--res ul .mddb-navigation a.btn-secondary:focus,.main-nav.menu--res ul .mddb-navigation a.focus.btn-secondary,.moreFromButton.smallButton .ux-modal-container .modal a.focus:not(.btn):not(.dropdown-item),.moreFromButton.smallButton .ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),.moreFromButton.smallButton a.focus,.moreFromButton.smallButton a:focus,.ux-modal-container .modal .moreFromButton.smallButton a.focus:not(.btn):not(.dropdown-item),.ux-modal-container .modal .moreFromButton.smallButton a:focus:not(.btn):not(.dropdown-item){color:#fff;background-color:#0f595a;border-color:#0d4e4f;box-shadow:0 0 0 .1875rem rgba(55,141,143,.5)}.btn-secondary.disabled,.btn-secondary:disabled,.main-nav.menu--res ul .mddb-navigation a.btn-secondary:disabled,.main-nav.menu--res ul .mddb-navigation a.disabled.btn-secondary,.moreFromButton.smallButton .ux-modal-container .modal a.disabled:not(.btn):not(.dropdown-item),.moreFromButton.smallButton .ux-modal-container .modal a:disabled:not(.btn):not(.dropdown-item),.moreFromButton.smallButton a.disabled,.moreFromButton.smallButton a:disabled,.ux-modal-container .modal .moreFromButton.smallButton a.disabled:not(.btn):not(.dropdown-item),.ux-modal-container .modal .moreFromButton.smallButton a:disabled:not(.btn):not(.dropdown-item){color:#fff;background-color:#14797b;border-color:#14797b}.btn-secondary:not(:disabled):not(.disabled).active,.btn-secondary:not(:disabled):not(.disabled):active,.main-nav.menu--res ul .mddb-navigation .show>a.dropdown-toggle.btn-secondary,.main-nav.menu--res ul .mddb-navigation a.btn-secondary:not(:disabled):not(.disabled).active,.main-nav.menu--res ul .mddb-navigation a.btn-secondary:not(:disabled):not(.disabled):active,.moreFromButton.smallButton .show>a.dropdown-toggle,.moreFromButton.smallButton .ux-modal-container .modal .show>a.dropdown-toggle:not(.btn):not(.dropdown-item),.moreFromButton.smallButton a:not(:disabled):not(.disabled).active,.moreFromButton.smallButton a:not(:disabled):not(.disabled):active,.show>.btn-secondary.dropdown-toggle{color:#fff;background-color:#0d4e4f;border-color:#0b4344}.btn-secondary:not(:disabled):not(.disabled).active:focus,.btn-secondary:not(:disabled):not(.disabled):active:focus,.main-nav.menu--res ul .mddb-navigation .show>a.dropdown-toggle.btn-secondary:focus,.moreFromButton.smallButton .show>a.dropdown-toggle:focus,.moreFromButton.smallButton a:not(:disabled):not(.disabled).active:focus,.moreFromButton.smallButton a:not(:disabled):not(.disabled):active:focus,.show>.btn-secondary.dropdown-toggle:focus{box-shadow:0 0 0 .1875rem rgba(55,141,143,.5)}.btn-dark{color:#fff;background-color:#888;border-color:#888}.btn-dark.focus,.btn-dark:focus,.btn-dark:hover{color:#fff;background-color:#757575;border-color:#6f6f6f}.btn-dark.focus,.btn-dark:focus{box-shadow:0 0 0 .1875rem hsla(0,0%,60.4%,.5)}.btn-dark.disabled,.btn-dark:disabled{color:#fff;background-color:#888;border-color:#888}.btn-dark:not(:disabled):not(.disabled).active,.btn-dark:not(:disabled):not(.disabled):active,.show>.btn-dark.dropdown-toggle{color:#fff;background-color:#6f6f6f;border-color:#686868}.btn-dark:not(:disabled):not(.disabled).active:focus,.btn-dark:not(:disabled):not(.disabled):active:focus,.show>.btn-dark.dropdown-toggle:focus{box-shadow:0 0 0 .1875rem hsla(0,0%,60.4%,.5)}.btn-outline-secondary{color:#14797b;border-color:#14797b}.btn-outline-secondary:hover,.jcf-file .jcf-upload-button:hover,.jcf-file .main-nav.menu--res ul .mddb-navigation a.jcf-upload-button:hover,.main-nav.menu--res ul .mddb-navigation .jcf-file a.jcf-upload-button:hover,.main-nav.menu--res ul .mddb-navigation a.btn-outline-secondary:hover{color:#fff;background-color:#14797b;border-color:#14797b}.btn-outline-secondary.focus,.btn-outline-secondary:focus,.jcf-file .focus.jcf-upload-button,.jcf-file .jcf-upload-button:focus,.main-nav.menu--res ul .mddb-navigation a.btn-outline-secondary:focus,.main-nav.menu--res ul .mddb-navigation a.focus.btn-outline-secondary{box-shadow:0 0 0 .1875rem rgba(20,121,123,.5)}.btn-outline-secondary.disabled,.btn-outline-secondary:disabled,.jcf-file .disabled.jcf-upload-button,.jcf-file .jcf-upload-button:disabled,.main-nav.menu--res ul .mddb-navigation a.btn-outline-secondary:disabled,.main-nav.menu--res ul .mddb-navigation a.disabled.btn-outline-secondary{color:#14797b;background-color:transparent}.btn-outline-secondary:not(:disabled):not(.disabled).active,.btn-outline-secondary:not(:disabled):not(.disabled):active,.jcf-file .jcf-upload-button:not(:disabled):not(.disabled).active,.jcf-file .jcf-upload-button:not(:disabled):not(.disabled):active,.jcf-file .show>.dropdown-toggle.jcf-upload-button,.main-nav.menu--res ul .mddb-navigation .show>a.dropdown-toggle.btn-outline-secondary,.main-nav.menu--res ul .mddb-navigation a.btn-outline-secondary:not(:disabled):not(.disabled).active,.main-nav.menu--res ul .mddb-navigation a.btn-outline-secondary:not(:disabled):not(.disabled):active,.show>.btn-outline-secondary.dropdown-toggle{color:#fff;background-color:#14797b;border-color:#14797b}.btn-outline-secondary:not(:disabled):not(.disabled).active:focus,.btn-outline-secondary:not(:disabled):not(.disabled):active:focus,.jcf-file .jcf-upload-button:not(:disabled):not(.disabled).active:focus,.jcf-file .jcf-upload-button:not(:disabled):not(.disabled):active:focus,.jcf-file .show>.dropdown-toggle.jcf-upload-button:focus,.main-nav.menu--res ul .mddb-navigation .show>a.dropdown-toggle.btn-outline-secondary:focus,.show>.btn-outline-secondary.dropdown-toggle:focus{box-shadow:0 0 0 .1875rem rgba(20,121,123,.5)}.btn-link:hover{color:#555}.btn-link.focus,.btn-link:focus,.btn-link:hover{text-decoration:underline}.btn-link.disabled,.btn-link:disabled{color:#707070;pointer-events:none}.dropdown{position:relative}.dropdown-toggle{white-space:nowrap}.dropdown-toggle:after{display:inline-block;margin-left:.255em;vertical-align:.255em;content:"";border-top:.3em solid;border-right:.3em solid transparent;border-bottom:0;border-left:.3em solid transparent}.dropdown-toggle:empty:after{margin-left:0}.form-control{display:block;background-clip:padding-box}.form-control:focus{color:#555;background-color:#fff;border-color:#31dade;outline:0;box-shadow:0 0 0 .2rem #00309f}.form-control::-moz-placeholder{color:#63666a;opacity:1}.form-control::placeholder{color:#63666a;opacity:1}.form-control:disabled,.form-control[readonly]{background-color:#eee;opacity:1}.form-group{margin-bottom:1rem}.form-row{display:flex;flex-wrap:wrap;margin-right:-.75rem;margin-left:-.75rem}.form-row>.col,.form-row>[class*=col-]{padding-right:.75rem;padding-left:.75rem}.form-check{position:relative;padding-left:1.25rem}.form-check-input{margin-top:.3rem;margin-left:-1.25rem}.form-check-input:disabled~.form-check-label,.form-check-input[disabled]~.form-check-label{color:#707070}.form-check-label{margin-bottom:0}.input-group{position:relative;display:flex;flex-wrap:wrap;align-items:stretch;width:100%}h2,h4,h6{line-height:1.2}.modal{width:100%;height:100%;outline:0}@media (min-width:532px){.modal-dialog{max-width:500px;margin:1.75rem auto}}.border-0{border:0!important}.position-relative{position:relative!important}.position-absolute{position:absolute!important}@supports (position:sticky){.sticky-top{position:sticky;top:0;z-index:1020}}.text-center{text-align:center!important}@media (min-width:1024px){.text-lg-right{text-align:right!important}}body{margin:0;padding:0;color:#333;font-size:1rem;font-family:Open Sans,sans-serif}.offscreen{position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden}.container:after,.container:before{content:unset}.content{padding:.1rem 0 0}.row:after,.row:before{content:none;display:none}::-webkit-input-placeholder{letter-spacing:normal}input{overflow:hidden;text-overflow:ellipsis;white-space:nowrap}body:not(.mouse-user) :focus,body:not(.mouse-user) :focus-visible{outline:none;box-shadow:0 0 0 1px #00309f,inset 0 0 0 1px #00309f}.sr-only-focusable:active,.sr-only-focusable:focus{color:#14797b!important;background:#fff!important;border-color:#14797b!important;box-shadow:0 0 0 1px #00309f,inset 0 0 0 1px #00309f!important;border-radius:2px;z-index:1200!important;text-decoration:none!important}.sr-only-focusable:hover{opacity:1}.hidden{display:none!important}button{-webkit-appearance:none;-moz-appearance:none;appearance:none;font-size:inherit}.btn{border-radius:2px;display:inline-flex;flex-direction:row;align-items:center;justify-content:center;height:40px;padding:0 1rem}.btn-link{height:auto;border:none;background:0 0;color:#006acc}.btn-link:hover,.btn-link:not(:disabled):not(.disabled).focus,.btn-link:not(:disabled):not(.disabled):active,.btn-link:not(:disabled):not(.disabled):focus{color:#005099;background:0 0;text-decoration:none}.btn:disabled,.btn[aria-disabled=true]{background-color:#eee;border-color:#eee;color:#888;opacity:1;pointer-events:none}.btn-outline-secondary:hover,.jcf-file .jcf-upload-button:hover,.jcf-file .main-nav.menu--res ul .mddb-navigation a.jcf-upload-button:hover,.main-nav.menu--res ul .mddb-navigation .jcf-file a.jcf-upload-button:hover,.main-nav.menu--res ul .mddb-navigation a.btn-outline-secondary:hover{background-color:#e6f2f2;color:#14797b}.billingBtn .payPallBtn[class*=btn-outline].disabled,.billingBtn .payPallBtn[class*=btn-outline]:disabled,.billingBtn .payPallBtn[class*=btn-outline][aria-disabled=true],.billingBtn .payPallBtn[class*=btn-outline][disabled],.btn[class*=btn-outline].disabled,.btn[class*=btn-outline]:disabled,.btn[class*=btn-outline][aria-disabled=true],.btn[class*=btn-outline][disabled],.jcf-file .jcf-upload-button[class*=btn-outline].disabled,.jcf-file .jcf-upload-button[class*=btn-outline]:disabled,.jcf-file .jcf-upload-button[class*=btn-outline][aria-disabled=true],.jcf-file .jcf-upload-button[class*=btn-outline][disabled],.main-nav.menu--res ul .mddb-navigation a.btn[class*=btn-outline].disabled,.main-nav.menu--res ul .mddb-navigation a.btn[class*=btn-outline]:disabled,.main-nav.menu--res ul .mddb-navigation a.btn[class*=btn-outline][aria-disabled=true],.main-nav.menu--res ul .mddb-navigation a.btn[class*=btn-outline][disabled],.moreFromButton.smallButton a[class*=btn-outline].disabled,.moreFromButton.smallButton a[class*=btn-outline]:disabled,.moreFromButton.smallButton a[class*=btn-outline][aria-disabled=true],.moreFromButton.smallButton a[class*=btn-outline][disabled]{background-color:transparent;border-color:#888;color:#888;opacity:1;pointer-events:none}.btn--collapse{flex-direction:row;align-items:center}.btn--collapse:not(.collapsed) [class*=icon-],.btn--collapse:not(.collapsed) [class^=icon-]{transform:rotate(180deg)}.btn-submit{display:inline-flex;width:100%;height:40px;padding:0;font-weight:600;text-transform:uppercase;text-decoration:none;align-items:center;justify-content:center}@media (min-width:532px){.btn-submit{max-width:288px}}.billingBtn .ux-modal-container .modal a.payPallBtn:not(.btn-link):not(.btn):not(.dropdown-item),.billingBtn a.payPallBtn:not(.btn-link),.btn--icon:hover span,.jcf-file .ux-modal-container .modal a.jcf-upload-button:not(.btn-link):not(.btn):not(.dropdown-item),.jcf-file a.jcf-upload-button:not(.btn-link),.main-nav.menu--res ul .mddb-navigation a.btn:not(.btn-link),.moreFromButton.smallButton .ux-modal-container .modal a:not(.btn-link):not(.btn):not(.dropdown-item),.moreFromButton.smallButton a:not(.btn-link),.ux-modal-container .modal .billingBtn a.payPallBtn:not(.btn-link):not(.btn):not(.dropdown-item),.ux-modal-container .modal .jcf-file a.jcf-upload-button:not(.btn-link):not(.btn):not(.dropdown-item),.ux-modal-container .modal .moreFromButton.smallButton a:not(.btn-link):not(.btn):not(.dropdown-item),.ux-modal-container .modal a.btn:not(.btn-link):not(.btn):not(.dropdown-item),a.btn:not(.btn-link){text-decoration:none}.btn-primary.focus,.btn-primary:focus{outline:none;box-shadow:0 0 0 1px #00309f,inset 0 0 0 1px #00309f}.btn-primary:disabled,.btn-primary[aria-disabled=true]{background-color:#eee;border-color:#eee;color:#888;opacity:1;pointer-events:none}.btn-secondary.focus,.btn-secondary:focus,.main-nav.menu--res ul .mddb-navigation a.btn-secondary:focus,.main-nav.menu--res ul .mddb-navigation a.focus.btn-secondary,.moreFromButton.smallButton .ux-modal-container .modal a.focus:not(.btn):not(.dropdown-item),.moreFromButton.smallButton .ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),.moreFromButton.smallButton a.focus,.moreFromButton.smallButton a:focus,.ux-modal-container .modal .moreFromButton.smallButton a.focus:not(.btn):not(.dropdown-item),.ux-modal-container .modal .moreFromButton.smallButton a:focus:not(.btn):not(.dropdown-item){outline:none;box-shadow:0 0 0 1px #00309f,inset 0 0 0 1px #00309f}.btn-secondary.disabled,.btn-secondary:disabled,.btn-secondary[aria-disabled=true],.btn-secondary[disabled],.main-nav.menu--res ul .mddb-navigation a.btn-secondary:disabled,.main-nav.menu--res ul .mddb-navigation a.btn-secondary[aria-disabled=true],.main-nav.menu--res ul .mddb-navigation a.btn-secondary[disabled],.main-nav.menu--res ul .mddb-navigation a.disabled.btn-secondary,.moreFromButton.smallButton .ux-modal-container .modal a.disabled:not(.btn):not(.dropdown-item),.moreFromButton.smallButton .ux-modal-container .modal a:disabled:not(.btn):not(.dropdown-item),.moreFromButton.smallButton .ux-modal-container .modal a[aria-disabled=true]:not(.btn):not(.dropdown-item),.moreFromButton.smallButton .ux-modal-container .modal a[disabled]:not(.btn):not(.dropdown-item),.moreFromButton.smallButton a.disabled,.moreFromButton.smallButton a:disabled,.moreFromButton.smallButton a[aria-disabled=true],.moreFromButton.smallButton a[disabled],.ux-modal-container .modal .moreFromButton.smallButton a.disabled:not(.btn):not(.dropdown-item),.ux-modal-container .modal .moreFromButton.smallButton a:disabled:not(.btn):not(.dropdown-item),.ux-modal-container .modal .moreFromButton.smallButton a[aria-disabled=true]:not(.btn):not(.dropdown-item),.ux-modal-container .modal .moreFromButton.smallButton a[disabled]:not(.btn):not(.dropdown-item){background-color:#eee;border-color:#eee;color:#888;opacity:1;pointer-events:none}.btn-outline-secondary.focus,.btn-outline-secondary:focus,.jcf-file .focus.jcf-upload-button,.jcf-file .jcf-upload-button:focus,.main-nav.menu--res ul .mddb-navigation a.btn-outline-secondary:focus,.main-nav.menu--res ul .mddb-navigation a.focus.btn-outline-secondary{outline:none;box-shadow:0 0 0 1px #00309f,inset 0 0 0 1px #00309f;color:#14797b}.btn-outline-secondary:focus:hover,.jcf-file .jcf-upload-button:focus:hover,.jcf-file .main-nav.menu--res ul .mddb-navigation a.jcf-upload-button:focus:hover,.main-nav.menu--res ul .mddb-navigation .jcf-file a.jcf-upload-button:focus:hover,.main-nav.menu--res ul .mddb-navigation a.btn-outline-secondary:focus:hover{color:#fff}.btn-outline-secondary.disabled,.btn-outline-secondary:disabled,.btn-outline-secondary[aria-disabled=true],.btn-outline-secondary[disabled],.jcf-file .disabled.jcf-upload-button,.jcf-file .jcf-upload-button:disabled,.jcf-file .jcf-upload-button[aria-disabled=true],.jcf-file .jcf-upload-button[disabled],.main-nav.menu--res ul .mddb-navigation a.btn-outline-secondary:disabled,.main-nav.menu--res ul .mddb-navigation a.btn-outline-secondary[aria-disabled=true],.main-nav.menu--res ul .mddb-navigation a.btn-outline-secondary[disabled],.main-nav.menu--res ul .mddb-navigation a.disabled.btn-outline-secondary{background-color:#eee;border-color:#eee;color:#888;opacity:1;pointer-events:none}.btn-dark.focus,.btn-dark:focus{outline:none;box-shadow:0 0 0 1px #00309f,inset 0 0 0 1px #00309f}.btn-dark.disabled,.btn-dark:disabled,.btn-dark[aria-disabled=true],.btn-dark[disabled]{background-color:#eee;border-color:#eee;color:#888;opacity:1;pointer-events:none}[data-toggle=collapse]:not(.collapsed) [class*=icon-],[data-toggle=collapse]:not(.collapsed)[class^=icon-]{transform:rotate(180deg)}[data-toggle=collapse].collapsed .whenCollapsed{display:block}[class*=" icon-"]:before,[class^=icon-]:before{color:inherit}@media (min-width:532px){.heading-s{font-size:1.125rem;line-height:1.55}}@media (min-width:1024px){.heading-s{font-size:1.25rem;line-height:1.6}}@media (min-width:532px){.heading-xs{font-size:1rem;line-height:1.75}}@media (min-width:1024px){.heading-xs{font-size:1.125rem;line-height:1.55}}input[type=password],input[type=search],input[type=text]{-webkit-appearance:none;font-size:.875rem;font-weight:400;line-height:1.5714;height:40px;padding:0 12px}.form-control:focus,.ms-ctn:focus,input[type=email]:focus,input[type=password]:focus,input[type=search]:focus,input[type=tel]:focus,input[type=text]:focus,select:focus,textarea:focus{box-shadow:0 0 0 1px #00309f,inset 0 0 0 1px #00309f}label{flex-shrink:0;font-size:1rem;line-height:1.75}.form-control:focus{border-color:inherit;box-shadow:0 0 0 1px #00309f,inset 0 0 0 1px #00309f}.required:before{content:"*";color:#dd3142}.form-check{display:flex;gap:.5rem;justify-content:flex-start;align-items:center;padding:0}.form-check-label{flex-shrink:1}.form-check-input{flex-shrink:0;position:static}input[type=checkbox]{-webkit-appearance:none;-moz-appearance:none;appearance:none;display:block;margin:0;background-color:transparent;border:none}input[type=checkbox],input[type=checkbox]:before{width:20px;width:1.25rem;height:20px;height:1.25rem}input[type=checkbox]:before{display:flex;color:#14797b;background-color:#fff;border:1px solid #888;border-radius:3px}input[type=checkbox]:checked{background:0 0}input[type=checkbox]:checked:before{content:"";color:#14797b;border-color:#888;background:#fff}.form-group{position:relative}.form-group,.form-group label{font-size:.875rem}.form-group label{display:block;line-height:1.57;margin-bottom:4px}@supports (-webkit-touch-callout:none) and (not (translate:none)){.form-buttons:not(:last-child),.form-custom-row:not(:last-child){margin:0 0 1rem}}@media (min-width:532px){@supports (-webkit-touch-callout:none) and (not (translate:none)){.form-buttons:not(:last-child),.form-custom-row:not(:last-child){margin:0 1.5rem 0 0}}}input[type=search]::-webkit-search-cancel-button,input[type=search]::-webkit-search-decoration,input[type=search]::-webkit-search-results-button,input[type=search]::-webkit-search-results-decoration{display:none}h1,h2{margin-top:0;margin-bottom:1.2rem}h3,h4{margin-top:0;margin-bottom:1.2rem;color:#555;font-weight:400}h4{font-size:1.5rem}h6{font-weight:400}p{font-size:1rem;color:#333;font-weight:400}.error{color:#dd3142}.ux-modal-container .modal a:not(.btn):not(.dropdown-item),a{color:#006acc;text-decoration:underline}.ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),a:hover{color:#006acc;text-decoration:none}ul:not(.rlist):not(.figure-viewer__hold__supplementary-nav):not(.table-viewer__hold__supplementary-nav):not(.rlist--inline):not(.error):not(.disabled){color:#333}ul:not(.rlist):not(.figure-viewer__hold__supplementary-nav):not(.table-viewer__hold__supplementary-nav):not(.rlist--inline):not(.error):not(.disabled) li::marker{color:#14797b;font-size:12px;font-size:.75rem}.accordion{display:flex;flex-direction:column}.accordion-tabbed__control:hover{color:inherit}.js--open .accordion-tabbed__control{margin-bottom:0}.js--open .accordion-tabbed__control .icon-arrow_down{transform:rotate(180deg)}.accordion-tabbed__control [class*=icon-]{font-size:1.5rem}.dropBlock__holder:not(.quick-search__dropBlock) li{padding:0}.dropdown{font-size:.875rem}.dropdown-toggle{color:inherit;text-decoration:none}.dropdown-toggle{align-items:center;justify-content:space-between;gap:12px;font-size:.875rem;font-weight:400;line-height:1.57;text-transform:none;padding:9px 12px;background-color:#fff;border:1px solid #ccc}.dropdown-toggle:active,.dropdown-toggle:focus,.dropdown-toggle:hover{text-decoration:none;background-color:transparent;color:inherit}.dropdown-toggle[disabled]{pointer-events:none;background-color:#eee!important;color:#888!important}.dropdown-toggle:after{display:none}.dropdown-toggle span{display:inline-block;overflow:hidden;text-overflow:ellipsis}.dropdown-toggle [class*=icon-]{font-size:1rem}.dropdown-selectable .dropdown-toggle{width:100%;border:1px solid #ccc;background-color:#fff}footer{background-color:#fff}.footer{position:relative;padding-top:40px}.footer:before{content:"";display:block;position:absolute;top:0;left:0;width:100%;height:20px;background:linear-gradient(180deg,#ececec,#f5f5f5 40.1%,#fff)}.footer__row__one{padding-bottom:24px;border-bottom:1px solid #ccc}.footer__row__one .col-12:not(:last-child){margin-bottom:24px}.footer__row__two{padding:24px 0}.footer__heading{display:flex;flex-direction:row;align-items:center;margin-bottom:1rem}@media (min-width:532px){.footer__heading{flex-direction:column;align-items:flex-start;margin-bottom:0}}.footer__icon{width:40px;height:40px;margin-right:8px}@media (min-width:532px){.footer__icon{margin:0;width:54px;height:54px}}.footer__title{font-size:1rem;font-weight:600;line-height:1.75;margin-bottom:1rem;margin-top:1rem;color:#555}@media (min-width:1024px){.footer__title{font-size:1.125rem;font-weight:400;line-height:1.75}}.footer__nav li{font-size:.75rem;line-height:1.667;padding-left:0}.footer__nav li.top-gap{margin-top:1rem}.footer__nav a{font-weight:400;color:#333;text-decoration:none}.footer__nav .ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),.footer__nav .ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),.footer__nav a:focus,.footer__nav a:hover,.ux-modal-container .modal .footer__nav a:focus:not(.btn):not(.dropdown-item),.ux-modal-container .modal .footer__nav a:hover:not(.btn):not(.dropdown-item){color:#0d0d0d}.footer__nav .ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),.footer__nav a:focus,.ux-modal-container .modal .footer__nav a:focus:not(.btn):not(.dropdown-item){text-decoration:underline}.footer__nav .figure-viewer__hold__supplementary-nav li:not(:last-of-type),.footer__nav .rlist li:not(:last-of-type),.footer__nav .table-viewer__hold__supplementary-nav li:not(:last-of-type){margin-bottom:8px}.footer__nav .rlist--inline.separator>li:not(:last-of-type){display:block;border:none;padding:0;margin-bottom:8px}@media (min-width:532px){.footer__nav .rlist--inline.separator>li:not(:last-of-type){display:inline-block;border-right:1px solid #ccc;padding-right:1rem;margin-right:1rem;margin-bottom:0}}.footer__copyright p{margin:8px 0;font-size:.75rem;line-height:1.667}.more-sage-products{color:#626262}.more-sage-products__container{background-color:#fff;padding-top:24px;padding-bottom:24px;border-top:1px solid #ccc}.more-sage-products__title{text-align:center;font-size:1.25rem;font-weight:400;margin:0 0 24px;color:inherit}.more-sage-products__list{display:flex;flex-wrap:wrap;list-style:none;padding:0;justify-content:flex-start}@media (min-width:532px){.more-sage-products__list{gap:24px 8px}}@media (min-width:1024px){.more-sage-products__list{gap:24px}}.more-sage-products__list__item{display:block;flex-basis:100%;flex-grow:0;flex-shrink:0;margin-bottom:8px}@media (min-width:532px){.more-sage-products__list__item{margin-bottom:0;flex-basis:calc(50% - 12px)}}@media (min-width:1024px){.more-sage-products__list__item{flex-basis:calc(25% - 18px)}}.more-sage-products__link{position:relative;display:block;width:100%;height:100%;padding:24px 8px;color:inherit;background-color:#fff;text-align:center;font-size:.875rem;font-weight:400;line-height:1.57;text-decoration:none;box-shadow:0 2px 6px 0 rgba(0,0,0,.13);box-sizing:border-box;border-radius:2px}.browse-card__link:focus,.browse-card__link:hover,.more-sage-products__link:focus,.more-sage-products__link:hover{color:inherit;text-decoration:none;box-shadow:0 0 8px 0 rgba(0,0,0,.5)}.more-sage-products__link .product-name{font-size:1rem;line-height:1.75}.browse-card__link .product-name:after,.more-sage-products__link .product-name:after{content:"";display:block;width:120px;height:1px;margin:8px auto}.more-sage-products .cqlibrary .product-name:after{background-color:#fbae16}.more-sage-products .cqlibrary:focus{outline-color:#fbae16}.more-sage-products .dataplanet .product-name:after{background-color:#00b7af}.more-sage-products .dataplanet:focus{outline-color:#00b7af}.more-sage-products .leanlibrary .product-name:after{background-color:#002e54}.more-sage-products .leanlibrary:focus{outline-color:#002e54}.more-sage-products .sagebusinesscases .product-name:after{background-color:#ec6608}.more-sage-products .sagebusinesscases:focus{outline-color:#ec6608}.more-sage-products .sagecampus .product-name:after{background-color:#008563}.more-sage-products .sagecampus:focus{outline-color:#008563}.more-sage-products .sageknowledge .product-name:after{background-color:#630361}.more-sage-products .sageknowledge:focus{outline-color:#630361}.more-sage-products .sageresearchmethods .product-name:after{background-color:#14797b}.more-sage-products .sageresearchmethods:focus{outline-color:#14797b}.more-sage-products .sagevideo .product-name:after{background-color:#f0536a}.more-sage-products .sagevideo:focus{outline-color:#f0536a}.header{background:#fff;box-shadow:0 1px 4px #e4e3e3}.header__inner{width:100%;max-width:1280px;margin:0 auto;padding:0}@media (max-width:1023px){.header__inner{display:flex;flex-direction:row-reverse;width:100%}}@media (min-width:1024px){.header__inner{padding-left:24px;padding-right:24px}}.header__quick-menu{position:static}.header__quick-menu a{font-size:.625rem;font-weight:400;color:#333;flex-direction:column;text-decoration:none}@media (min-width:532px){.header__quick-menu a{font-size:.75rem}}.header__quick-menu a [class*=icon-]{margin-bottom:4px;color:#dd3142}@media (min-width:532px){.header__quick-menu a [class*=icon-]{font-size:1.75rem}}@media (max-width:767.98px){.header__quick-menu a [class*=icon-]{font-size:1.25rem}}.header__quick-menu .cart-wrapper{margin-right:0;margin-left:28px;line-height:inherit}@media (max-width:1023px){.header__quick-menu .cart-wrapper{margin-left:0}}@media (max-width:767.98px){.header__quick-menu .cart-wrapper{padding:0 .25rem}}.header__quick-menu .cart-wrapper .cartLabel{display:flex;flex-direction:column}.header__quick-menu .sign-in{font-size:.625rem;font-weight:400;color:#333;line-height:inherit;display:block;margin-left:0}@media (min-width:532px){.header__quick-menu .sign-in{font-size:.75rem}}.header--first-row{align-items:center;gap:.5rem;border-bottom:1px solid #ccc;background:#fff;width:100%;height:56px}@media (min-width:768px){.header--first-row{height:78px}}@media (max-width:1023px){.header--first-row{border:0;z-index:11}}.header--second-row{min-width:38px;height:auto;align-items:flex-start}@media (max-width:1023px){.header--second-row{z-index:1}.header--second-row .generic-menu{z-index:-1}}.header--second-col{flex:none}@media (max-width:1023px){.header--first-col{justify-content:center}}.header__logo:focus{box-shadow:none}@media (max-width:767.98px){.header__logo{justify-content:center}}@media (max-width:531.98px){.header__logo{justify-content:start}}.header__logo img{max-height:100%}.header .institution-wrapper{margin:0 28px;width:218px}@media (max-width:1023px){.header .institution-wrapper{display:none}}.header .institution img{display:block!important;max-width:unset;padding:0}.journal-menu-banner{position:relative;display:flex;gap:24px;width:100%;height:68px;flex-direction:row;align-items:center;justify-content:space-between;background-color:#f7f7f7;padding:0 24px;border-radius:2px}.journal-menu-banner__title{display:flex;align-items:center;justify-content:flex-start;flex-basis:100%}.journal-menu-banner__nav{display:none}@media (min-width:1024px){.journal-menu-banner__nav{display:flex;justify-content:flex-end;gap:24px}}.journal-menu-banner__nav .mddb-navigation__button{text-transform:uppercase;white-space:nowrap}.article-aside-grid{margin:24px 0;display:grid;row-gap:1.5rem;grid-template-columns:1fr;grid-template-rows:auto auto auto;grid-template-areas:"ad1""mid""ad2"}@media (min-width:768px){.article-aside-grid{-moz-column-gap:48px;column-gap:48px;grid-template-columns:1fr 1fr;grid-template-rows:auto auto;grid-template-areas:"ad1 ad2""mid mid"}}@media (min-width:1024px){.article-aside-grid{grid-template-columns:1fr;grid-template-rows:auto auto auto;grid-template-areas:"ad1""mid""ad2"}}.article-aside-grid__block-1{grid-area:ad1;text-align:center}.article-aside-grid>.article-aside-grid__block-1{-ms-grid-row:1;-ms-grid-column:1}.article-aside-grid__block-2{-ms-grid-row:3;-ms-grid-column:1;grid-area:mid}.article-aside-grid>.article-aside-grid__block-2{-ms-grid-row:3;-ms-grid-column:1;-ms-grid-column-span:1}.article-aside-grid__block-3{grid-area:ad2;text-align:center}.article-aside-grid>.article-aside-grid__block-3{-ms-grid-row:5;-ms-grid-column:1}@media (min-width:768px){.article-aside-grid>.article-aside-grid__block-1{-ms-grid-row:1;-ms-grid-column:1}.article-aside-grid>.article-aside-grid__block-2{-ms-grid-row:2;-ms-grid-column:1;-ms-grid-column-span:3}.article-aside-grid>.article-aside-grid__block-3{-ms-grid-row:1;-ms-grid-column:3}}@media (min-width:1024px){.article-aside-grid>.article-aside-grid__block-1{-ms-grid-row:1;-ms-grid-column:1}.article-aside-grid>.article-aside-grid__block-2{-ms-grid-row:2;-ms-grid-column:1;-ms-grid-column-span:1}.article-aside-grid>.article-aside-grid__block-3{-ms-grid-row:3;-ms-grid-column:1}}.article-aside-grid .rhs__container{margin-bottom:0}.article-aside-grid .accordion-tabbed__control{font-size:1.125rem;font-weight:400;line-height:1.75;margin:0 0 .5rem;padding:0;border:none;display:flex;justify-content:space-between;align-items:center}.rhs__container{border:1px solid #ccc;padding:1rem}.rhs__container:empty{display:none}.tab__content .tab__pane{font-size:.875rem;padding:0}.tab--flex .tab__nav{min-width:100%;font-size:1rem;white-space:nowrap;margin-bottom:1.5rem}.tab--flex .tab__nav li{overflow:visible}.tab--flex .tab__nav li+li{margin-left:1.5rem}@media (min-width:1280px){.tab--flex .tab__nav li+li{margin-left:40px}}.tab--flex .tab__nav__item:before,.tab--flex .tab__nav li:before,.tab--generic .tab__nav__item:before,.tab--generic .tab__nav li:before{display:none;height:0;transform:none;transition:height .3s ease-out}.tab--flex .tab__nav a{font-size:1rem;font-weight:600;line-height:1.75;text-transform:none;color:#555;border:none;background:0 0;transform:perspective(.0625rem) translateZ(0);vertical-align:middle;position:relative;overflow:hidden}.tab--flex .tab__nav .ux-modal-container .modal a:not(.dropdown-item):not(.btn):before,.tab--flex .tab__nav__item__link:before,.tab--flex .tab__nav a:before,.tab--flex .tab__nav button:before,.tab--generic .tab__nav .ux-modal-container .modal a:not(.dropdown-item):not(.btn):before,.tab--generic .tab__nav__item__link:before,.tab--generic .tab__nav a:before,.tab--generic .tab__nav button:before,.ux-modal-container .modal .tab--flex .tab__nav a:not(.dropdown-item):not(.btn):before,.ux-modal-container .modal .tab--generic .tab__nav a:not(.dropdown-item):not(.btn):before{content:"";position:absolute;z-index:-1;left:0;right:0;bottom:0;height:3px;transform:translateY(3px);transition:transform .3s ease-out}.tab--flex .tab__nav .ux-modal-container .modal a.active:not(.dropdown-item):not(.btn):before,.tab--flex .tab__nav__item__link.active:before,.tab--flex .tab__nav a.active:before,.tab--flex .tab__nav button.active:before,.tab--generic .tab__nav .ux-modal-container .modal a.active:not(.dropdown-item):not(.btn):before,.tab--generic .tab__nav__item__link.active:before,.tab--generic .tab__nav a.active:before,.tab--generic .tab__nav button.active:before,.ux-modal-container .modal .tab--flex .tab__nav a.active:not(.dropdown-item):not(.btn):before,.ux-modal-container .modal .tab--generic .tab__nav a.active:not(.dropdown-item):not(.btn):before{transform:translateY(0)}.tab--flex .tab__nav .ux-modal-container .modal a:not(.dropdown-item):not(.btn):before,.tab--flex .tab__nav__item__link:before,.tab--flex .tab__nav a:before,.tab--flex .tab__nav button:before,.tab--generic .tab__nav .ux-modal-container .modal a:not(.dropdown-item):not(.btn):before,.tab--generic .tab__nav__item__link:before,.tab--generic .tab__nav a:before,.tab--generic .tab__nav button:before,.ux-modal-container .modal .tab--flex .tab__nav a:not(.dropdown-item):not(.btn):before,.ux-modal-container .modal .tab--generic .tab__nav a:not(.dropdown-item):not(.btn):before{background:#14797b}.tab--flex .tab__nav a.active{border-bottom-width:0;color:#14797b;height:100%}.tab--flex .tab__nav .ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),.tab--flex .tab__nav__item__link:hover,.tab--flex .tab__nav a:hover,.tab--flex .tab__nav button:hover,.tab--generic .tab__nav .ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),.tab--generic .tab__nav__item__link:hover,.tab--generic .tab__nav a:hover,.tab--generic .tab__nav button:hover,.ux-modal-container .modal .tab--flex .tab__nav a:hover:not(.btn):not(.dropdown-item),.ux-modal-container .modal .tab--generic .tab__nav a:hover:not(.btn):not(.dropdown-item){cursor:pointer;color:#14797b}.tab .dropBlock__link{justify-content:space-between;align-items:center}.tab .dropBlock [class*=icon-]{margin:0;font-weight:400}.impact-factor{font-size:.75rem;line-height:1.66667;text-align:start;margin-left:0}@media (min-width:768px){.impact-factor{text-align:end;margin-left:auto}}@media (min-width:1280px){.impact-factor{font-size:.875rem;line-height:1.57}}.impact-factor__text{display:block}@media (min-width:1280px){.impact-factor__text{display:inline}}.impact-factor__link{color:#333;text-decoration:underline}.impact-factor__link:hover{color:#333;text-decoration:none}.impact-factor__slash{display:none}@media (min-width:1280px){.impact-factor__slash{display:inline-block}}.teaser{border-bottom:1px solid #ccc}.teaser__access-icon{position:absolute;left:0;top:0}.teaser__access-icon:not(:empty){display:flex;align-items:center;width:24px}@media (min-width:532px){.teaser__access-icon{display:flex;align-items:center;width:24px}}.teaser__access-icon svg{width:100%}.teaser__content{display:flex;flex-direction:row;justify-content:space-between;gap:1rem}@media (min-width:532px){.teaser__content{gap:1.5rem}}.teaser--collection{margin-bottom:1rem;padding-bottom:1rem}@media (min-width:532px){.teaser--collection{padding-left:2rem}}.teaser--collection .teaser__meta__row{margin-left:2rem}.teaser--collection .teaser__meta__row+.teaser__meta__row:before{display:none}.teaser--collection .teaser__meta{position:relative;display:flex;flex-direction:column;align-items:flex-start;flex-wrap:wrap;font-size:.875rem;line-height:1.57;margin-bottom:.5rem}@media (min-width:532px){.teaser--collection .teaser__meta{margin-left:-2rem}}.teaser--collection .teaser__title{font-size:.875rem;line-height:1.57;margin-bottom:8px}.teaser--collection .teaser__content{font-size:.75rem;line-height:1.66667}.teaser--collection .teaser__collapsible-details{display:flex;flex-direction:column-reverse}@media (min-width:532px){.teaser--collection-external{padding-left:0}}@media (min-width:532px){.teaser--collection-external .teaser__meta{margin-left:0;flex-direction:column;align-items:flex-start}}.teaser--collection-external .teaser__meta__row{margin-left:0}@media (min-width:532px){.teaser--collection-external .teaser__meta__row{display:flex}}.teaser--collection-external .teaser__meta__row+.teaser__meta__row{margin-left:0}.modal__header{display:flex;flex-direction:row-reverse;align-items:center;justify-content:space-between}.modal__header .close{float:none;justify-self:flex-end}.modal__header .close:focus{outline:0}.modal__title{margin:0}@media (min-width:768px){.modal__dialog{width:80%;max-width:720px}}.modal-dialog{pointer-events:unset}.billingBtn .ux-modal-container .modal a.payPallBtn:hover,.jcf-file .ux-modal-container .modal a.jcf-upload-button:hover,.main-nav.menu--res ul .mddb-navigation .ux-modal-container .modal a.btn:hover,.moreFromButton.smallButton .ux-modal-container .modal a:hover,.ux-modal-container .modal .billingBtn a.payPallBtn:hover,.ux-modal-container .modal .jcf-file a.jcf-upload-button:hover,.ux-modal-container .modal .main-nav.menu--res ul .mddb-navigation a.btn:hover,.ux-modal-container .modal .moreFromButton.smallButton a:hover,.ux-modal-container .modal a.btn:hover,.ux-modal-container .modal a.btn:hover:not(.btn):not(.dropdown-item),.ux-modal-container .modal a.dropdown-item:hover,.ux-modal-container .modal a:focus,.ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item){text-decoration:none}@media (min-width:768px){.ux-modal-container .modal__dialog{width:80%;max-width:640px}}.back-to-top{position:fixed;bottom:1.33333rem;width:54px;height:54px;visibility:hidden;opacity:0;transform:translateY(40px);transition:opacity .25s ease-in-out,transform .25s ease-in-out,visibility 0s .4s;z-index:5}.back-to-top [class*=icon-]{font-size:2.125rem;color:var(--primary)}@media (min-width:1024px){.back-to-top{bottom:2rem;left:2rem;width:54px;height:54px}}.back-to-top__action{width:54px;height:54px;background:0 0;cursor:pointer;z-index:2;border-radius:50%}@media (min-width:1024px){.back-to-top__action{width:54px;height:54px}}.back-to-top__action:hover .back-to-top__action-icon{animation:bounce .35s ease-in-out infinite alternate}.back-to-top__action__ring{stroke:var(--primary);fill:none;stroke-width:4px;stroke-linecap:butt;animation:progress .3s ease-out forwards}.back-to-top__action__ring-bg{fill:none;stroke:rgba(221,49,66,.3);stroke-width:4px}.back-to-top--align-right{left:auto;right:1rem}@media (min-width:1024px){.back-to-top--align-right{right:2rem}}@keyframes bounce{0%{transform:translateY(0)}to{transform:translateY(-4px)}}.pb-ad{margin:0 auto;text-align:center}.user-login-bar{position:static}@media (min-width:1024px){.user-login-bar{position:relative}}.user-login-bar [class*=icon-]{margin-left:0}.user-login-bar [data-db-target-for]{padding:0}.user-login-bar [data-db-target-for]~.dropBlock__holder{left:0;right:0;top:var(--header-height);margin:0;border-radius:0;height:calc(100vh - var(--header-height));display:flex;flex-direction:column;justify-content:space-between}@media (min-width:1024px){.user-login-bar [data-db-target-for]~.dropBlock__holder{left:50%;right:auto;top:auto;margin:10px -50% 10px 0;transform:translate(-50%);border-radius:5px;height:auto}}.user-login-bar [data-db-target-for]~.dropBlock__holder:before{display:none}@media (min-width:1024px){.user-login-bar [data-db-target-for]~.dropBlock__holder:before{display:block}}.user-login-bar [data-db-target-for]~.dropBlock__holder ul{padding:0}.user-login-bar [data-db-target-for]~.dropBlock__holder a{align-items:flex-start}.user-login-bar li a{padding:1rem .75rem;font-size:.875rem}.user-login-bar li .ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),.user-login-bar li a:hover,.ux-modal-container .modal .user-login-bar li a:hover:not(.btn):not(.dropdown-item){background:#e6f2f2;box-shadow:inset 2px 0 0#14797b}@media (min-width:1280px){.quick-search{width:504px}}@media (max-width:1023.98px){.quick-search{flex-grow:1}.quick-search .quickSearchFormContainer{height:100%}.quick-search .quick-search__form{justify-content:space-between}.quick-search .tab{display:flex;height:100%;flex-direction:column;gap:24px}.quick-search .tab .quick-search__searchbox{display:flex;flex-grow:1;flex-direction:column}.quick-search .tab__content{display:flex;flex-grow:1}.quick-search .tab__content .tab__pane.active{display:flex;flex-grow:1;flex-direction:column}}@media (max-width:1023px){.quick-search__form{flex-direction:column;flex-grow:1}}.quick-search__form .quick-search__input[type=search]{border-radius:0;border:1px solid #ccc;font-size:.875rem;font-weight:400;padding:9px 12px;height:40px}@media (min-width:532px){.quick-search__form .quick-search__input[type=search]{padding:9px 16px}}@media (min-width:1024px){.quick-search__form .quick-search__input[type=search]{border-right:0}}.quick-search__form .quick-search__input[type=search]:focus{box-shadow:0 0 0 2px #00309f}.quick-search__button.btn{border-radius:0;background:#fff;border:1px solid #ccc;border-left:0;color:#dd3142;padding:0;font-size:1.25rem}@media (max-width:1023px){.billingBtn .quick-search:not(.quick-search--microsites):not(.quick-search--home) .quick-search__button.payPallBtn,.jcf-file .quick-search:not(.quick-search--microsites):not(.quick-search--home) .quick-search__button.jcf-upload-button,.moreFromButton.smallButton .quick-search:not(.quick-search--microsites):not(.quick-search--home) a.quick-search__button,.quick-search:not(.quick-search--microsites):not(.quick-search--home) .billingBtn .quick-search__button.payPallBtn,.quick-search:not(.quick-search--microsites):not(.quick-search--home) .jcf-file .quick-search__button.jcf-upload-button,.quick-search:not(.quick-search--microsites):not(.quick-search--home) .moreFromButton.smallButton a.quick-search__button,.quick-search:not(.quick-search--microsites):not(.quick-search--home) .quick-search__button.btn{width:100%;border:0;background:#14797b;padding:.75rem}.billingBtn .quick-search:not(.quick-search--microsites):not(.quick-search--home) .quick-search__button.payPallBtn span,.jcf-file .quick-search:not(.quick-search--microsites):not(.quick-search--home) .quick-search__button.jcf-upload-button span,.moreFromButton.smallButton .quick-search:not(.quick-search--microsites):not(.quick-search--home) a.quick-search__button span,.quick-search:not(.quick-search--microsites):not(.quick-search--home) .billingBtn .quick-search__button.payPallBtn span,.quick-search:not(.quick-search--microsites):not(.quick-search--home) .jcf-file .quick-search__button.jcf-upload-button span,.quick-search:not(.quick-search--microsites):not(.quick-search--home) .moreFromButton.smallButton a.quick-search__button span,.quick-search:not(.quick-search--microsites):not(.quick-search--home) .quick-search__button.btn span{font-size:.75rem;color:#f7f7f7;font-weight:500}.billingBtn .quick-search:not(.quick-search--microsites):not(.quick-search--home) .quick-search__button.payPallBtn i[class*=icon-],.jcf-file .quick-search:not(.quick-search--microsites):not(.quick-search--home) .quick-search__button.jcf-upload-button i[class*=icon-],.moreFromButton.smallButton .quick-search:not(.quick-search--microsites):not(.quick-search--home) a.quick-search__button i[class*=icon-],.quick-search:not(.quick-search--microsites):not(.quick-search--home) .billingBtn .quick-search__button.payPallBtn i[class*=icon-],.quick-search:not(.quick-search--microsites):not(.quick-search--home) .jcf-file .quick-search__button.jcf-upload-button i[class*=icon-],.quick-search:not(.quick-search--microsites):not(.quick-search--home) .moreFromButton.smallButton a.quick-search__button i[class*=icon-],.quick-search:not(.quick-search--microsites):not(.quick-search--home) .quick-search__button.btn i[class*=icon-]{display:none}}.billingBtn .quick-search__button.payPallBtn:hover,.jcf-file .main-nav.menu--res ul .mddb-navigation a.quick-search__button.jcf-upload-button:hover,.jcf-file .quick-search__button.jcf-upload-button:hover,.main-nav.menu--res ul .mddb-navigation .jcf-file a.quick-search__button.jcf-upload-button:hover,.main-nav.menu--res ul .mddb-navigation a.quick-search__button.btn:hover,.moreFromButton.smallButton a.quick-search__button:hover,.quick-search__button.btn:hover{border:1px solid #ccc;color:#bc1f2f}.quick-search--all{background:0 0;margin:0;padding:0;box-shadow:none}.quick-search--all .quick-search__advanced-link{display:block;padding:0;margin-top:.25rem;width:auto;text-align:end;font-size:.875rem;font-weight:400;color:#006acc}@media (min-width:532px){.quick-search--all .quick-search__advanced-link{font-size:.75rem}}@media (max-width:1279.98px){.quick-search--all .quick-search__advanced-link{float:none;margin:0}}.quick-search--all .quick-search__advanced-link:hover{text-decoration:none;color:#006acc}.quick-search--all .quick-search__wrapper{position:relative}@media (min-width:1024px){.quick-search--all .quick-search__form .quick-search__input{padding-left:178px;padding-right:60px;height:40px}}.quick-search--all .quick-search__button{position:relative;margin-top:1rem}@media (min-width:1024px){.quick-search--all .quick-search__button{position:absolute;right:0;top:0;margin:0;z-index:1090}}.quick-search .dropBlock__link:first-child{border-radius:0;background:#eee;color:#333;border:1px solid #ccc;font-size:14px;font-size:.875rem;font-weight:400;text-decoration:none}@media (max-width:1023px){.quick-search .dropBlock__link:first-child{color:#333;background:#f7f7f7}}.quick-search .tab{flex-direction:column;align-items:flex-end}.quick-search .tab .dropBlock>a{height:40px;padding:0 12px}.quick-search .tab .quick-search__searchbox{position:relative;align-items:center;flex-direction:column;gap:12px}.quick-search .tab .quick-search__searchbox .dropBlock{position:relative;width:100%;height:auto;margin-bottom:.5rem;flex:0 0 auto;white-space:nowrap}@media (min-width:1024px){.quick-search .tab .quick-search__searchbox .dropBlock{position:absolute!important;left:0;top:0;z-index:1090;width:166px;height:40px;margin-bottom:0}}.quick-search__advanced-link{width:-moz-max-content;text-transform:none}@media (max-width:1023px){.quick-search__advanced-link{margin-top:1rem}}@media (max-width:1023.98px){#search-overlay{display:flex;z-index:-1;position:absolute;top:var(--header-height);left:0;right:0;height:calc(100vh - var(--header-height));padding:24px 34px;background-color:#fff}#search-overlay.js--hidden{transform:translateY(-100vh);transition:transform .5s ease}}@media (max-width:531px){#search-overlay{padding-left:16px;padding-right:16px}}.institution{width:100%;display:flex;flex-direction:row;justify-content:flex-start;-moz-column-gap:.5rem;column-gap:.5rem}.institution__intro{display:flex;align-items:center;height:40px;color:#333;font-size:.875rem;line-height:1.57;white-space:nowrap}@media (min-width:1024px){.institution__intro{font-size:.75rem;line-height:1.66667}}.institution__institution{display:flex;flex-direction:column;align-items:flex-start;width:116px}.institution__image{flex:0 0 auto;width:100%;max-height:100%;-o-object-fit:contain;object-fit:contain;-o-object-position:left;object-position:left}.institution__image__wrapper{display:flex;justify-content:center;align-items:center;width:116px;height:40px;overflow:hidden}.institution__image__wrapper a{display:block;width:100%;height:100%}.institution__name{width:100%;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:.625rem;line-height:1.57}@media (min-width:1024px){.institution__name{font-size:.625rem;line-height:1.66667}}.header .institution a{color:#006acc;padding:0}.header .institution .ux-modal-container .modal a:focus:not(.btn):not(.dropdown-item),.header .institution .ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),.header .institution a:focus,.header .institution a:hover,.ux-modal-container .modal .header .institution a:focus:not(.btn):not(.dropdown-item),.ux-modal-container .modal .header .institution a:hover:not(.btn):not(.dropdown-item){text-decoration:underline;color:#006acc}.main-nav .ux-modal-container .modal a:not(.btn):not(.dropdown-item),.main-nav a{text-transform:none;font-size:14px;font-size:.875rem;font-weight:400}.main-nav .ux-modal-container .modal a.btn:not(.btn):not(.dropdown-item),.main-nav a.btn{padding:0 1rem}.main-nav .dropdown-toggle{display:flex;text-decoration:none;height:auto;padding:8px 8px 12px 0;cursor:pointer}@media (max-width:1023px){.main-nav .dropdown-toggle{padding:1.125rem 0;margin:0}}.main-nav .dropdown-toggle i,.main-nav .dropdown-toggle span{color:#333}.main-nav .dropdown-toggle:focus{text-decoration:none}.main-nav .menu-parent>.dropdown-toggle{border:none}.main-nav .menubar>li+li{margin-left:32px}.main-nav .modal{position:fixed;z-index:1040;top:100%;width:450px;min-height:425px;overflow:visible;box-shadow:0 2px 6px 0 rgba(0,0,0,.13);background-color:#fff}.main-nav .modal:before{content:" ";position:absolute;z-index:-1;left:10%;transform:rotate(45deg) translateY(-10px);width:10px;height:10px;border:1px solid #ccc;border-width:1px 0 0 1px;background-color:#fff}.main-nav .modal__dialog{width:100%;height:100%;max-height:100%;padding:0;margin:0}.main-nav .modal__close{position:absolute;top:2px;right:2px}.menubar>.menu-item:before,.menubar>.menu-parent:before{background:0 0}.journals-categories{margin:.375rem 0;padding-bottom:1rem;color:#333;font-size:.875rem;font-weight:400}@media (min-width:768px){.journals-categories{margin:1rem}}.journals-categories__disciplines,.journals-categories__subjects{display:flex;align-items:center;justify-content:space-between;flex-direction:column;-moz-column-gap:1rem;column-gap:1rem;color:inherit;margin-bottom:1rem}@media (min-width:768px){.journals-categories__disciplines,.journals-categories__subjects{flex-direction:row}}.journals-categories__disciplines{margin-bottom:.58rem}.journals-categories__text{width:100%;margin-bottom:.3rem}@media (min-width:768px){.journals-categories__text{width:25%;margin-bottom:0}}.journals-categories__label{color:inherit;font-size:.875rem;white-space:nowrap}.journals-categories .dropdown{width:100%}@media (min-width:768px){.journals-categories .dropdown{width:calc(75% - 1rem)}}.journals-categories .dropdown-toggle{padding:9px 12px}.journals-categories__btn{margin-left:0;width:100%;line-height:inherit;font-size:.75rem}@media (min-width:768px){.journals-categories__btn{margin-left:calc(25% + 1rem);width:auto}}.alternative{margin:1rem;padding-top:1rem;border-top:1px solid #ccc;color:#333}@media (max-width:1023px){.alternative{margin:0;padding-bottom:2rem}}.alternative__list{list-style-type:disc;padding-left:1.5rem}.alternative__item,.alternative p{font-size:.875rem;font-weight:400;margin-bottom:10px}.alternative__item p{margin:0}.alternative__link.btn[role=link]{display:inline-flex;width:auto;color:#14797b;font-size:.75rem;margin-top:.625rem;margin-left:0;border:1px solid #14797b}@media (min-width:768px){.alternative__link.btn[role=link]{margin-left:calc(25% + 1rem)}}.alternative__link.btn[role=link]:hover,.billingBtn .alternative__link.payPallBtn[role=link]:hover,.jcf-file .alternative__link.jcf-upload-button[role=link]:hover,.main-nav.menu--res ul .mddb-navigation a.alternative__link.btn[role=link]:hover,.moreFromButton.smallButton a.alternative__link[role=link]:hover{color:#14797b}.alternative li[data-id=listItem]{display:list-item}.alternative li[data-id=listItem]:after,.alternative li[data-id=listItem]:before{display:none}@media (max-width:1023px){.alternative li[data-id=listItem]{margin-left:2rem}}.email-alerts__journals{border-bottom:1px solid #ccc;margin:1rem 0}.email-alerts__journals thead{background:#f7f7f7}.email-alerts__journals thead th{font-size:.75rem;font-weight:600;color:#333;text-align:center}@media (max-width:531.98px){.email-alerts__journals thead{display:none}}.email-alerts__journals tbody td{text-align:center}.email-alerts__journals tbody td:first-child{text-align:left}@media (max-width:531.98px){.email-alerts__journals tbody tr{display:flex;flex-direction:column}}.email-alerts__journals--title{font-size:.875rem;color:#333;font-weight:600;border-bottom:1px solid #ccc}@media (min-width:532px){.email-alerts__journals--title{border-bottom:none}}.email-alerts__journals input[type=checkbox]{-webkit-appearance:none;-moz-appearance:none;appearance:none;display:flex;align-items:center;margin:0;border:none;height:auto;width:auto;background-color:transparent}@media (min-width:532px){.email-alerts__journals input[type=checkbox]{width:20px;flex-basis:20px;margin:0 auto}}.email-alerts__journals input[type=checkbox]:before{color:#14797b;background:0 0;display:inline-flex;width:20px;height:20px;border-color:#888}@media (min-width:532px){.email-alerts__journals input[type=checkbox]:before{margin:0}}.email-alerts__journals input[type=checkbox]:checked{background:0 0}@media (max-width:531.98px){.email-alerts__journals input[name=journalCode]:after{content:"New Content";font-size:.875rem;color:#333;font-weight:600}}.email-alerts button[type=submit]{text-transform:uppercase;float:right}.banner-widget{background-color:#ccc;background-size:cover;background-repeat:no-repeat;background-position:50%;width:100%;max-width:1440px}.banner-widget__container{position:relative}.banner-widget__heading{font-weight:400;color:#fff;font-size:1.25rem;line-height:1.275}@media (min-width:532px){.banner-widget__heading{margin:2rem 0;font-size:1.5rem;line-height:1.275}}@media (min-width:768px){.banner-widget__heading{margin:2rem 0;font-size:2rem;line-height:1.375}}.banner-widget__heading a{color:inherit;text-decoration:none}.banner-widget__heading .ux-modal-container .modal a:hover:not(.btn):not(.dropdown-item),.banner-widget__heading a:hover,.ux-modal-container .modal .banner-widget__heading a:hover:not(.btn):not(.dropdown-item){text-decoration:underline}.banner-widget__box{position:absolute;width:100%}.banner-widget__content{flex-wrap:wrap}.banner-widget__content-main{align-items:center;display:flex}.banner-widget--main-content{overflow-x:clip;padding:0 0 2rem;margin:0 auto 2rem}@media (min-width:768px){.banner-widget--main-content{padding:0 0 2rem;margin:0 auto 2rem}}.banner-widget--main-content .banner-widget__heading{margin:.5rem 0;padding:.5rem 0;position:relative}.banner-widget--main-content .banner-widget__heading a{margin:0!important;position:relative;z-index:1}.banner-widget--main-content .banner-widget__heading:before{content:"";display:block;position:absolute;z-index:0;top:0;left:-24px;right:-24px;bottom:0;background:#000;background:rgba(0,0,0,.7)}@media (min-width:1024px){.banner-widget--main-content .banner-widget__heading{display:inline-block;max-width:100%;padding-right:18rem;background-image:linear-gradient(90deg,rgba(0,0,0,.7),rgba(0,0,0,.7) calc(100% - 18rem),transparent)}.banner-widget--main-content .banner-widget__heading:before{left:auto;right:100%;width:144px}}.banner-widget--article-page .banner-widget .banner-widget__content-main{min-height:90px}.society-logos-widget{display:none}@media (min-width:768px){.society-logos-widget{display:flex;flex-direction:row;justify-content:flex-start;align-items:center;row-gap:1.5rem}}.sage-special-collections{margin-bottom:1rem}.sage-special-collections:last-child{margin-bottom:0}.sage-special-collections__title{font-weight:400;padding:1rem 0 .5rem;border-top:1px solid #ccc;border-bottom:1px solid #ccc}.sage-special-collections .btn--collapse{display:inline-flex;padding:0;width:auto;height:auto;justify-content:flex-start;font-size:.875rem;font-weight:600;line-height:1.57}.sage-special-collections .btn--collapse span{color:#333}.sage-special-collections .btn--collapse [class*=icon-]{font-size:1rem;margin-left:8px}.sage-special-collections__view-more{text-align:center}.sage-special-collections__view-more .btn{font-size:.875rem;line-height:1.57;padding:0;text-decoration:underline;font-weight:600}.billingBtn .sage-special-collections__view-more .payPallBtn:hover,.jcf-file .main-nav.menu--res ul .mddb-navigation .sage-special-collections__view-more a.jcf-upload-button:hover,.jcf-file .sage-special-collections__view-more .jcf-upload-button:hover,.main-nav.menu--res ul .mddb-navigation .jcf-file .sage-special-collections__view-more a.jcf-upload-button:hover,.main-nav.menu--res ul .mddb-navigation .sage-special-collections__view-more a.btn:hover,.moreFromButton.smallButton .sage-special-collections__view-more a:hover,.sage-special-collections__view-more .billingBtn .payPallBtn:hover,.sage-special-collections__view-more .btn:hover,.sage-special-collections__view-more .jcf-file .jcf-upload-button:hover,.sage-special-collections__view-more .jcf-file .main-nav.menu--res ul .mddb-navigation a.jcf-upload-button:hover,.sage-special-collections__view-more .main-nav.menu--res ul .mddb-navigation .jcf-file a.jcf-upload-button:hover,.sage-special-collections__view-more .main-nav.menu--res ul .mddb-navigation a.btn:hover,.sage-special-collections__view-more .moreFromButton.smallButton a:hover{color:#005099;text-decoration:none}.sage-special-collections li:last-of-type .teaser{border-bottom:none;padding-bottom:0}.content-navigation{flex-grow:1;flex-wrap:nowrap}@media (min-width:768px){.content-navigation{flex-grow:0;-moz-column-gap:2.5rem;column-gap:2.5rem}}.login-form{font-size:.875rem}.login-form [type=password],.login-form [type=text]{width:100%}.login-form .form-row .col-12{margin-bottom:1rem}.form-password{position:relative}</style>
<meta http-equiv=X-UA-Compatible content="IE=edge">
<meta name=viewport content="width=device-width, initial-scale=1">
<meta property=og:image content=/pb-assets/Images/SJ_Twitter_Card-1557144152440.jpg>
<meta name=google-site-verification content=6b_U8gTbwxPAJSSIOBxO9mKsWVht9WAMuijMWNDwNCs>
<style>#_atssh{width:1px!important;height:1px!important;border:0!important}</style><meta http-equiv=origin-trial content="Az6AfRvI8mo7yiW5fLfj04W21t0ig6aMsGYpIqMTaX60H+b0DkO1uDr+7BrzMcimWzv/X7SXR8jI+uvbV0IJlwYAAACFeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjgwNjUyNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv=origin-trial content="A+USTya+tNvDPaxUgJooz+LaVk5hPoAxpLvSxjogX4Mk8awCTQ9iop6zJ9d5ldgU7WmHqBlnQB41LHHRFxoaBwoAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjgwNjUyNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv=origin-trial content="A7FovoGr67TUBYbnY+Z0IKoJbbmRmB8fCyirUGHavNDtD91CiGyHHSA2hDG9r9T3NjUKFi6egL3RbgTwhhcVDwUAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjgwNjUyNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><link rel="shortcut icon" type=image/png href=data:image/png;base64,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><style>.sf-hidden{display:none!important}</style><link rel=canonical href="https://journals.sagepub.com/doi/10.1345/aph.1R501?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed"><meta http-equiv=content-security-policy content="default-src 'none'; font-src 'self' data:; img-src 'self' data:; style-src 'unsafe-inline'; media-src 'self' data:; script-src 'unsafe-inline' data:;"><style>img[src="data:,"],source[src="data:,"]{display:none!important}</style></head>
<body class="pb-ui mouse-user"><div style=display:none id=lightningjs-usabilla_live></div><div class=qc-cmp2-container id=qc-cmp2-container data-nosnippet><a class=qc-cmp2-persistent-link id=qc-cmp2-persistent-link data-nosnippet tabindex=0 href=#><img data-nosnippet src="data:image/svg+xml,%3Csvg viewBox='0 0 16 17' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' style='margin-right: 5px; height: 17px;'%3E%3Cg id='Page-1' stroke='none' stroke-width='1' fill='none' fill-rule='evenodd'%3E%3Cg id='cog' fill='%23FFFFFF' fill-rule='nonzero'%3E%3Cpath d='M15.596917,9.98326938 L14.5041079,9.33798816 C14.5728064,8.7815386 14.5728064,8.2184614 14.5041079,7.66201184 L15.596917,7.01673062 C15.9178229,6.82726259 16.0726124,6.43742732 15.9670848,6.0741546 C15.5912871,4.78033611 14.9223646,3.61573153 14.0390021,2.66061113 C13.7831755,2.38401797 13.3749053,2.32348965 13.0525249,2.51384881 L11.9613243,3.15813608 C11.5248519,2.81840117 11.0481221,2.53648663 10.542482,2.31910255 L10.542482,1.02991108 C10.542482,0.648438733 10.2860522,0.316869683 9.92305592,0.229024792 C8.66155,-0.07632446 7.33871809,-0.0763587342 6.07694408,0.229024792 C5.71398131,0.316869683 5.457518,0.648404458 5.457518,1.02991108 L5.457518,2.31910255 C4.95187406,2.53647872 4.47514334,2.81839382 4.03867572,3.15813608 L2.94747511,2.51384881 C2.62506122,2.32348965 2.21679094,2.38401797 1.96099786,2.66061113 C1.07763542,3.61573153 0.40871289,4.78037038 0.0329152236,6.0741546 C-0.072612407,6.43742732 0.0821770899,6.82722832 0.403082962,7.01673062 L1.49589212,7.66201184 C1.42719356,8.2184614 1.42719356,8.7815386 1.49589212,9.33798816 L0.403082962,9.98326938 C0.0821770899,10.1727374 -0.072612407,10.5625727 0.0329152236,10.9258454 C0.40871289,12.2196296 1.07763542,13.3842685 1.96099786,14.3393889 C2.21682445,14.615982 2.62509474,14.6765103 2.94747511,14.4861855 L4.03867572,13.8418982 C4.47514096,14.1816349 4.95187243,14.4635389 5.457518,14.6808975 L5.457518,15.9700889 C5.457518,16.3515613 5.7139478,16.6831303 6.07694408,16.7709752 C7.33848351,17.0763245 8.66128191,17.0763587 9.92305592,16.7709752 C10.2860187,16.6831303 10.542482,16.3515955 10.542482,15.9700889 L10.542482,14.6808975 C11.0481183,14.4635198 11.5248475,14.1816171 11.9613243,13.8418982 L13.0525249,14.4861855 C13.3749053,14.6765446 13.7831755,14.6160163 14.0390021,14.3393889 C14.9223646,13.3842685 15.5912871,12.2196296 15.9670848,10.9258454 C16.0726124,10.5625727 15.9178229,10.1727717 15.596917,9.98326938 Z M13.4026193,13.4264943 L11.8507364,12.510001 C10.9463288,13.3007421 10.6255905,13.4997041 9.47011484,13.9172673 L9.47011484,15.7502196 C8.50024808,15.9548373 7.49975192,15.9548373 6.52988516,15.7502196 L6.52988516,13.9172673 C5.4031959,13.5101235 5.07699522,13.3210668 4.14926358,12.510001 L2.59738075,13.4264943 C1.9368696,12.6693763 1.43490124,11.7817076 1.12525522,10.8230912 L2.67780828,9.90659789 C2.4588108,8.69270694 2.45871027,8.30790999 2.67780828,7.09340211 L1.12525522,6.17690879 C1.43490124,5.21829242 1.93690311,4.33058946 2.59738075,3.57312864 L4.14926358,4.49030745 C5.0667072,3.68712478 5.39129933,3.4941265 6.52988516,3.08269846 L6.52988516,1.24978037 C7.49971774,1.04482059 8.50028226,1.04482059 9.47011484,1.24978037 L9.47011484,3.08273274 C10.6087677,3.49419505 10.9333933,3.6872276 11.8507364,4.49034172 L13.4026193,3.57316291 C14.0630969,4.33058946 14.5650988,5.21829242 14.8747448,6.17694306 L13.3221917,7.09343638 C13.5412227,8.3076358 13.5412897,8.69212428 13.3221917,9.90663217 L14.8747448,10.8231255 C14.5650988,11.7817076 14.0631304,12.6694105 13.4026193,13.4264943 Z M8,5.20968958 C6.22607014,5.20968958 4.78289853,6.68570996 4.78289853,8.50001714 C4.78289853,10.3143243 6.22607014,11.7903447 8,11.7903447 C9.77392986,11.7903447 11.2171015,10.3143243 11.2171015,8.50001714 C11.2171015,6.68570996 9.77392986,5.20968958 8,5.20968958 Z M8,10.6935688 C6.81738009,10.6935688 5.85526568,9.70955526 5.85526568,8.50001714 C5.85526568,7.29047902 6.81738009,6.30646543 8,6.30646543 C9.18261991,6.30646543 10.1447343,7.29047902 10.1447343,8.50001714 C10.1447343,9.70955526 9.18261991,10.6935688 8,10.6935688 Z' id='Shape'%3E%3C/path%3E%3C/g%3E%3C/g%3E%3C/svg%3E" alt=Privacy>Privacy</a></div>
<div id=pb-page-content data-ng-non-bindable>
<div data-pb-dropzone=main data-pb-dropzone-name=Main>
<a href=#skipNavigationTo class=sr-only-focusable>Skip to main content</a>
<style class=sf-hidden>#healthcare-banner{font-size:14px;color:#333333;padding:4px 0px;background-color:#D9EDF7;border:1px solid #BCE8F1;text-align:center}</style>
<div class=top-leaderboard-container role=region aria-label=advertising>
<div id=healthcare-banner>Intended for healthcare professionals</div>
<div data-widget-def=literatumAd data-widget-id=b3cb37b8-3035-4a1b-ae52-2bc4895fee1b class="d-none d-lg-block">
<div class=pb-ad><div id=div-gpt-ad-123456789-0 data-google-query-id=CKr81d_czvsCFS_2KAUdJygK0g><div id=google_ads_iframe_/53867575/health_sciences//pharmacology_toxicology//AOP//728x90_Top_0__container__ style="border:0pt none"></div></div>
</div>
</div>
</div>
<div>
<div>
</div>
<div class="popup login-popup hidden">
<div class=content>
<a href=# class=close>
<span class=sr-only>close</span>
<i class=icon-close_thin></i>
</a>
<div class=login-form-container>
<div class="tab tab--flex">
<ul class="rlist tab__nav" role=tablist>
<li class=active role=presentation>
<a class=active id=pane-m1x01con href=#pane-m1x01 aria-controls=pane-m1x01 role=tab data-toggle=tab title=login aria-selected=true data-simple-tab-id aria-expanded=true>
<span>Sign In</span>
</a>
</li>
<li role=presentation>
<a id=pane-m1x11con href=#pane-m1x11 aria-controls=pane-m1x11 role=tab data-toggle=tab title=register aria-selected=false>
<span>CREATE PROFILE</span>
</a>
</li>
</ul>
<ul class="rlist tab__content">
<li class="tab__pane active" id=pane-m1x01 aria-labelledby=pane-m1x01con role=tabpanel>
<div class=login-form>
<form action=/action/doLogin id=frmLogin name=sageDoLogin method=post><div class=useAJAX_SSO_error>
<p class="message error d-none sf-hidden" role=alert aria-live=assertive>
Login failed. Please check you entered the correct user name and password.
</p>
</div>
<h3 class=heading-s>Sign in</h3>
<p>
Access personal subscriptions, purchases, paired institutional or society access and free tools such as email alerts and saved searches.
</p>
<div class=mb-2>
<em class=required>Required fields</em>
</div>
<div class=form-group>
<label class=required for=login>Email:</label>
<span role=alert class="error useAJAX_error_emptyEmail ajaxError" style=display:none>
</span>
<input id=login class="form-control login textInput" aria-invalid=false aria-required=true type=text name=login value size=15 placeholder="Enter email address">
</div>
<div class=form-group>
<label class=required for=password>Password:</label>
<div class=form-password>
<input id=password class=form-control aria-invalid=false aria-required=true type=password name=password value autocomplete=off placeholder="Enter password" aria-describedby=new-password-rules showarearequired=true>
<span class="icon-eye d-none sf-hidden" tabindex=0 aria-live=polite></span>
</div>
</div>
<div class=form-row>
<div class="col-12 col-lg-6">
<div class=form-check>
<input id=e867645a-f190-4d22-a906-237d744a9339-remember class=form-check-input type=checkbox name=remember value=true>
<label class=form-check-label for=e867645a-f190-4d22-a906-237d744a9339-remember>
<span class=label>Remember me</span>
</label>
</div>
</div>
<div class="col-12 col-lg-6 text-lg-right">
<a href=https://journals.sagepub.com/action/requestResetPassword>Forgotten your password?</a>
</div>
</div>
<div class=form-row>
<div class="col text-center">
<button type=submit data-id=article-access-signin class="btn btn-primary btn-submit">
<span>Sign in</span>
</button>
</div>
</div></form>
</div>
</li>
<li class="tab__pane sf-hidden" id=pane-m1x11 aria-labelledby=pane-m1x11con role=tabpanel>
</li>
</ul>
</div>
</div>
</div>
</div>
<header role=banner aria-label=banner class=header style=position:relative!important;top:0px><div class=header__inner><div role=navigation aria-label="SAGE Journals" class=header--first-row><div class=header--first-col>
<div data-widget-def=ux3-general-image data-widget-id=97983108-3751-403e-8375-37f9120d3fa4 class=header__logo data-id=global-header-home>
<a href=https://journals.sagepub.com/ title="SAGE Journals Home"><img alt="SAGE Journals Home" src="data:image/svg+xml;base64,<svg width="214" height="32" viewBox="0 0 214 32" fill="none" xmlns="http://www.w3.org/2000/svg">
<path d="M102.666 7.1202V26.8002C102.667 27.4436 102.614 28.0859 102.506 28.7202C102.413 29.2838 102.209 29.8233 101.905 30.3069C101.609 30.7634 101.199 31.1355 100.716 31.3869C100.122 31.6753 99.4663 31.8127 98.8064 31.7869H98.0586H97.3108V29.9069H97.9117C98.0982 29.9251 98.2861 29.9251 98.4726 29.9069C99.3629 29.9069 99.9104 29.658 100.115 29.1602C100.364 28.5702 100.483 27.9335 100.462 27.2935V7.1202H102.666ZM102.666 0.200195V3.73353H100.462V0.200195H102.666Z" fill="#E13345"/>
<path d="M118.183 7.37352C119.211 7.86502 120.121 8.56957 120.854 9.44019C121.593 10.333 122.151 11.361 122.497 12.4669C123.243 14.8682 123.243 17.4389 122.497 19.8402C122.151 20.9459 121.593 21.9738 120.854 22.8669C120.124 23.7333 119.212 24.4296 118.183 24.9069C115.847 25.9092 113.201 25.9092 110.865 24.9069C109.837 24.4296 108.925 23.7333 108.194 22.8669C107.455 21.974 106.897 20.946 106.552 19.8402C105.806 17.4389 105.806 14.8682 106.552 12.4669C106.888 11.3584 107.437 10.3259 108.168 9.42685C108.901 8.55624 109.811 7.85168 110.839 7.36019C113.17 6.33371 115.826 6.33371 118.157 7.36019L118.183 7.37352ZM111.76 9.12019C110.981 9.55078 110.306 10.1471 109.784 10.8669C109.248 11.6148 108.846 12.4492 108.595 13.3335C108.058 15.1707 108.058 17.123 108.595 18.9602C108.845 19.8451 109.247 20.6797 109.784 21.4269C110.306 22.1469 110.981 22.7433 111.76 23.1735C113.496 24.0591 115.552 24.0591 117.289 23.1735C118.068 22.7433 118.743 22.1469 119.265 21.4269C119.802 20.6799 120.204 19.8451 120.453 18.9602C120.99 17.1229 120.99 15.1708 120.453 13.3335C120.204 12.4486 119.802 11.6138 119.265 10.8669C118.742 10.1471 118.068 9.55078 117.289 9.12019C115.552 8.23679 113.497 8.23679 111.76 9.12019Z" fill="#E13345"/>
<path d="M138.962 25.1601V21.9068H138.882C138.341 23.069 137.455 24.0371 136.345 24.6801C135.224 25.3229 133.952 25.6544 132.659 25.6401C131.664 25.6674 130.672 25.5091 129.735 25.1734C128.98 24.8973 128.306 24.4393 127.772 23.8401C127.253 23.2189 126.879 22.4902 126.677 21.7068C126.431 20.7714 126.314 19.807 126.329 18.8401V7.12012H128.533V18.8668C128.48 20.1951 128.88 21.502 129.668 22.5735C131.411 23.9746 133.815 24.2251 135.811 23.2134C136.508 22.8127 137.102 22.2559 137.547 21.5868C138.003 20.8752 138.333 20.0903 138.522 19.2668C138.733 18.3936 138.841 17.4985 138.842 16.6001V7.12012H141.046V25.1601H138.962Z" fill="#E13345"/>
<path d="M147.188 7.12015V11.3468H147.255C147.761 9.96281 148.697 8.77634 149.926 7.96015C151.177 7.1504 152.659 6.77114 154.146 6.88015V9.08015C153.237 9.03045 152.329 9.16657 151.475 9.48015C149.876 10.077 148.605 11.322 147.976 12.9068C147.638 13.7549 147.47 14.6609 147.482 15.5735V25.1868H145.158V7.12015H147.188Z" fill="#E13345"/>
<path d="M158.913 7.12011V10.2268H158.98C159.408 9.11228 160.198 8.17331 161.223 7.56011C162.31 6.92471 163.557 6.61462 164.815 6.66678C165.892 6.63921 166.964 6.80635 167.98 7.16011C168.761 7.42999 169.463 7.88797 170.024 8.49345C170.554 9.12557 170.925 9.8754 171.105 10.6801C171.326 11.6285 171.434 12.5997 171.426 13.5734V25.1734H169.222V13.9068C169.226 13.1858 169.154 12.4664 169.009 11.7601C168.887 11.1376 168.637 10.5473 168.274 10.0268C167.91 9.52856 167.422 9.13342 166.859 8.88011C166.159 8.58234 165.402 8.44126 164.642 8.46678C163.829 8.44996 163.023 8.60917 162.278 8.93345C161.605 9.24624 161.008 9.70116 160.529 10.2668C160.033 10.8426 159.652 11.5079 159.407 12.2268C159.116 13.0094 158.949 13.8327 158.913 14.6668V25.1868H156.776V7.12011H158.913Z" fill="#E13345"/>
<path d="M176.06 9.92035C176.414 9.16506 176.945 8.50636 177.609 8.00035C178.284 7.49699 179.05 7.13011 179.866 6.92035C180.799 6.71291 181.755 6.62774 182.71 6.66702C183.508 6.66803 184.304 6.74392 185.087 6.89369C185.849 7.03233 186.576 7.32252 187.224 7.74702C187.877 8.19432 188.405 8.79994 188.76 9.50702C189.193 10.4272 189.399 11.4376 189.36 12.4537V22.027C189.299 22.396 189.42 22.7717 189.685 23.0361C189.95 23.3005 190.326 23.4212 190.696 23.3604C190.934 23.3651 191.171 23.3197 191.39 23.227V25.0804L190.709 25.187C190.46 25.2013 190.21 25.2013 189.961 25.187C189.505 25.2034 189.051 25.1262 188.626 24.9604C188.306 24.8232 188.032 24.5963 187.838 24.307C187.645 24.0048 187.521 23.6631 187.478 23.307C187.411 22.8657 187.38 22.4199 187.384 21.9737H187.317C186.952 22.5197 186.55 23.0408 186.115 23.5337C185.728 23.9746 185.278 24.3564 184.78 24.667C184.209 24.9827 183.591 25.2077 182.951 25.3337C182.198 25.5075 181.426 25.5881 180.654 25.5737C179.856 25.5801 179.061 25.4815 178.29 25.2804C177.591 25.0978 176.937 24.7758 176.367 24.3337C175.798 23.9004 175.34 23.3383 175.032 22.6937C174.702 21.9514 174.543 21.1452 174.564 20.3337C174.504 19.2849 174.801 18.2467 175.405 17.387C175.989 16.6609 176.754 16.1 177.622 15.7604C178.622 15.3679 179.667 15.1036 180.734 14.9737L184.286 14.667C184.749 14.6226 185.158 14.5648 185.514 14.4937C185.827 14.4395 186.124 14.3165 186.383 14.1337C186.65 13.9302 186.85 13.6516 186.957 13.3337C187.096 12.9542 187.16 12.551 187.144 12.147C187.171 11.5138 187.048 10.8832 186.783 10.307C186.552 9.84603 186.201 9.45488 185.768 9.17369C185.308 8.88459 184.795 8.6897 184.259 8.60035C183.651 8.49134 183.034 8.43779 182.416 8.44035C181.193 8.387 179.987 8.73854 178.984 9.44035C178.062 10.2394 177.568 11.4238 177.649 12.6404H175.446C175.474 11.7028 175.682 10.7793 176.06 9.92035ZM187.09 15.2537C186.91 15.5408 186.621 15.7429 186.289 15.8137C185.943 15.9169 185.591 15.997 185.234 16.0537C184.344 16.2137 183.382 16.3604 182.35 16.4937C181.444 16.6078 180.551 16.7996 179.679 17.067C178.934 17.2853 178.246 17.6629 177.662 18.1737C177.12 18.71 176.833 19.4525 176.874 20.2137C176.865 20.7266 176.98 21.2342 177.208 21.6937C177.428 22.1233 177.732 22.5042 178.103 22.8137C178.497 23.1387 178.95 23.3833 179.438 23.5337C179.925 23.6946 180.435 23.7757 180.947 23.7737C181.769 23.7766 182.585 23.646 183.364 23.387C184.104 23.1491 184.789 22.7686 185.381 22.267C185.945 21.7699 186.4 21.1616 186.716 20.4804C187.066 19.7387 187.24 18.9266 187.224 18.107V15.307L187.09 15.2537Z" fill="#E13345"/>
<path d="M195.997 0.200195V25.1602H193.794V0.200195H195.997Z" fill="#E13345"/>
<path d="M210.633 10.667C210.417 10.1526 210.083 9.69601 209.658 9.33363C209.215 9.00043 208.712 8.75594 208.176 8.61363C207.592 8.45904 206.991 8.38281 206.387 8.38696C205.888 8.3894 205.392 8.44301 204.904 8.54696C204.435 8.64946 203.984 8.82493 203.569 9.06696C203.159 9.30202 202.811 9.63108 202.554 10.027C202.285 10.4681 202.151 10.9776 202.167 11.4936C202.15 11.9349 202.277 12.3698 202.527 12.7336C202.78 13.0764 203.098 13.3663 203.462 13.587C203.848 13.8249 204.26 14.0173 204.691 14.1603C205.136 14.3114 205.545 14.4314 205.919 14.5203L208.857 15.187C209.498 15.2839 210.125 15.4539 210.727 15.6936C211.321 15.9253 211.876 16.2493 212.369 16.6536C212.855 17.059 213.255 17.5577 213.544 18.1203C213.861 18.7622 214.017 19.4715 213.998 20.187C214.023 21.0652 213.791 21.9316 213.331 22.6803C212.898 23.3592 212.318 23.9332 211.635 24.3603C210.92 24.7999 210.134 25.1113 209.311 25.2803C208.473 25.4642 207.618 25.5581 206.761 25.5603C204.918 25.6459 203.099 25.1157 201.593 24.0536C200.172 22.8497 199.348 21.0872 199.336 19.227H201.539C201.496 20.5452 202.056 21.8114 203.061 22.667C204.132 23.449 205.435 23.8482 206.761 23.8003C207.321 23.799 207.881 23.7409 208.43 23.627C208.988 23.5129 209.525 23.3103 210.019 23.027C210.491 22.7609 210.901 22.3973 211.221 21.9603C211.541 21.4942 211.705 20.9386 211.688 20.3736C211.702 19.907 211.587 19.4455 211.354 19.0403C211.127 18.6755 210.822 18.3658 210.46 18.1336C210.043 17.8718 209.594 17.6656 209.124 17.5203C208.643 17.3603 208.158 17.2225 207.669 17.107L204.838 16.4803C204.161 16.3061 203.496 16.0878 202.848 15.827C202.277 15.6027 201.742 15.2973 201.259 14.9203C200.806 14.5622 200.441 14.1063 200.19 13.587C199.916 12.9801 199.784 12.319 199.803 11.6536C199.779 10.8289 199.992 10.0146 200.417 9.30696C200.815 8.66469 201.36 8.12555 202.007 7.73363C202.685 7.32576 203.424 7.02868 204.197 6.85363C204.985 6.66969 205.791 6.57576 206.6 6.57363C207.458 6.56561 208.313 6.68239 209.138 6.92029C209.893 7.13736 210.597 7.50472 211.207 8.00029C211.806 8.4948 212.289 9.11362 212.623 9.81363C212.994 10.6133 213.198 11.4796 213.224 12.3603H210.994C210.994 11.7769 210.871 11.1999 210.633 10.667Z" fill="#E13345"/>
<path d="M86.2004 25.4001H71.9116V6.08008H86.0135V8.38674H74.529V14.3067H85.1188V16.6267H74.529V23.0934H86.2004V25.4001Z" fill="#003399"/>
<path d="M61.5887 15.0667H70.0819V25.4001H67.8384L67.7583 22.8934C66.2357 24.83 63.894 25.9447 61.4285 25.9067C59.2328 26.0546 57.0776 25.2646 55.4993 23.7334C53.3285 21.595 52.2142 18.6087 52.4546 15.5734C52.4546 10.8667 55.3123 5.56006 61.6154 5.56006C65.221 5.56006 69.2406 7.60006 69.8148 11.9467H67.2775C66.4496 8.58673 63.6052 7.94673 61.4819 7.94673C58.0098 7.94673 55.1521 10.7201 55.1521 15.7734C55.1521 19.7067 56.4875 23.7734 61.5887 23.7734C63.0283 23.841 64.4461 23.4022 65.5949 22.5334C67.0967 21.2458 67.8578 19.2961 67.6247 17.3334H61.5887V15.0667Z" fill="#003399"/>
<path d="M48.6753 19.7734L50.5849 25.4001H53.416L46.4452 6.08008H43.4806L36.2026 25.4001H38.8734L40.8899 19.7734H48.6753ZM41.7179 17.4667L44.816 8.96008L47.6738 17.4667H41.7179Z" fill="#003399"/>
<path d="M33.5986 11.92C33.465 8.94662 30.9946 8.01329 28.8312 8.01329C27.202 8.01329 24.4377 8.46662 24.4377 11.3866C24.4377 13.0133 25.5862 13.56 26.7213 13.8266L32.2231 15.08C34.7203 15.6666 36.5899 17.1733 36.5899 20.2133C36.5899 24.76 32.3567 26.0133 29.0582 26.0133C25.4927 26.0133 24.1039 24.9466 23.2359 24.1733C21.8629 22.9424 21.1422 21.1434 21.2862 19.3066H23.73C23.73 22.7866 26.5744 23.8 29.0716 23.8C30.9411 23.8 34.106 23.32 34.106 20.56C34.106 18.5466 33.1713 17.8933 30.0064 17.16L26.0001 16.2533C23.6918 15.9861 21.9386 14.0532 21.9005 11.7333C21.9005 8.73329 23.8501 5.78662 28.5775 5.78662C35.2545 5.78662 35.9756 9.78662 36.0824 11.92H33.5986Z" fill="#003399"/>
<path d="M10.0022 4.00012C5.58199 4.00012 1.98975 9.33346 1.98975 15.8401C1.98975 22.3468 5.58199 27.6801 10.0022 27.6801C14.4224 27.6801 18.0146 22.3468 18.0146 15.8401C18.0146 9.33346 14.3957 4.00012 10.0022 4.00012ZM10.0022 3.29346C15.3438 3.29346 19.9242 8.96012 19.9242 15.8801C19.9242 22.8001 15.3972 28.5068 10.0022 28.5068C4.60714 28.5068 0 22.8535 0 15.8935C0 8.93346 4.40683 3.30679 9.92205 3.30679" fill="#003399"/>
<path d="M16.1317 12.4C16.0115 10.0533 13.541 6.42664 10.2693 6.30664V12.6933H15.8513C15.9268 12.6972 16.0004 12.6689 16.0538 12.6156C16.1073 12.5622 16.1356 12.4887 16.1317 12.4133" fill="#003399"/>
<path d="M16.1316 19.3468C16.1285 19.2141 16.0705 19.0886 15.9714 19.0001L9.58814 12.6135V6.29346C6.30305 6.42679 3.85926 10.0801 3.72572 12.4135C3.71388 12.5539 3.76818 12.6919 3.87262 12.7868L10.2558 19.2135V25.5201C13.5676 25.3868 16.0515 21.6801 16.1183 19.3468" fill="#003399"/>
<path d="M3.73925 19.4402C3.87279 21.7869 6.34328 25.3869 9.60167 25.5202V19.1335H4.00633C3.92638 19.1275 3.84827 19.1595 3.79566 19.2199C3.74306 19.2803 3.72214 19.362 3.73925 19.4402Z" fill="#003399"/>
</svg>
"></a>
</div>
</div><div class=header--second-col>
<div data-widget-def=UX3QuickSearchWidget data-widget-id=91a67f5d-48d7-493e-912e-2af5faaaceef class="search-overlay js--hidden" id=search-overlay>
<div class="quick-search quick-search--all"><div class="full-width quickSearchFormContainer"><div class=tab><div role=search aria-label="quick search" class=quick-search__searchbox><div class="dropBlock no-auto-width" data-db-parent-of=dbTab-1 aria-label="search categories" role=navigation><a href=# class=dropBlock__link data-db-target-for=dbTab-1 data-id=global-header-quick-search-filter><span>Search this journal</span><i class=icon-arrow_down aria-hidden=true></i></a><ul role=tablist class="rlist tab__nav dropblock--tab sf-hidden" data-db-target-of=dbTab-1></ul></div><div class="quick-search__wrapper tab__content"><div id=pane-91a67f5d-48d7-493e-912e-2af5faaaceef0 role=tabpanel class="tab__pane quick-search-pane__anywhere active" aria-labelledby=pane-91a67f5d-48d7-493e-912e-2af5faaaceef0-con><form action=/action/doSearch name=thisJournalQuickSearch class=quick-search__form><div class="input-group option-0 option-journal"><label for=AllField91a67f5d-48d7-493e-912e-2af5faaaceef0 class=sr-only>Enter search terms...</label><input autocomplete=off type=search id=AllField91a67f5d-48d7-493e-912e-2af5faaaceef0 name=AllField aria-label="site search" placeholder="Enter search terms..." data-auto-complete-max-words=7 data-auto-complete-max-chars=32 data-contributors-conf=0 data-topics-conf=0 data-publication-titles-conf=0 data-history-items-conf=0 value class="quick-search__input autocomplete" aria-controls=autoComplete_list_1 aria-autocomplete=both role=combobox aria-owns=autoComplete_list_1 aria-haspopup=true aria-expanded=false><div id=autoComplete_list_1 role=listbox class="autocomplete dropdown-menu show sf-hidden" hidden></div></div><button type=submit title=Search data-id=global-header-quick-search class="btn quick-search__button"><span class=sr-only>Search</span><span class="hidden-lg sf-hidden">Search</span><i aria-hidden=true class="icon-search hvr-grow"></i></button></form></div><div id=pane-91a67f5d-48d7-493e-912e-2af5faaaceef1 role=tabpanel class="tab__pane quick-search-pane__anywhere sf-hidden" aria-labelledby=pane-91a67f5d-48d7-493e-912e-2af5faaaceef1-con></div><div class=advanced-and-citation-block></div></div></div>
<a href="https://journals.sagepub.com/search/advanced?SeriesKey=aopd" class=quick-search__advanced-link>Advanced search</a>
</div></div></div>
</div>
<div class=institution-wrapper>
<div class=institution><div class=institution__intro>I have access via:</div><div class=institution__institution><div class=institution__image__wrapper><a href=http://www.uflib.ufl.edu/ title="UNIV OF FLORIDA Smathers Libraries" data-id=institution-banner-url-dataId><img src=data:image/jpeg;base64,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 alt="University of Florida" class=institution__image></a></div><a href=http://www.uflib.ufl.edu/ title="UNIV OF FLORIDA Smathers Libraries" data-id=global-header-inst-branding class=institution__name>UNIV OF FLORIDA Smathers Libraries</a></div></div>
</div><div class=header__quick-menu><ul class=rlist--inline><li>
<a href=# data-toggle-target-id=search-overlay class="search-trigger sf-hidden"> </a>
<li>
<div class=user-login-bar><div class=dropBlock><a href=# data-db-target-for=loginBarDB2 data-db-switch=none data-id=global-header-access><i class=icon-person_outline></i><i class="icon-close sf-hidden"></i><span class="d-none d-sm-block sign-in">Access/Profile</span><span class="d-sm-none sign-in sf-hidden">Access</span></a><div data-db-target-of=loginBarDB2 class=dropBlock__holder><ul><li><a href="https://journals.sagepub.com/action/showLogin?uri=%2Fdoi%2F10.1345%2Faph.1R501%3Furl_ver%3DZ39.88-2003%26rfr_id%3Dori%253Arid%253Acrossref.org%26rfr_dat%3Dcr_pub%2B%2B0pubmed" data-id=global-header-access-view-access>View access options</a><li><a href="https://journals.sagepub.com/action/showLogin?uri=%2Fdoi%2F10.1345%2Faph.1R501%3Furl_ver%3DZ39.88-2003%26rfr_id%3Dori%253Arid%253Acrossref.org%26rfr_dat%3Dcr_pub%2B%2B0pubmed" data-id=global-header-access-view-profile>View profile</a><li><a href=https://journals.sagepub.com/action/registration data-id=global-header-access-create>Create profile</a></ul><div class="institution__holder hidden-lg sf-hidden"></div></div></div></div>
<li class=cart-wrapper>
<div data-widget-def=eCommerceCartIndicatorWidget data-widget-id=05e0aa7c-df3d-4312-a5f7-7f9e528398ef class=eCommerceCartIndicatorWidget>
<div class=eCommerceCartIndicatorWidget>
<a href="https://journals.sagepub.com/action/showCart?FlowID=1&amp;alt=Empty+cart&amp;aria-label=Shopping+Cart" id=cartLabel alt="Empty cart" class=quick-menu__item aria-label="Shopping Cart">
<div class=cartLabel title>
<i aria-hidden=true class=icon-shopping_cart></i>
<span class=cart__title>Cart</span>
<span class="filter-count filter-count-bubble shopping-cart hidden sf-hidden" data-id=cart-size>0</span>
</div>
</a>
</div>
</div>
</ul></div></div></div><div class=header--second-row><div class=generic-menu>
<div data-mv="The main menu" class=main-nav><a href=#main1 data-target=main1 data-toggle=nav class="main-nav__toggle__controller sf-hidden"></a><nav role=navigation id=main1 data-ctrl-res=screen-md aria-label="Browse and Info" class="drawer__nav hidden-md hidden-sm hidden-xs"><ul id=menubar role=menubar class="menubar rlist--inline"><li role=menuitem tabindex=-1 aria-haspopup=true aria-label="Browse by discipline" id=menu-item-main1-0 class=menu-parent><button type=button id=main1-1 data-id=global-header-browse-menu data-toggle=modal data-target=#main1-modal-1 data-backdrop=false class=dropdown-toggle><span>Browse by discipline</span><i aria-hidden=true class="icon-arrow_down pull-right"></i></button><div class=ux-modal-container><div id=main1-modal-1 aria-hidden=true style=display:none tabindex=-1 class=modal><div aria-label="Journal Categories" class="modal-dialog modal__dialog menu-item"><div class=modal__body>
<div class=journals-categories><div class=journals-categories__disciplines><div id=selectDiscipline class=journals-categories__text><span class=journals-categories__label>Select discipline:</span></div><div aria-describedby=selectDiscipline class="dropdown dropdown-selectable dropdown-selectable--form-control"><button id=disciplinesDropdownBtn type=button data-toggle=dropdown aria-describedby=selectDiscipline aria-haspopup=true aria-expanded=false data-id=global-header-select-discipline class="btn dropdown-toggle"><span> All disciplines</span><i aria-hidden=true class=icon-arrow_down></i></button><div aria-labelledby=disciplinesDropdownBtn class="dropdown-menu sf-hidden"></div></div></div><div class=journals-categories__subjects><div id=selectSubject class=journals-categories__text><span class=journals-categories__label>Select subject:</span></div><div aria-describedby=selectSubject class="dropdown dropdown-selectable dropdown-selectable--form-control"><button id=subjectsDropdownBtn type=button data-toggle=dropdown aria-describedby=selectSubject aria-haspopup=true aria-expanded=false data-id=global-header-select-subject class="btn dropdown-toggle" disabled aria-disabled=true><span> All subjects</span><i aria-hidden=true class=icon-arrow_down></i></button><div aria-labelledby=subjectsDropdownBtn class="dropdown-menu sf-hidden"></div></div></div><button name=submit type=button role=button data-id=global-header-browse-journals class="btn btn-secondary journals-categories__btn">BROWSE JOURNALS</button></div>
<div class=alternative>
<p class=alternative__title>Alternatively, you can explore our Disciplines Hubs, including:</p>
<ul class=alternative__list>
<li data-id=listItem class=alternative__item><p>Journal portfolios in each of our subject areas.</p></li>
<li data-id=listItem class=alternative__item><p>Links to Books and Digital Library content from across SAGE.</p>
</ul>
<a href=https://journals.sagepub.com/disciplines role=link data-id=global-header-browse-discipline-hubs class="btn btn-outline-secondary alternative__link">VIEW DISCIPLINE HUBS</a></div>
</div><button type=button data-dismiss=modal aria-label=Close class="modal__close sr-only-focusable"><i class="icon icon-close"></i></button></div></div></div><li role=menuitem tabindex=-1 aria-haspopup=true aria-label="Information for" id=menu-item-main1-1 class="dropdown menu-parent"><button type=button id=main1-2 data-id=global-header-info-menu data-toggle=dropdown aria-haspopup=true aria-expanded=false class=dropdown-toggle><span>Information for</span><i aria-hidden=true class="icon-arrow_down pull-right"></i></button><div aria-labelledby=main1-2 role=list class="dropdown-menu sf-hidden"></div></li>
<li role=menuitem aria-haspopup=true aria-label="In this journal" id=menu-item-extra class="menu-parent dropdown show d-lg-none sf-hidden"></li>
</ul><div class=main-nav__right-menu></div></nav></div>
</div></div></div></header>
<main class=content>
<div data-widget-def=UX3Banner data-widget-id=c9ae5b6e-d03a-4615-80b8-2dfab86523c4 class=banner-widget--article-page>
<section aria-label style=background-image:url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wCEAAUFBQUFBQUGBgUICAcICAsKCQkKCxEMDQwNDBEaEBMQEBMQGhcbFhUWGxcpIBwcICkvJyUnLzkzMzlHREddXX0BBQUFBQUFBQYGBQgIBwgICwoJCQoLEQwNDA0MERoQExAQExAaFxsWFRYbFykgHBwgKS8nJScvOTMzOUdER11dff/CABEIAKoGQAMBIgACEQEDEQH/xAA1AAEAAQUBAQAAAAAAAAAAAAAAAgMEBQYHAQgBAQADAQEBAQAAAAAAAAAAAAABAgMFBAYH/9oADAMBAAIQAxAAAAD62AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA13Yi/KbXrmpT1NQxOYw09HFoa3b2Z3VsTC3qCdeX2d5Z7RTssiUxK+s64UxMPbnJTpZX8jd0jm/R6N0l5LLH317ESl5KI6NeQvK8anVnVjOFSclN7DigAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAWfHO38knp8Mts3itfr6ImQOX2d5Z7wA8qX8MRWz3icSuLY9A6RzfpFK7rLyWWPsvJQ9nK6inQsnzPZ68zaZ060ePz2XqN2DjgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAOR9c5BPQ5NCEdPr7eyydObY5XoTbl9neQ2i3vbyqtGQslEmVpZ4pnfVcVcKXvSeZ9NpO7e06GOVzVsKxf1bOpFLypaVFMruHPqzDrfvOd0rzujiOCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA472Ljc9DkMYQ1+xnCMEzp+QTp+P33GaW1Vc215Ao69nddZAzPdrhrfYJZ3K3lW58rWFb2tFfKk60UsKlrKbXtSzqxW7rWc1fpgU+JAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAcY7Pxa3R45CMNfspwhElGMJmcIQTLD5OKdXhs2Juwuu7Fi5ysc/uGzUrreSs4xtf7BqG2xTNyqSz8tvKOIm2yVsTlGev+xhO91Us6sReVbKqp9TDP4YAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABpe6GnyFg/tHjOv0vEoVrO/bnCEUyjGKZRjCU57R0evm0Pzp06ePiFLqHM7e7Bwl0q19L6Nt1jn4MEyFKJw2qbXr1vR7uOyZmvj0jWOs4xHOPcrib+6pVtpQ+tBl8EAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABheBfS6fb8Kw+tvnXX6jUYZHtVvRyzqHTtay5GBnH2NKk/KkVeVKimWwPWfXM5Bjt40l1bGtms+nA5arQYRozophTlTaQwuYpzpoNr0LX7e36UGfxAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADz0ab75aurca7l8C9OMo4nDX6ea2LTdwil9WsL2PL0+6tbqPnXKuq8Yn3XuU4pss9vfqVvVjywpSpLxpTpLxpztJ0nj8Drs+v7FFPiQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAANDsvbGe7c6pndaevXIVad+jebvpfUK+HEZvKVK83ZK1Kq47jHZ+K26PNvKcL/WXO1aTGKde85XuNfFnqeJ0eZ2fULSFvfVjShbX7VGH54AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABi9G6aenjOt9i5lbuaXn902tbEZgrzAV2WrSquc4j27hs9LmMaUdfrqkaUU1I0oTNWFKJUjSjM1I0YJ+5R5/zoAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAB57g18nX1DY2lvjNpsFsITeipmLr14wZOE924Nbp8qhGGv2EoxhMyhGBOEIJnCMEzjGB//8QAQxAAAQMCAQcHCQUIAgMAAAAAAQACAwQRBQYQEiExQVETIlJwcXJzByAyNGGBsbLCI0JidIIUJDM1Q4PB0VOEkaLh/9oACAEBAAE/AOqIi6xDJ6nqdJ9PaGTh90qroqqik0J4i3gdoPYVdXWJm5h/VnqaynpG6UsgHAbSVWY1UVF2RfZRnh6Rz4h6/W+PJ8xzSRMk2jXxUkL2e0cfOALiABcqKj3yf+AmtDQA0WGbIr1Cr8f6Qh5gQVKz7CDw2/BNYg1BqaxBvVLLDFOx0csYew7QRdYhkyReSid/acfgVJFJC8skYWOG0EWKxPbD+pSSRxML5HhrRtJVZjpN2Uo/uEfAJ8j5Xl73lzjtJ8zEPX63x5PmPmSU7X6xqKfG5h5wzxUj32Lua1RxMiFmt8zIr1Ks8b6cwQQzBUrf3an8NvwQagxBqDVbqnrKClrmaE8QPB2xw7CsuqaTAP2MxDlhKJND8Ojbaqmqnqn6U0hPAbh52Iev1vjyfMfNIBFiEMPkl1xbPao6VsB1i7uJ87In1Ks8b6c4zBNa55s0XWHTQT08TWSAuYxocN4sEGoNVlZW6qPKj6WCdlR9Cmpo5bm1ncQpYJItouOI83EPX67x5PmPmMY+Q2aLqKka2xfrPDchuT42SCzgpKZzdbecPNyJ9SrPH+nOEAmR8U0hosAo5XRuD2PLXDYRqKocfI0WVQuP+QbfeFFLFOwPieHNO8KyA6qfKkbOwPsqPoRciVLTtOtmo8NycxzDZwz4h6/W+PJ8xzAEkAC6ioybGQ2HBNa1gs0WGYZ6r9nYLyO0TuttKZKx+w6+GfIj1Gs8f6UEEZWNNtqY8HWCg5ByBTXqlrailfpwylp3jce0Kgx6nnsyoAifx+6UCCLjYeqnyqmzsD7Kj6ESiUSnWcLEXCfDb0VZYh6/XePJ8xUVNJJrPNCjhZEOaNfHzXPaxpc5wAG8qfEtrYR+opznPJc5xJO85mTkanawmva8XBWRHqNZ4/0p0jWbSnSvf7Ag1NBCaSg5ByDkHWQeqHFqqiIDX6UfQds93BUOLUldZodoSdB3+OPVR5V/SwLsqPoRKLkSiUXJ1nKuweSGonqQ3lGve59x925vs86eQwxPeACQpZpZnXe6/Abh5tLT1NTK2Omic+Q7mrJnD6vDaCVkr2GR8mkQ3dqQab60AmtTWprVoAoGxIQeg5Apr01/VR5WTZ2A9lR9CJRKLkSrouRKqsOgqLuaNB/EbD2hVFJNTGz26ukNnmVnq0vYPMALiGgXJ1ABYZktPUaMla4wx9Aemf8ASo6WjoYhFTQtY3fbae0qis5j+8tAFckQmtTWprU1qcee7tKDk1yDkHIO6qPK36WA9lT9CJRKJRciUSiUSnEOBBAIKqMNY67oTononYnxvidovaQc1Z6tL2DPhWTtfiei8N5GD/leNvdG9UWF0WGOcImaUgJBkdrcuU9q5RYPz4ZT+NBqDVJzGF1tiieyTYdfBNagAE82kf3ig5ByDkHoO6qPK96WAdlT9CJRciUSiUSi5FyJRcpGMlbovaCFPQuZcxHSHDeq0EU0wVDhtZiMmhTQl3ScdTW9pWF5MUVDoS1Np5hx9Bp9gRlAUkn2kneK5RcosnjpU8/if4QarKsOjTSHs+KbKoK8tsJOcOO9MkZI0Oa64Un8STvHMHIOQcmu6qMsskRlTT0xZVmCoptPkri7Dp2uHb9yxrAcWwGfkq+kdHckMkGtj+65EolEouRciUSrolFyhhnqpWxQROkkdsa0XKo8gIauIuxV5BI1Rxn5iq3J+pwmK0ELXUzNhjFtEe0Iyoy+1SP57+8VprC8GxHF32poeYDZ0rtTAqTAWYTAImzmR7+c9xFhf2BOY5psQg0rFeZQTu7vzBMnTJrkALCcCrptCaYmCP8A93DsWI5OysLpaRxkbtLD6Sc1zHFrmkOG0HVmug5B3VTV0dLXQSU9VTsmheLOY9ocCspfJV/EqcBk/wCpIfkeVWUtXQTyU9XTyQzM9Jj2lpCLkSiVdEouVyTYLCckayt0Zau9PDw/qO925UGGUWGxcnSwBg3u2ud2lAZsVyWo8QDpIf3efi0c13aFieF1+EyaNVCQ0mzZBrY7sKpqSrxCpMNLA6WQk6m/E8AsGyGhh0JsTeJX7RCw8wd471HHHExscbGsY0WDWiwCrPTZ3UQDtRj4LHuZhNWe584WCYBimMkPhi0IL65n6m+7isKydw/CQHNbys++V4+UbkSnFVuH0taPtWWdueNTgq7B6mj0nNHKRdIbR2jOHW6q8ayewjKCn5HEaNstgdB+x7O64LKfyX4vhHKVGG3r6UfdaPtmD2t3o3BINwRtBRKLkXLAMkMZyhc18EPJUt9dRJqZ+npJmSGF5O/s/JAzVBaS6eTbf8I3ZgEEAgFJDFPG+OWNr43CzmuFwVBkXSU2H078JiZEXxMe+PpOIvtU0E1PI6OaNzHjaCM1b6bO7mhp5qh+hFGXFMwKldHo1jGzAkEsIuzUb6+Ks1oDWgBoFgBsATiiUSiUSq3CKapu9g5OTiBqPaFU0VRSOtKzVucNYPVdlNkDgWUoklfF+zVp2VMQsSfxjY5ZTZEY7kw5z6mDlqTdVRAln6uiVheEYljVQIKCkfK/7xHotHFx2BZO+TbD8P0KjFHNq6jaI/6LT9SAaxrWtAAAsANQAWOm8lP3TmDk2xzAIBYf6hReBH8qq6Glro9CoiDhuO8dhWI5M1NNpSUpM0fR++P9qrY90zGBhLrWsBrVJgbyA+qOiOgNvvKZFHCwMjYGtG4JxTiiU4olOKKKka17S1zQQdoKq8Ha676c6J6B2e7quc1r2ua5oc1wIIOsEFMpaPDzLBR0sUEQkfZkbQ1u3gEZEZFjJvJB3TmnqYacXkfY7hvKjxKaeqiazmMLveVHNufqPFNF00Kg9RovAj+XPlvic2EYzRSwRxkSU/2jS30rO4rD8eosSAa13Jzb4nbfdxTyiU4olFEoolEolVddT0g+0fztzBtPVfVutU1HiO+KL0XrF5WMMTnvAAB1lVOLE3bALfjP+AnOc9xc5xJO8qg9cg7y0UwuYdSjla/UdRVD6lR+DH8ufym/zPDvyx+ZC4IIWH5SVVNaOpvNHxPphU1fS1rNOCUO4jeO0JxTiiiiiVPUQ07C+WQMbxKrsee/SZTDQb0ztT5HPJc5xJO0nqvrX2q6rxX/ABRkRkWUVpH0wPBydGRs1jNhovXUw/EtBRwSSu0WMLiqbCmMs6Y6R6I2KmAFPAALARt+Gfym/wAzw78sfmV1pKKeWB4kikcx42FpsVQZTg2jrW/3Wj4hMljmYJI3hzDsINwiUSnua0FziABtJVflDDFdlKBI/pn0R/tVFVPUvL5pC93tRci7qvxB9q2s8Z/xRkRkWOv59P2ORejYrChpYjSgdNU+GudZ0vNbw3qKKOJuixoAzQfwIe434Z/KebYnh35Y/Mi5FyLkSqTEKmhfpQSkcW7WntCoMoqWrtHNaGU8fRPYViON0lDdl+Ul6DTs7TuVditXXk8o+zN0bdTUXIuRci7qvr8IpK8EuGhJ027ffxWI4TW4fdz2acW6Ruz38EXrHH8+n7HIvWFZO4himi/R5GA/1Hjb3RvWGYJQYU0cjHpS75X63f8AzzKf+BD3G/DP5UjbFMN/LH5kXIuRci5FyLkXLSRei5FyLurAgEEEXCxLJimqtKSlIhl6P3D/AKWMZPYxLWU9O2kcCA67z6AHeWE5J0VBoy1NqicdIcxvYPOg1QQ9xufyqm2K4Z+VPzFFyLkXIuRci5FyLkXIuRei7qwc4NBLiABvKZWU8jywSa/bqunMa8EOaCFPhxF3Qn9JTmlpIcCDnhp5ZzzW6t5OxQUUUNiec7ifM8rBtiuGflT85Rci5FyLkXIuRci9FyLlpIu6sMTc7lWt0ja2xFYc5zqZpc4k335sRa3kb2F77c0YvIwe0IAAAAWHm+Vr+bYX+VPzlFFFHMUcxzFHav/EACARAAIBBQEAAwEAAAAAAAAAAAECABARIDFgURIwMkH/2gAIAQIBAT8A5W1BqWoKvrmhuCoyf84EcsN4DWT6xtCOUXYwDe43tGa/NLsY3tAaFvKNrmw4/uJYCfIwEGEgQsTQahbyBpvlwxEVgYWCwuT9YbmrQ1G4VxC8yKGq7oReFYBeAW5oQt5gu+kXef8A/8QAMBEAAgIBAgIJAgYDAAAAAAAAAQIAAxEEIRAxBRIgIjI0QVFgcYIUQlJygbJhscH/2gAIAQMBAT8A+I12PUco2JTrUfAs7p9/SV46yxUZ+QiUqu53PFkDRlKwRUJgULyjcuwzbmFoT8U6Lsf8XVXnKHOR/EBGMDs4JgqUbji3LiTLdO4yV3HtDn4r0X56j7v6ngCeIXi1g9IG943hmIQIRCJbQlnMb+8t07178x7j4p0V5+j7v6nsDjYTnHAAmEYEzCYTMTEI+KdE+fo+7+p7dnMQLAJZshmYF6wjAjnwIhHxSq2yixbK2wy8jNJ0zVbhLwK2/V+UwEEAg5B7FupRNl7xg1VgfJwf8Sq6u3kcH2MsuSod47+0bUvY2BsvtOvK2Va2ZmAAMu1ecisfyZVqSMB9x7xWVxkHMI+LaTX6jSHuNlPVDymk6T0+rwuepZ+lv+TUaunTjvtlv0jnPx12otA8Kb90Q8MxNfYrsLMuMnf1lFtdveRgRH1CjIXcwsz8zAIBEZlOQYl4OzbH4woJAJOSZQuLFi1E+LaXKoIAHpGBj+NvqZ0WobVqrDIKtkS3RYyaz9pnVIOCMGDgolenJ8W3xite6v0E064tWCatwjLk+ke9m5bCN4j9Z0T51Po0xHqSwd5f5j6Z03G4lVDvudhK6kr5Df3+M06qynA8S+xmk1VFjA9cLgbg7S/pADK0j7jGdnJZmJPA8zOifO1/taYmOOPjKL12AzLahWAQTKrWJCnfg9rNkchw6I89X+1v9dnHD//Z) class="banner-widget banner-widget--main-content"><div class="container banner-widget__container"><div class="row banner-widget__content banner-widget__content-main"><div class=col-12>
<h1 class=banner-widget__heading><a class="heading-xs mt-2 mb-2" href=https://journals.sagepub.com/home/AOP>Annals of Pharmacotherapy</a></h1>
</div></div><div class="row banner-widget__box"><div class=col-12>
<div class=journal-menu-banner><div class=journal-menu-banner__title>
<div class=society-logos-widget></div>
<div class=impact-factor>
<a data-id=view-impact href=https://journals.sagepub.com/metrics/aop class=impact-factor__link>
<span class=impact-factor__text>Impact Factor:<strong> 3.463 </strong></span>
<span class=impact-factor__slash>/</span>
<span class=impact-factor__text> 5-Year Impact Factor:<strong> 3.291 </strong></span>
</a>
</div>
</div><div role=navigation aria-label="journal navigation" class=journal-menu-banner__nav>
<div data-widget-def=UX3journalMddbNavigationMenus data-widget-id=ae075785-d2ea-4ea6-8ffb-f9f692dcad74>
<div class=mddb-navigation><a href=https://journals.sagepub.com/home/AOP data-id class="mddb-navigation__button btn btn-outline-secondary">JOURNAL HOMEPAGE</a></div>
</div>
<div data-widget-def=UX3journalMddbNavigationMenus data-widget-id=c63110e0-267c-4e84-a05a-40f7127b70d2>
<div class=mddb-navigation><a href=https://journals.sagepub.com/author-instructions/AOP data-id=view-submit-paper class="mddb-navigation__button btn btn-secondary">SUBMIT PAPER</a></div>
</div>
</div></div>
</div></div></div></section>
</div>
<div class=ux-modal-container><div id=emailAlertsModal aria-hidden=true aria-modal=true class=modal><div class=modal__dialog><div class=modal__header><button type=button data-dismiss=modal class=close><i aria-hidden=true class=icon-close></i><span class=sr-only>Close</span></button><h4 class=modal__title>Add email alerts</h4></div><div class=modal__body><p>You are adding the following journal to your email alerts<form id=emailAlertsfrm action=/action/doUpdateAlertSettings method=post class=email-alerts><table class=email-alerts__journals><thead><tr><th><th>New content<tbody><tr><td class=email-alerts__journals--title>Annals of Pharmacotherapy<td class=email-alerts__journals--action><input type=checkbox name=journalCode data-alert-type=new-content-alerts value=aopd></table><button type=submit data-id=create-email-alerts aria-disabled=true disabled class="btn btn-primary">Create email alert</button></form></div></div></div></div>
<span id=skipNavigationTo tabindex=-1 aria-hidden=true></span>
<style>:root{--journal-color:#14797b;--secondary-color:#14797b}[data-design] h2{align-items:center;justify-content:flex-start;gap:1rem;margin-bottom:1rem;font-size:1.25rem;line-height:1.6}@media (min-width:532px){[data-design] h2{font-size:1.25rem;line-height:1.6}}@media (min-width:1024px){[data-design] h2{font-size:1.5rem;line-height:1.5}}.heading-s,[data-design] h3{display:flex;align-items:center;justify-content:flex-start;gap:1rem;margin-bottom:1rem;font-size:1.125rem;line-height:1.55}@media (min-width:532px){.heading-s,[data-design] h3{font-size:1.125rem;line-height:1.55}}@media (min-width:1024px){.heading-s,[data-design] h3{font-size:1.25rem;line-height:1.6}}.heading-xs,[data-design] h4{display:flex;align-items:center;justify-content:flex-start;gap:1rem;margin-bottom:1rem;font-size:1rem;line-height:1.75}@media (min-width:532px){.heading-xs,[data-design] h4{font-size:1rem;line-height:1.75}}@media (min-width:1024px){.heading-xs,[data-design] h4{font-size:1.125rem;line-height:1.55}}@keyframes fadeOut{0%{opacity:1}to{opacity:0}}:root{--btn-access-background:#66a22b;--btn-access-background-hover:#5c9227;--btn-access-border:unset;--btn-access-border-hover:unset;--btn-access-color:#fff;--btn-access-color-hover:#fff;--btn-inverse-background:transparent;--btn-inverse-background-hover:#f0f0f0;--btn-inverse-border:1px solid #ccc;--btn-inverse-border-hover:1px solid #ccc;--btn-inverse-color:inherit;--btn-inverse-color-hover:inherit;--btn-pdf-background:#eb5757;--btn-pdf-background-hover:#e94545;--btn-pdf-border:unset;--btn-pdf-border-hover:unset;--btn-pdf-color:#fff;--btn-pdf-color-hover:#fff;--btn-primary-background:#dd3142;--btn-primary-background-hover:#d62335;--btn-primary-border:unset;--btn-primary-border-hover:unset;--btn-primary-color:#fff;--btn-primary-color-hover:#fff;--btn-secondary-background:#14797b;--btn-secondary-background-hover:#116869;--btn-secondary-border:unset;--btn-secondary-border-hover:unset;--btn-secondary-color:#fff;--btn-secondary-color-hover:#fff;--scroll-padding:14rem auto auto;--highlight-color:#e6f2f2;--link-color:#006acc;--primary:#dd3142;--secondary:#14797b;--secondary-lighten-15:#1fbabd;--secondary-lighten-30:#47dee1;--text-color:#707070}@keyframes blinking{0%{transform:scale(.5);opacity:.7}to{transform:scale(1.5);opacity:0}}@keyframes bounceUp{0%{transform:rotate(180deg) translateY(0)}to{transform:rotate(180deg) translateY(-.25rem)}}@keyframes bounceDown{0%{transform:rotate(0) translateY(0)}to{transform:rotate(0) translateY(.25rem)}}html{scroll-padding:var(--scroll-padding)}article[data-design]{color:#333;font-size:1rem;font-weight:400;line-height:1.75rem;padding-bottom:2rem;margin:3.25rem 0 2rem}article[data-design] [role=paragraph]{margin:0 0 .5em}article[data-design] [role=paragraph]:last-child{margin-bottom:0}@media (max-width:767px){article[data-design]{font-size:1rem}article[data-design] a{word-break:break-word}}article a{color:#006acc}article a:focus-visible{background-color:#e6f2f2;box-shadow:0 0 .063rem .25rem #e6f2f2}article a:hover{color:#006acc;text-decoration:underline}article h2,article h3,article h4{color:#000}article h2{font-weight:400}article h3{font-weight:400}article img{height:auto;max-width:100%;vertical-align:middle}body{background:#fff}[data-extent=frontmatter] .core-container>[property=name]{color:#555}[data-extent=frontmatter] .core-container h1[property=name]{font-size:1.25rem;font-weight:600;line-height:2rem;margin:.5rem 0 1rem;padding:0}header[data-extent=frontmatter]{position:relative}@media (max-width:1255px){header[data-extent=frontmatter] .core-container{max-width:none}header[data-extent=frontmatter] .core-container>.core-self-citation{margin-left:unset;padding-left:0!important}}[data-extent=backmatter]{line-height:1.5rem}@media (max-width:1255px){[data-extent=article-wrapper],[data-extent=backmatter]{padding-left:1rem;padding-right:1rem}}[role~=doc-bibliography] [role~=list] [role~=listitem],[role~=doc-footnote]{padding:1rem 0}[role~=doc-bibliography] [role~=list] [role~=listitem]~[role~=doc-biblioentry],[role~=doc-footnote]~[role~=doc-footnote]{margin:0;border-top:.063rem solid #ccc}[role~=doc-footnote][data-has~=label]{align-items:flex-start;display:flex}[role~=doc-footnote] .label{align-items:center;flex-shrink:0;justify-content:center}[role~=doc-footnote]>.label{color:#14797b;display:inline-block;font-size:inherit;font-weight:400;line-height:1.5rem;margin-right:.25rem;margin-top:-3px;min-width:1.5rem;padding:0;text-align:center;background:0 0;border-radius:50%}#abstracts{margin:0 auto;max-width:1224px}#abstracts+[data-extent=bodymatter]{padding-top:0}@media (min-width:768px) and (max-width:1079px){#abstracts,[data-extent=article-wrapper],[data-extent=backmatter],[data-extent=bodymatter]{max-width:none}}.after-credits{margin:3rem 0;text-align:center}.after-credits a{color:#006acc}.after-credits a:focus-visible{background-color:#e6f2f2;box-shadow:0 0 .063rem .25rem #e6f2f2}.after-credits a:hover{color:#006acc;text-decoration:underline}.after-credits a{font-size:.875rem;font-weight:400;text-transform:none;text-decoration:none}.after-credits a~a{line-height:1;margin:.4rem 0 .4rem 2rem}.after-credits a~a:before{content:"|";color:#ccc;margin-right:2rem;-webkit-user-select:none;-moz-user-select:none;user-select:none}.after-credits a:focus-within,.after-credits a:hover{text-decoration:none}.after-credits a:focus-within span,.after-credits a:hover span{text-decoration:underline}.core-container{margin:0 auto;max-width:1224px;width:100%}#abstracts .core-container{border-bottom:1px solid #ccc;padding:.5rem 0 2rem}@media (max-width:1023px){[data-has~=right-rail]{display:flex;flex-flow:column}[data-has~=right-rail] [data-extent=backmatter],[data-has~=right-rail] [data-extent=bodymatter],[data-has~=right-rail] [data-extent=frontmatter]:not(nav){padding:0 1.5rem}}@media (min-width:1024px){[data-has~=right-rail]{display:grid;gap:0 1.5rem;grid-template-columns:1fr minmax(320px,808px) minmax(300px,392px) 1fr}[data-has~=right-rail] header[data-extent=frontmatter]{grid-column-start:2;grid-column-end:4}[data-has~=right-rail] [data-core-nav=header]{grid-column-start:1;grid-column-end:5}[data-has~=right-rail]>*{grid-column:2}}@media (min-width:1024px){[data-core-aside=right-rail]{grid-column:3;grid-row-start:3;grid-row-end:8;margin:0 0 0 auto;width:300px}}@media (max-width:1023px){[data-core-aside=right-rail]{order:2;margin:2rem 1.5rem 0}}nav[data-core-nav]{top:0;z-index:1}nav[data-core-nav] a{text-decoration:none}nav[data-core-nav] ul{list-style:none}@media (min-width:769px){nav[data-core-nav=header]{display:block}}.citations{color:#333;font-family:inherit;font-size:inherit;font-weight:400;line-height:1.5rem}[data-extent=backmatter] .citations{width:100%}.citations a{word-break:break-all;color:#006acc}.citations a:not(.to-citation):hover{text-decoration:none}.external-links{align-items:center;display:flex;flex-wrap:wrap;margin-top:.5rem}.external-links .to-citation,.external-links .to-citation__toggle,.external-links a{align-items:center;color:#006acc;display:inline-flex;font-size:.75rem;font-weight:400;line-height:1.55}.external-links .to-citation__toggle [class^=icon-]{color:inherit;font-size:.65em;font-weight:700;margin-right:.6em;transition:color 0s,transform .2s ease-in-out;vertical-align:middle;border-radius:50%;text-align:center}.external-links .to-citation [class^=icon-]:last-child,.external-links .to-citation__toggle [class^=icon-]:last-child,.external-links a [class^=icon-]:last-child{margin-left:.6em;margin-right:0}.external-links .to-citation__toggle span,.external-links .to-citation span{color:#14797b}.external-links .to-citation:focus-visible,.external-links .to-citation:hover,.external-links .to-citation__toggle:focus-visible,.external-links .to-citation__toggle:hover,.external-links a:focus-visible,.external-links a:hover{color:#006acc;text-decoration:none}.external-links .to-citation:focus-visible [class^=icon-],.external-links .to-citation:hover [class^=icon-],.external-links .to-citation__toggle:focus-visible [class^=icon-],.external-links .to-citation__toggle:hover [class^=icon-],.external-links a:focus-visible [class^=icon-],.external-links a:hover [class^=icon-]{border-color:#ccc}.external-links .to-citation:focus-visible span,.external-links .to-citation:hover span,.external-links .to-citation__toggle:focus-visible span,.external-links .to-citation__toggle:hover span,.external-links a:focus-visible span,.external-links a:hover span{text-decoration:none}.external-links .to-citation:focus-visible,.external-links .to-citation:hover,.external-links a:focus-visible,.external-links a:hover{color:#006acc}.external-links a:not(.to-citation):not(.pill__to-original):not(.open-in-viewer):focus-visible,.external-links a:not(.to-citation):not(.pill__to-original):not(.open-in-viewer):hover{text-decoration:none}.external-links>div~div:not(.to-citation__accordion){line-height:1;margin:.4rem 0 .4rem 2rem;align-items:center;display:flex}.external-links>div~div:not(.to-citation__accordion):before{content:"|";color:#ccc;margin-right:2rem;-webkit-user-select:none;-moz-user-select:none;user-select:none}.to-citation__accordion{border-top:none;margin:0;width:100%}.to-citation__toggle .accordion__toggle__title:before{content:attr(data-collapsed-title);font-family:inherit}.to-citation__wrapper .to-citation,.to-citation__wrapper .to-citation__toggle{background:0 0;border:.063rem solid #14797b;border-radius:2px;padding:.625rem 1rem;box-shadow:none;filter:unset;min-height:2rem}.to-citation__wrapper .to-citation__toggle [class^=icon-]{border:none;height:auto;line-height:1;width:auto}[property=email]{font-size:0}[property=email]:before{content:"";display:inline-block;font-size:14.4px;font-size:.9rem}.orcid-id:before,[property=email]:before{font-family:icomoon!important;speak:none;font-style:normal;font-weight:400;font-variant:normal;text-transform:none;line-height:1;-webkit-font-smoothing:antialiased}.contributors{font-size:.875rem;font-weight:500;line-height:1.375rem}.contributors [property=author]{text-decoration:none}.contributors [property=author] a{line-height:1}.contributors [property=author] [property=email]{color:#555}.to-authors-affiliations{font-size:.875rem;font-weight:400;margin-left:.5rem;text-decoration:underline}[data-design] figure{background:inherit}[data-design] figure.table{cursor:default}[data-design] figure.graphic>.table-wrap:last-of-type:not(:last-child)+*,[data-design] figure.graphic>img:last-of-type:not(:last-child)+*,[data-design] figure.table>.table-wrap:last-of-type:not(:last-child)+*,[data-design] figure.table>img:last-of-type:not(:last-child)+*{border-top:1px solid #f0f0f0}[data-design] figure.graphic>.table-wrap:first-of-type:not(:first-child)+*,[data-design] figure.graphic>img:first-of-type:not(:first-child)+*,[data-design] figure.table>.table-wrap:first-of-type:not(:first-child)+*,[data-design] figure.table>img:first-of-type:not(:first-child)+*{border-bottom:1px solid #f0f0f0}[data-design] figure>figcaption{color:#707070;font-size:.875rem;padding:1rem;text-align:left}[data-design] figure .collapsible-wrapper>figcaption:not(:first-child),[data-design] figure>figcaption:not(:first-child){border-top:1px solid #f0f0f0}[data-design] figure .collapsible-wrapper>figcaption:first-child,[data-design] figure>figcaption:first-child{border-bottom:1px solid #f0f0f0}figure{cursor:default!important;margin:0;padding:0}figure table{border-collapse:collapse;border-spacing:0;font-size:.95rem;line-height:1.2;min-width:100%}.fv table:not([data-shading=custom]) tbody:not([data-shading=custom])>tr:nth-child(2n),.fv table:not([data-shading=custom]) thead:not([data-shading=custom]),figure table:not([data-shading=custom]) tbody:not([data-shading=custom])>tr:nth-child(2n),figure table:not([data-shading=custom]) thead:not([data-shading=custom]){background-color:#f0f0f0}.fv table thead tr:first-child td,.fv table thead tr:first-child th,figure table thead tr:first-child td,figure table thead tr:first-child th{border-top:none}figure table td{font-size:inherit;font-weight:400;vertical-align:baseline}figure table tr>td,figure table tr>th{padding:.6rem 1rem}.fv table tr>td:first-child,.fv table tr>th:first-child,figure table tr>td:first-child,figure table tr>th:first-child{border-left:none;padding:.6rem 1rem}.fv table tr>td:last-child,.fv table tr>th:last-child,figure table tr>td:last-child,figure table tr>th:last-child{border-right:none;padding:.6rem 1rem}figure table td[data-xml-align=center],figure table th[data-xml-align=center]{text-align:center}figure table td[data-xml-align=left],figure table th[data-xml-align=left]{text-align:left}figure .table-wrap{overflow:auto}figure .table-wrap+.notes{border-top:1px solid #ccc;padding-top:1em}figure figcaption .heading{font-weight:600}figcaption a{color:#006acc}figcaption a:focus-visible{background-color:#e6f2f2;box-shadow:0 0 .063rem .25rem #e6f2f2}figcaption a:hover{color:#006acc;text-decoration:underline}.figure-wrap{background-color:#fff;border:1px solid #f0f0f0;box-shadow:0 .125rem .25rem rgba(51,51,51,.1);font-size:.8rem;line-height:2;margin:2rem 0;position:relative;overflow:hidden}.figure-wrap .btn.figure-pop-btn{border:none;border-radius:2rem 0 0 2rem;display:flex;font-size:.75rem;padding:.5rem 1rem;position:absolute;right:0;text-transform:uppercase;top:.5rem;transform:translateX(101%);transition:all .3s ease}.figure-wrap .btn.figure-pop-btn [class^=icon-]{font-size:1rem;margin-right:.5rem}.figure-wrap .btn.figure-pop-btn:focus-within,.figure-wrap .btn.figure-pop-btn:hover{background:#14797b;color:#fff}.figure-wrap .figure-pop-btn:focus-within,.figure-wrap:hover .figure-pop-btn{transform:translateX(0)}.figure-wrap .notes{color:#888;font-size:.875rem;line-height:1.5;text-align:left}.figure-wrap .notes{padding:1rem}.figure-wrap .notes [role~=doc-footnote],.figure-wrap .notes [role~=doc-footnote] [role=paragraph]:last-child{margin-bottom:0}.figure-wrap .notes [role~=doc-footnote] .label+[role=paragraph]{margin-top:0}.figure-wrap .notes [role~=doc-footnote]:first-child{padding-top:0}.figure-wrap .notes [role~=doc-footnote]:last-child{padding-bottom:0}table tbody{border-top:1px solid #707070}table td,table th{border:1px solid #ccc;padding:.75rem 1rem}table td:first-child,table th:first-child{padding-left:0}table td:last-child,table th:last-child{padding-right:0}table td:not([align]),table th:not([align]){text-align:unset}.table{width:unset}.meta-panel{align-items:center;display:flex;flex-flow:row wrap;justify-content:space-between}.meta-panel__left-content,.meta-panel__right-content{align-items:center;display:flex;flex-wrap:wrap}.meta-panel__left-content>div{display:flex}.meta-panel{color:#333;font-weight:400;line-height:1rem}.meta-panel,.meta-panel__access{font-size:.875rem}.meta-panel__access--full{color:inherit}.meta-panel__access [class^=icon-]{font-size:1.5rem}.meta-panel__access [class^=icon-]+span{margin-left:.5rem}.meta-panel__left-content{overflow:hidden}.meta-panel__left-content>div{align-items:center;transform:translateX(-2.063rem)}.meta-panel__left-content>div:before{background-color:#ccc;height:12px;height:.75rem;border-radius:50%;content:"";display:inline-block;margin:0 1rem;vertical-align:middle;width:1.008px;width:.063rem}.core-collateral{background:#fff;font-size:1rem;height:100%;max-width:604px;overflow:auto;padding:1.5rem;position:fixed;right:0;top:0;transform:translateX(100%);transition:transform .4s ease;width:100%;z-index:1400}.content-navigation{line-height:1}.content-navigation a{flex:unset;font-weight:inherit;text-transform:inherit}.content-navigation span+i{margin-left:.2em}header[data-extent=frontmatter] .core-self-citation{font-size:.875rem;font-weight:500;line-height:1.25rem;padding-bottom:.5rem;padding-top:.5rem}header[data-extent=frontmatter] .core-self-citation span[property]{color:#888}header[data-extent=frontmatter] .core-self-citation [property=sameAs]{color:#888;text-decoration:underline}.self-citation [property=sameAs]:hover,[data-extent=frontmatter]>header .core-self-citation [property=sameAs]:hover,header[data-extent=frontmatter] .core-self-citation [property=sameAs]:hover{color:#006acc}header[data-extent=frontmatter] .core-self-citation{display:flex;flex-wrap:wrap;overflow:hidden;overflow-y:visible;overflow-x:clip}header[data-extent=frontmatter] .core-self-citation>div{margin:0 0 0 2.063rem;text-indent:-2.063rem;transform:translateX(-2.063rem)}[data-extent=frontmatter]>header .core-self-citation>div:before,header[data-extent=frontmatter] .core-self-citation>div:before{background-color:#ccc;border-radius:50%;content:"";display:inline-block;height:12px;height:.75rem;margin:0 1rem;vertical-align:middle;width:1.008px;width:.063rem}.st-header{box-shadow:none;position:fixed;width:100%;color:#fff;left:0;top:0;z-index:1300;transition:transform .3s ease;transform:translateY(-110%)}@media (max-width:1023px){.st-header{display:none!important}}@media (max-width:767px){.st-header{display:none!important}}.st-header__content{background:#000;display:flex;justify-content:space-between;min-height:56px;padding:0}.st-header__item{align-items:center;display:flex;justify-content:center;padding:0;margin:0 .5rem}.st-header__item [class*=icon-]{font-size:1.25rem}.st-header__item .content-navigation>a,.st-header__item .share-dropblock>a{align-items:center;border-radius:2px;color:inherit;display:flex;height:2rem;justify-content:center;width:2rem}.st-header__item .content-navigation>a:focus-visible,.st-header__item .content-navigation>a:hover,.st-header__item .share-dropblock>a:focus-visible,.st-header__item .share-dropblock>a:hover,.st-header__item>a:focus-visible,.st-header__item>a:hover{background:#333;color:#fff}.st-header__item:empty{display:none}.st-header__current{align-items:flex-start;flex:1 0;flex-flow:column;justify-content:center;min-width:0;padding-left:1rem}.st-header__label{color:#bbb;font-size:.75rem}.st-header__nav{border-left:1px solid #333}.st-header__share .dropdown{align-items:inherit;background:0 0;display:flex;height:100%;position:relative}.st-header__title{display:-webkit-box;font-size:1rem;font-weight:700;overflow:hidden;min-width:0;max-width:100%;-webkit-line-clamp:1;-webkit-box-orient:vertical}.st-header__track{height:8px;background:#333}.st-header__tracker{height:100%;width:0;background:var(--secondary);overflow:hidden}.st-header .content-navigation{align-items:center;border:none;display:flex;height:100%;margin:0;padding:0;justify-content:space-between;font-size:.875rem}.st-header .content-navigation__hint{display:block;line-height:1rem;opacity:0;padding-top:1.25rem;pointer-events:none;position:absolute;right:-.25rem;top:100%;transform:translateY(-25%);z-index:-1}.st-header .content-navigation__hint h6{color:#bbb;font-size:inherit;margin-bottom:.3125rem;margin-top:0}.st-header .content-navigation__hint__content{background:#333;color:#fff;display:block;font-size:.75rem;min-width:300px;padding:1.25rem 1rem;position:relative;text-align:left;text-decoration:none;text-transform:none}.st-header .content-navigation__hint__content:after{content:"";height:16px;height:1rem;width:16px;width:1rem;background:inherit;transform:rotate(45deg);top:-8px;top:-.5rem;z-index:-1;right:24px;right:1.5rem;position:absolute}.st-header .content-navigation a{background:0 0;justify-content:center;margin-left:.5rem;position:relative}.st-header .content-navigation a:focus-visible,.st-header .content-navigation a:hover{background:#fff;background:hsla(0,0%,100%,.35)}.st-header .content-navigation a:focus-visible .content-navigation__hint,.st-header .content-navigation a:hover .content-navigation__hint{transition:transform .4s ease,opacity .4s ease,z-index 0s ease .4s;z-index:5;transform:translateY(0);opacity:1;pointer-events:auto}.st-header .content-navigation span+i{margin:0}.st-header .content-navigation i{font-size:1.25rem}[data-core=tabs] [role=tablist]{border-bottom:1px solid #ccc}[data-core=tabs] [role=tablist] button{background:0 0;border:none;border-radius:0;box-shadow:none;color:#555;cursor:pointer;font-family:Open Sans,sans-serif;font-size:1rem;font-weight:600;line-height:1.75rem;max-height:none;padding:0 0 12px}[data-core=tabs] [role=tablist] button~button{margin-left:3rem}[data-core=tabs] [role=tablist] button.active{color:#14797b;border-bottom-color:#14797b;pointer-events:none}[data-core=tabs] [role=tablist] button:focus-visible,[data-core=tabs] [role=tablist] button:hover{border-bottom-color:#14797b}body:after{background:#000;background:rgba(0,0,0,.3);-webkit-backdrop-filter:blur(6px);backdrop-filter:blur(6px);content:"";height:0;left:0;opacity:0;position:fixed;top:0;transition:opacity .5s,height 0s;width:100vw}.hidden{display:none!important}@-webkit-keyframes loading-icon{0%{-webkit-transform:rotate(0deg);transform:rotate(0deg)}to{-webkit-transform:rotate(1turn);transform:rotate(1turn)}}@keyframes loading-icon{0%{-webkit-transform:rotate(0deg);transform:rotate(0deg)}to{-webkit-transform:rotate(1turn);transform:rotate(1turn)}}body,html{scroll-behavior:smooth}button{font-family:Open Sans,sans-serif}[data-design] h1{max-width:90ch}[data-design] h2{display:block;margin:2rem 0 .5rem}[data-design] h3,[data-design] h4{display:block;margin:1rem 0 .5rem}[data-design] h4{font-weight:600}article[data-design] [role=paragraph]:last-child{margin-bottom:1em}header[data-extent=frontmatter]{z-index:2}[data-extent=bodymatter] .core-container>[role=paragraph]:first-child{margin-top:2rem}#abstracts{width:100%}#abstracts [aria-controls]{position:relative}#abstracts [aria-controls].active:before,#abstracts [aria-controls]:focus-visible:before,#abstracts [aria-controls]:hover:before{background:#14797b;border-radius:100px;bottom:0;content:"";height:3px;left:0;position:absolute;width:100%}#abstracts [role=paragraph]{margin-top:.5em}#abstracts [role=paragraph]:last-child{margin-bottom:0}#abstracts h2{margin-top:1rem}[data-extent=backmatter] [role~=doc-bibliography] [role~=list] [role~=listitem]{display:block}[data-extent=backmatter] [role~=doc-bibliography] [role~=list] [role~=listitem] .citation,[data-extent=backmatter] [role~=doc-bibliography] [role~=list] [role~=listitem] .citation-content,[data-extent=backmatter] [role~=doc-bibliography] [role~=list] [role~=listitem]>div{display:inline}[data-extent=backmatter] [role~=doc-biblioentry]:first-of-type,[data-extent=backmatter] [role~=doc-bibliography] [role~=list] [role~=listitem]:first-of-type,[data-extent=backmatter] [role~=doc-footnote]:first-of-type{padding-top:0}[data-extent=backmatter] [role~=doc-biblioentry]:last-child,[data-extent=backmatter] [role~=doc-bibliography] [role~=list] [role~=listitem]:last-child,[data-extent=backmatter] [role~=doc-footnote]:last-child{padding-bottom:0}.after-credits a span{text-decoration:underline}.external-links .btn-outline-secondary{font-weight:600;min-width:11.5rem;text-transform:uppercase}.external-links .btn-outline-secondary:focus-visible,.external-links .btn-outline-secondary:hover{background-color:#e6f2f2}.external-links .btn-outline-secondary:active span{color:#fff}.external-links a,.external-links button{font-size:.75rem;align-items:center;cursor:pointer;display:inline-flex;text-decoration:none}.external-links button i{margin-left:.4em}.external-links a i:first-child,.external-links button i:first-child{margin-left:0}.external-links a i:last-child,.external-links button i:last-child{margin-right:0}.external-links a:disabled,.external-links a[disabled],.external-links button:disabled,.external-links button[disabled]{cursor:default;opacity:.4;pointer-events:none}.external-links .btn-outline-secondary{color:#14797b;flex:1;justify-content:center}.external-links .btn-outline-secondary:focus,.external-links .btn-outline-secondary:hover{color:#14797b;text-decoration:none}.external-links a:not(.btn-outline-secondary){font-size:14px;font-size:.875rem;text-decoration:underline}.external-links>.to-citation__wrapper+div:not(.to-citation__accordion):before{content:none}@media (max-width:767px){.external-links{align-items:flex-start;flex-direction:column}.external-links .btn-outline-secondary,.external-links .to-citation__wrapper{width:100%}.external-links .to-citation__accordion{order:1;margin-top:.5rem}.external-links>div~div:not(.to-citation__accordion){margin:1rem 0;order:2}.external-links>div~div:not(.to-citation__accordion):before{display:none}}.meta-panel__left-content>div{margin-bottom:.5rem}[data-core-nav=collateral] li{display:flex}[data-core-nav=collateral] ul{padding:0}@media screen and (min-width:1224px){[data-core-nav=collateral]:not(:first-child),[data-core-nav=collateral] li~li{margin-left:1.75rem}}@media screen and (max-width:1223px){.core-collateral{padding:.75rem 1.5rem}}.core-enumeration a{color:#888}#article_collateral_menu{display:flex}@media screen and (max-width:1223px){#article_collateral_menu{display:none}}[data-core-nav=header]{background-color:#fff;border-bottom:1px solid #ccc;border-top:1px solid #ccc;height:2.875rem;position:sticky;width:100%}[data-core-nav=header] a,[data-core-nav=header] button{align-items:center;cursor:pointer;display:inline-flex;text-decoration:none}[data-core-nav=header] a i,[data-core-nav=header] button i{margin-left:.4em}[data-core-nav=header] a i:first-child,[data-core-nav=header] button i:first-child{margin-left:0}[data-core-nav=header] a i:last-child,[data-core-nav=header] button i:last-child{margin-right:0}[data-core-nav=header] a:disabled,[data-core-nav=header] a[disabled],[data-core-nav=header] button:disabled,[data-core-nav=header] button[disabled]{cursor:default;opacity:.4;pointer-events:none}[data-core-nav=header] a,[data-core-nav=header] button{background-color:transparent;border:none;color:#333;font-size:.875rem;line-height:1.5;padding:2px 0}[data-core-nav=header] a i,[data-core-nav=header] button i{font-size:1.5rem;margin-right:.5rem!important}[data-core-nav=header] a:hover,[data-core-nav=header] a i:not(.icon-contents),[data-core-nav=header] button:hover,[data-core-nav=header] button i:not(.icon-contents){color:#dd3142}[data-core-nav=header] a:focus,[data-core-nav=header] button:focus{background-color:transparent}[data-core-nav=header]>ul,[data-core-nav=header] [data-core-nav=collateral]>ul{align-items:center;display:flex;list-style:none;margin:0 auto}[data-core-nav=header] [role=none]{align-items:center;display:flex;position:relative}[data-core-nav=header] [role=none]:nth-of-type(2){justify-content:center}[data-core-nav=header] [role=none]:last-of-type{justify-content:flex-end}[data-core-nav=header] [role=none]+[role=none]{border-left:1px solid #ccc;height:1.375rem;margin-left:1.75rem;padding-left:1.75rem}[data-core-nav=header] .core-nav-wrapper{padding:.5rem 0}[data-core-nav=header] .icon-download:before{content:none}@media screen and (max-width:1223px){[data-core-nav=header] [role=none]{flex:1 0 auto}[data-core-nav=header] [role=none]+[role=none]{margin-left:.75rem;padding-left:.75rem}[data-core-nav=header] .core-container{padding-left:1rem;padding-right:1rem}}@media screen and (min-width:1224px){[data-core-nav=header] [role=none]:last-of-type{border-left:none;padding-left:0}}#article_sections_menu{background-color:#fff;border:1px solid #ccc;font-size:14px;left:0;margin:1rem -.75rem;max-height:80vh;overflow-y:auto;padding:.5rem 0;position:absolute;top:100%;width:320px}</style><article xmlns=http://www.w3.org/1999/xhtml data-design=pill-menubar data-has=right-rail data-type=research-article vocab=http://schema.org/ typeof=ScholarlyArticle lang=en><header data-extent=frontmatter><div class=core-container><div data-article-access=full data-article-access-type=full class=meta-panel><div class=meta-panel__left-content><div class="meta-panel__access meta-panel__access--full"><i aria-hidden=true data-toggle=tooltip data-original-title="Available access" class=icon-lock_open></i><span>Available access</span></div><div class=meta-panel__type><span>Research article</span></div><div class=meta-panel__onlineDate><span>First published online March 2013</span></div></div><div class=meta-panel__right-content></div></div><h1 property=name>Phentermine/Topiramate for the Treatment of Obesity</h1><div class=contributors><span class=authors><span role=list><span property=author typeof=Person role=listitem><a href=#con1><span property=givenName>Steven M</span> <span property=familyName>Smith</span></a></span>, <span property=author typeof=Person role=listitem><a href=#con2><span property=givenName>Melissa</span> <span property=familyName>Meyer</span></a></span>, and <span property=author typeof=Person role=listitem><a href=#con3><span property=givenName>Katy E</span> <span property=familyName>Trinkley</span></a> <a href=mailto:katy.trinkley@ucdenver.edu property=email>katy.trinkley@ucdenver.edu</a></span></span></span><a href=#tab-contributors class=to-authors-affiliations data-id=article-collateral-tab-contributors>View all authors and affiliations</a></div><div class=core-self-citation><div class=core-enumeration><a href=https://journals.sagepub.com/toc/aopd/47/3><span property=isPartOf typeof=PublicationVolume>Volume <span property=volumeNumber>47</span></span>, <span property=isPartOf typeof=PublicationIssue>Issue <span property=issueNumber>3</span></span></a></div><div class=doi><a href=https://doi.org/10.1345/aph.1R501 property=sameAs>https://doi.org/10.1345/aph.1R501</a></div></div></div></header><nav data-core-nav=header data-extent=frontmatter role=navigation aria-label="Article navigation"><ul class="core-nav-wrapper core-container"><li role=none><button data-id=article-toolbar-showhide aria-controls=article_sections_menu aria-expanded=false aria-haspopup=true role=menuitem><i class=icon-contents aria-hidden=true></i>Contents</button><div id=article_sections_menu role=menu aria-label=Contents style=display:none></div><li role=none><a role=menuitem href=https://journals.sagepub.com/doi/reader/10.1345/aph.1R501 data-id=article-toolbar-pdf-epub><i aria-hidden=true class=icon-download><span class=path1></span><span class=path2></span><span class=path3></span></i><span>PDF / ePub</span></a><li role=none><button data-back=collateral data-id=article-toolbar-more class=sf-hidden></button><div id=article_collateral_menu role=menu aria-label=More><div data-core-nav=collateral><ul><li><a href=#core-collateral-self-citation title="Cite article" data-id=article-nav-menubar-citations><i class=icon-cite aria-hidden=true></i>Cite article</a><li><a href=#core-collateral-share title="Share options" data-id=article-toolbar-share><i class=icon-share-alt aria-hidden=true></i>Share options</a><li><a href=#core-collateral-info title="Information, rights and permissions" data-id=article-toolbar-info><i class=icon-info-alt aria-hidden=true></i>Information, rights and permissions</a><li><a href=#core-collateral-metrics title="Metrics and citations" data-id=article-toolbar-metrics><i class=icon-metrics-alt aria-hidden=true></i>Metrics and citations</a><li><a href=#core-collateral-media title="Figures and tables" data-id=article-toolbar-figures><i class=icon-tables-alt aria-hidden=true></i>Figures and tables</a></ul></div></div></ul></nav><aside data-core-aside=right-rail>
<div class=article-aside-grid><div class=article-aside-grid__block-1>
<div class=pb-ad><div id=div-gpt-ad-123456789-1 data-google-query-id=CNPr1d_czvsCFU7zKAUdUM8EMQ><div id=google_ads_iframe_/53867575/health_sciences//pharmacology_toxicology//AOP//300x250_Top_0__container__ style="border:0pt none"></div></div>
</div>
</div><div class=article-aside-grid__block-2>
<div data-widget-def=UX3AccordionWidget data-widget-id=30df8f25-1de2-4c31-9863-b69f6e489c61 class=rhs__container>
<div class=accordion><ul class="accordion-tabbed rlist"><li class="accordion-tabbed__tab js--open"><a href=# title="Related content" aria-expanded=true aria-controls=30df8f25-1de2-4c31-9863-b69f6e489c610 class=accordion-tabbed__control>Related content<i aria-hidden=true class=icon-arrow_down></i></a><div id=30df8f25-1de2-4c31-9863-b69f6e489c610 class=accordion-tabbed__content>
<div class="sage-special-collections temis-related"><h3 class=sage-special-collections__title>Similar articles:</h3><ul class="rlist temis-related__list"><li><div class="teaser teaser--collection"><div class=teaser__meta><div class=teaser__access-icon><svg viewBox="0 0 32 32" xmlns=http://www.w3.org/2000/svg role=img><g fill=none fill-rule=evenodd><g fill=#00A87E><path d="M25.667 13.333a1 1 0 0 1 1 1v14a1 1 0 0 1-1 1H6.333a1 1 0 0 1-1-1v-14a1 1 0 0 1 1-1h19.334zM16 16.821a2.462 2.462 0 0 0-.82 4.783v3.422a.82.82 0 1 0 1.64 0l.001-3.423A2.463 2.463 0 0 0 16 16.821z"></path><path d="M16 4c3.754 0 6.898 2.059 7.07 5.018l.007.256v4.06H20.41v-4.06c0-1.353-1.851-2.607-4.41-2.607-2.464 0-4.272 1.163-4.403 2.457l-.007.15v1.393H8.923V9.274C8.923 6.178 12.14 4 16 4z"></path></g></g></svg>
</div><div class=teaser__meta__row><span>Available access</span></div></div><div class=teaser__content><div><div class=teaser__title><a href="https://journals.sagepub.com/doi/10.1345/aph.1R779?icid=int.sj-full-text.similar-articles.1" data-id=click-article-title class=teaser__title__link>New Obesity Agents: Lorcaserin and Phentermine/Topiramate</a></div><div class=teaser__collapsible-details><button type=button data-toggle=collapse data-target=#collapse523 aria-expanded=true aria-controls=collapse523 class="btn btn--collapse collapsed"><span class=whenCollapsed>Show details</span><span class="whenOpened sf-hidden"> Hide details</span><i aria-hidden=true class=icon-arrow_down></i></button><div id=collapse523 class="collapse sf-hidden"></div></div></div></div></div><li><div class="teaser teaser--collection"><div class=teaser__meta><div class=teaser__access-icon><svg viewBox="0 0 32 32" xmlns=http://www.w3.org/2000/svg role=img><g fill=none fill-rule=evenodd><g fill=#00A87E><path d="M25.667 13.333a1 1 0 0 1 1 1v14a1 1 0 0 1-1 1H6.333a1 1 0 0 1-1-1v-14a1 1 0 0 1 1-1h19.334zM16 16.821a2.462 2.462 0 0 0-.82 4.783v3.422a.82.82 0 1 0 1.64 0l.001-3.423A2.463 2.463 0 0 0 16 16.821z"></path><path d="M16 4c3.754 0 6.898 2.059 7.07 5.018l.007.256v4.06H20.41v-4.06c0-1.353-1.851-2.607-4.41-2.607-2.464 0-4.272 1.163-4.403 2.457l-.007.15v1.393H8.923V9.274C8.923 6.178 12.14 4 16 4z"></path></g></g></svg>
</div><div class=teaser__meta__row><span>Available access</span></div></div><div class=teaser__content><div><div class=teaser__title><a href="https://journals.sagepub.com/doi/10.1177/1060028013513557?icid=int.sj-full-text.similar-articles.2" data-id=click-article-title class=teaser__title__link>Lorcaserin and Phentermine/Topiramate: Two Leaps Forward in Weight Loss Pharmacotherapy</a></div><div class=teaser__collapsible-details><button type=button data-toggle=collapse data-target=#collapse900 aria-expanded=true aria-controls=collapse900 class="btn btn--collapse collapsed"><span class=whenCollapsed>Show details</span><span class="whenOpened sf-hidden"> Hide details</span><i aria-hidden=true class=icon-arrow_down></i></button><div id=collapse900 class="collapse sf-hidden"></div></div></div></div></div><li><div class="teaser teaser--collection"><div class=teaser__meta><div class=teaser__access-icon><svg viewBox="0 0 32 32" xmlns=http://www.w3.org/2000/svg role=img><g fill=none fill-rule=evenodd><g fill=#00A87E><path d="M25.667 13.333a1 1 0 0 1 1 1v14a1 1 0 0 1-1 1H6.333a1 1 0 0 1-1-1v-14a1 1 0 0 1 1-1h19.334zM16 16.821a2.462 2.462 0 0 0-.82 4.783v3.422a.82.82 0 1 0 1.64 0l.001-3.423A2.463 2.463 0 0 0 16 16.821z"></path><path d="M16 4c3.754 0 6.898 2.059 7.07 5.018l.007.256v4.06H20.41v-4.06c0-1.353-1.851-2.607-4.41-2.607-2.464 0-4.272 1.163-4.403 2.457l-.007.15v1.393H8.923V9.274C8.923 6.178 12.14 4 16 4z"></path></g></g></svg>
</div><div class=teaser__meta__row><span>Available access</span></div></div><div class=teaser__content><div><div class=teaser__title><a href="https://journals.sagepub.com/doi/10.1177/1060028015586806?icid=int.sj-full-text.similar-articles.3" data-id=click-article-title class=teaser__title__link>Liraglutide: An Injectable Option for the Management of Obesity</a></div><div class=teaser__collapsible-details><button type=button data-toggle=collapse data-target=#collapse84 aria-expanded=true aria-controls=collapse84 class="btn btn--collapse collapsed"><span class=whenCollapsed>Show details</span><span class="whenOpened sf-hidden"> Hide details</span><i aria-hidden=true class=icon-arrow_down></i></button><div id=collapse84 class="collapse sf-hidden"></div></div></div></div></div><li class="d-none sf-hidden"><li class="d-none sf-hidden"><li class="d-none sf-hidden"><li class="d-none sf-hidden"><li class="d-none sf-hidden"><li class="d-none sf-hidden"></ul><div class=sage-special-collections__view-more><button class="btn btn-link">View more</button></div></div>
<div class="sage-special-collections temis-related"><h3 class=sage-special-collections__title>SAGE recommends:</h3><ul class="rlist temis-related__list"><li><div class="teaser teaser--collection teaser--collection-external"><div class=teaser__meta><div class=teaser__meta__row><strong>SAGE Knowledge</strong></div><div class=teaser__meta__row><span>Case </span></div></div><div class=teaser__content><div><div class=teaser__title><a href=http://dx.doi.org/10.4135/9781526430717 data-id=click-article-title rel=noopener target=_blank class=teaser__title__link>Orexigen: Valuing Contrave</a></div><div class=teaser__collapsible-details><button type=button data-toggle=collapse data-target=#collapse841 aria-expanded=true aria-controls=collapse841 class="btn btn--collapse collapsed"><span class=whenCollapsed>Show details</span><span class="whenOpened sf-hidden"> Hide details</span><i aria-hidden=true class=icon-arrow_down></i></button><div id=collapse841 class="collapse sf-hidden"></div></div></div></div></div><li><div class="teaser teaser--collection teaser--collection-external"><div class=teaser__meta><div class=teaser__meta__row><strong>SAGE Knowledge</strong></div><div class=teaser__meta__row><span>Entry </span></div></div><div class=teaser__content><div><div class=teaser__title><a href=http://dx.doi.org/10.4135/9781483349985.n60 data-id=click-article-title rel=noopener target=_blank class=teaser__title__link>Appetite Depressants And Stimulants</a></div><div class=teaser__collapsible-details><button type=button data-toggle=collapse data-target=#collapse668 aria-expanded=true aria-controls=collapse668 class="btn btn--collapse collapsed"><span class=whenCollapsed>Show details</span><span class="whenOpened sf-hidden"> Hide details</span><i aria-hidden=true class=icon-arrow_down></i></button><div id=collapse668 class="collapse sf-hidden"></div></div></div></div></div><li><div class="teaser teaser--collection teaser--collection-external"><div class=teaser__meta><div class=teaser__meta__row><strong>SAGE Knowledge</strong></div><div class=teaser__meta__row><span>Book chapter </span></div></div><div class=teaser__content><div><div class=teaser__title><a href=http://dx.doi.org/10.4135/9781412976770.n8 data-id=click-article-title rel=noopener target=_blank class=teaser__title__link>Obesity and Body Image Disturbance</a></div><div class=teaser__collapsible-details><button type=button data-toggle=collapse data-target=#collapse29 aria-expanded=true aria-controls=collapse29 class="btn btn--collapse collapsed"><span class=whenCollapsed>Show details</span><span class="whenOpened sf-hidden"> Hide details</span><i aria-hidden=true class=icon-arrow_down></i></button><div id=collapse29 class="collapse sf-hidden"></div></div></div></div></div><li class="d-none sf-hidden"><li class="d-none sf-hidden"><li class="d-none sf-hidden"><li class="d-none sf-hidden"><li class="d-none sf-hidden"><li class="d-none sf-hidden"></ul><div class=sage-special-collections__view-more><button class="btn btn-link">View more</button></div></div>
</div></ul></div>
</div>
</div><div class=article-aside-grid__block-3>
<div class=pb-ad><div id=div-gpt-ad-123456789-2 data-google-query-id=CPjB1d_czvsCFXYJigMdQKUHdA><div id=google_ads_iframe_/53867575/health_sciences//pharmacology_toxicology//AOP//300x250_bottom_0__container__ style="border:0pt none"></div></div>
</div>
</div></div>
</aside><section id=abstracts data-extent=frontmatter><div class=core-container data-core-tabs=default data-core=tabs><div role=tablist><button aria-controls=abstract role=tab aria-selected=true class=active>Abstract</button><button aria-controls=abstract-es role=tab tabindex=-1 aria-selected=false data-id=article-translated-abstract>Resumen</button><button aria-controls=abstract-fr role=tab tabindex=-1 aria-selected=false data-id=article-translated-abstract>Résumé</button></div><h2>Abstract</h2><section id=abstract property=abstract typeof=Text role=tabpanel tabindex=0><h3 property=name data-core=tabHeader class=sf-hidden>Abstract</h3><section id=abs-sec-1><h4>OBJECTIVE</h4><div role=paragraph>To review the pharmacology, efficacy, and safety of phentermine/topiramate (PHEN/TPM) in the management of obese patients.</div></section><section id=abs-sec-2><h4>DATA SOURCES</h4><div role=paragraph>MEDLINE (1966-July 2012) was searched using the terms weight loss, obesity, phentermine and topiramate, phentermine, topiramate, Qnexa, Qsymia, and VI-0521. Additionally, the new drug application and prescribing information for PHEN/TPM were retrieved.</div></section><section id=abs-sec-3><h4>STUDY SELECTION/DATA EXTRACTION</h4><div role=paragraph>All studies considering the pharmacology, efficacy, and safety of PHEN/TPM were reviewed with a focus on efficacy and safety data from Phase 3 trials.</div></section><section id=abs-sec-4><h4>DATA SYNTHESIS</h4><div role=paragraph>In 3 Phase 3 trials (EQUIP, CONQUER, and SEQUEL), treatment with PHEN/TPM consistently demonstrated statistically significant weight loss compared with placebo. After 56 weeks of treatment, percent weight loss achieved with PHEN/TPM was 10.6%, 8.4%, and 5.1% with 15/92 mg, 7.5/46 mg, and 3.75/23 mg, respectively (p &lt; 0.0001). The 52-week extension study (SEQUEL) showed maintained weight loss over 2 years with 9.3% and 10.5% weight loss from baseline for 7.5/46 mg and 15/92 mg PHEN/TPM (p &lt; 0.0001). A significantly higher proportion of patients achieved greater than 5%, 10%, or 15% weight loss with PHEN/TPM compared with placebo. Significant reductions in waist circumference, fasting triglycerides, and fasting glucoses were also attributable to PHEN/TPM. The drug was generally well tolerated in clinical trials. Adverse reactions occurring in 5% or more of study subjects included paresthesia, dizziness, dysgeusia, insomnia, constipation, and dry mouth.</div></section><section id=abs-sec-5><h4>CONCLUSIONS</h4><div role=paragraph>PHEN/TPM is a new, once-daily, controlled-release, combination weight-loss product approved as an adjunct to diet and exercise for chronic weight management of obese or overweight patients with weight-related comorbidities. PHEN/TPM is modestly effective and a viable option for patients interested in losing weight, although long-term safety data are lacking.</div></section></section><section id=abstract-es property=abstract typeof=Text role=tabpanel tabindex=-1 class=sf-hidden lang=es></section><section id=abstract-fr property=abstract typeof=Text role=tabpanel tabindex=-1 class=sf-hidden lang=fr></section></div></section><section id=bodymatter data-extent=bodymatter property=articleBody typeof=Text><div class=core-container><div role=paragraph>The current obesity epidemic affects more than 30% of adults and 17% of children and adolescents across the US, representing a major public health threat.<sup><a href=#bibr1-aph-1R501 role=doc-biblioref data-xml-rid=bibr1-aph-1R501 id=body-ref-bibr1-aph-1R501-1 href-manipulated=true>1</a>,<a href=#bibr2-aph-1R501 role=doc-biblioref data-xml-rid=bibr2-aph-1R501 id=body-ref-bibr2-aph-1R501-1 href-manipulated=true>2</a></sup> Additionally, 1 in 20 Americans has a body mass index (BMI) greater than 40 kg/m<sup>2</sup> and is thus classified as extremely obese.<sup><a href=#bibr3-aph-1R501 role=doc-biblioref data-xml-rid=bibr3-aph-1R501 id=body-ref-bibr3-aph-1R501-1 href-manipulated=true>3</a>,<a href=#bibr4-aph-1R501 role=doc-biblioref data-xml-rid=bibr4-aph-1R501 id=body-ref-bibr4-aph-1R501-1 href-manipulated=true>4</a></sup> Although some data suggest that the population prevalence of obesity may be slowing,<sup><a href=#bibr1-aph-1R501 role=doc-biblioref data-xml-rid=bibr1-aph-1R501 id=body-ref-bibr1-aph-1R501-2 href-manipulated=true>1</a></sup> obesity remains one of the major causes of preventable death worldwide. Although the prevalence is similar for men and women, adults older than 60 years of age are more likely to be obese than are younger adults, and non-Hispanic whites have the lowest rate of obesity compared with other races and ethnicities.<sup><a href=#bibr4-aph-1R501 role=doc-biblioref data-xml-rid=bibr4-aph-1R501 id=body-ref-bibr4-aph-1R501-2 href-manipulated=true>4</a></sup></div><div role=paragraph>Despite the obesity epidemic, few long-term pharmacologic options are available for weight loss. Orlistat is the only product available in the US without restrictions on duration of therapy, but intolerable gastrointestinal adverse effects and reports of severe liver injury may limit its use.<sup><a href=#bibr5-aph-1R501 role=doc-biblioref data-xml-rid=bibr5-aph-1R501 id=body-ref-bibr5-aph-1R501-1 href-manipulated=true>5</a>,<a href=#bibr6-aph-1R501 role=doc-biblioref data-xml-rid=bibr6-aph-1R501 id=body-ref-bibr6-aph-1R501 href-manipulated=true>6</a></sup> Other prescription weight loss medications, including phentermine monotherapy, are Food and Drug Administration (FDA)–labeled for short-term use as monotherapy for obesity.<sup><a href=#bibr7-aph-1R501 role=doc-biblioref data-xml-rid=bibr7-aph-1R501 id=body-ref-bibr7-aph-1R501-1 href-manipulated=true>7</a></sup></div><div role=paragraph>Current pharmacologic options rarely achieve the initial treatment goal for obesity—a 10% reduction in weight over 6 months of therapy<sup><a href=#bibr3-aph-1R501 role=doc-biblioref data-xml-rid=bibr3-aph-1R501 id=body-ref-bibr3-aph-1R501-2 href-manipulated=true>3</a></sup> and, of the available agents, phentermine can cause rebound weight gain.<sup><a href=#bibr8-aph-1R501 role=doc-biblioref data-xml-rid=bibr8-aph-1R501 id=body-ref-bibr8-aph-1R501 href-manipulated=true>8</a></sup> Consequently, newer weight loss medications target 2 areas: initial treatment goals and maintenance of weight loss.<sup><a href=#bibr5-aph-1R501 role=doc-biblioref data-xml-rid=bibr5-aph-1R501 id=body-ref-bibr5-aph-1R501-2 href-manipulated=true>5</a></sup> Two weight loss therapies recently approved by the FDA include lorcaserin, a selective 5-HT<sub>2c</sub> agonist, and combination phentermine/topiramate (PHEN/TPM). FDA-approved on July 17, 2012, PHEN/TPM is a once-daily therapy combining low doses of phentermine and topiramate to promote weight loss while ostensibly reducing the risk of significant adverse effects when used at higher doses. PHEN/TPM is marketed in the US under the trade name Qsymia (VIVUS Inc.).<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-1 href-manipulated=true>9</a></sup> PHEN/TPM is approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult (≥18 years) obese patients (BMI ≥30 kg/m<sup>2</sup>) and overweight patients (BMI ≥27 kg/m<sup>2</sup>) with at least one weight-related comorbidity, including hypertension, type 2 diabetes, or dyslipidemia.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-2 href-manipulated=true>9</a></sup> The purpose of this review is to describe the pharmacology, efficacy, and safety of PHEN/TPM and its role in the management of overweight and obese patients.</div><section id=sec-11><h2>Pharmacology</h2><div role=paragraph>PHEN/TPM is a fixed-dose, controlled-release, combination product containing immediate-release phentermine hydrochloride and extended-release topiramate. As a centrally acting sympathomimetic amine structurally related to amphetamine, phentermine increases norepinephrine release and, to a lesser extent, dopamine release.<sup><a href=#bibr7-aph-1R501 role=doc-biblioref data-xml-rid=bibr7-aph-1R501 id=body-ref-bibr7-aph-1R501-2 href-manipulated=true>7</a></sup> As a result, phentermine works to suppress appetite, decrease food consumption, and increase heart rate secondary to increasing levels of catecholamines.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-3 href-manipulated=true>9</a></sup> Tachyphylaxis and tolerance have been observed with phentermine use; the latter occurs in most patients and usually develops within a few weeks following initiation.<sup><a href=#bibr7-aph-1R501 role=doc-biblioref data-xml-rid=bibr7-aph-1R501 id=body-ref-bibr7-aph-1R501-3 href-manipulated=true>7</a></sup></div><div role=paragraph>The exact mechanism for weight loss with topiramate is unknown.<sup><a href=#bibr5-aph-1R501 role=doc-biblioref data-xml-rid=bibr5-aph-1R501 id=body-ref-bibr5-aph-1R501-3 href-manipulated=true>5</a>,<a href=#bibr10-aph-1R501 role=doc-biblioref data-xml-rid=bibr10-aph-1R501 id=body-ref-bibr10-aph-1R501-1 href-manipulated=true>10</a></sup> As a fructose monosaccharide, topiramate modulates voltage-gated ion channels, augments λ-aminobutyric acid (GABA) neurotransmitter activity at GABA-A receptors, antagonizes the AMPA/kainite subtype of the glutamate receptor, and inhibits carbonic anhydrase isoenzymes II and IV.<sup><a href=#bibr5-aph-1R501 role=doc-biblioref data-xml-rid=bibr5-aph-1R501 id=body-ref-bibr5-aph-1R501-4 href-manipulated=true>5</a>,<a href=#bibr10-aph-1R501 role=doc-biblioref data-xml-rid=bibr10-aph-1R501 id=body-ref-bibr10-aph-1R501-2 href-manipulated=true>10</a></sup> Reduced caloric intake was identified as a significant factor associated with topiramate-induced weight loss in humans.<sup><a href=#bibr11-aph-1R501 role=doc-biblioref data-xml-rid=bibr11-aph-1R501 id=body-ref-bibr11-aph-1R501-1 href-manipulated=true>11</a></sup> However, animal studies suggest increased energy expenditure and decreased energy efficiency as contributors to weight loss with topiramate monotherapy.<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-1 href-manipulated=true>12</a></sup></div></section><section id=sec-12><h2>Pharmacokinetics</h2><div role=paragraph>Clinical pharmacokinetic data for phentermine and topiramate are highlighted in <a href=#table1-aph-1R501>Table 1</a>. Notably, PHEN/TPM is not extensively metabolized by cytochrome P450 isoenzymes, has low plasma protein binding, and is predominantly cleared as unchanged drug in the urine.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-4 href-manipulated=true>9</a></sup> Consequently, PHEN/TPM has minimal drug-drug interactions with a few notable exceptions. Non–potassium-sparing diuretics may potentiate hypokalemia when combined with PHEN/TPM.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-5 href-manipulated=true>9</a></sup> Additionally, PHEN/TPM in combination with oral contraceptives may reduce contraceptive efficacy by decreasing ethinyl estradiol serum concentrations.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-6 href-manipulated=true>9</a></sup></div></section><section id=sec-13><h2>Clinical Trials</h2><div role=paragraph>MEDLINE (1966-July 2012) was searched using the terms weight loss, obesity, phentermine and topiramate, phentermine, topiramate, Qnexa, Qsymia, and VI-0521. Additionally, the new drug application and prescribing information for PHEN/TPM were retrieved. All studies considering the pharmacology, efficacy, and safety of PHEN/TPM were reviewed with a focus on efficacy and safety data from Phase 3 trials.</div><div role=paragraph>FDA-approval of PHEN/TPM for the treatment of obesity was based primarily on 3 clinical trials<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-2 href-manipulated=true>12</a>–<a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-1 href-manipulated=true>14</a></sup>: controlled release phentermine/topiramate in severely obese adults: a randomized, controlled trial (EQUIP)<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-3 href-manipulated=true>12</a></sup>; effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial<sup><a href=#bibr13-aph-1R501 role=doc-biblioref data-xml-rid=bibr13-aph-1R501 id=body-ref-bibr13-aph-1R501-1 href-manipulated=true>13</a></sup>; and two-year sustained weight loss and metabolic benefits with controlled release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, Phase 3 extension study.<sup><a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-2 href-manipulated=true>14</a></sup> These Phase 3 randomized, double-blind, placebo-controlled trials evaluated a combination of 3 fixed-dose formulations of PHEN/TPM in patients with or without various weight-related comorbidities.<sup><a href=#bibr5-aph-1R501 role=doc-biblioref data-xml-rid=bibr5-aph-1R501 id=body-ref-bibr5-aph-1R501-5 href-manipulated=true>5</a>,<a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-4 href-manipulated=true>12</a>–<a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-3 href-manipulated=true>14</a></sup> Across these trials, the 3 PHEN/TPM doses studied were 3.75/23 mg (low-dose), 7.5/46 mg (mid-dose), and 15/92 mg (high-dose). In addition to pharmacotherapy, all patients received standardized diet and lifestyle modification counseling based on the LEARN (Lifestyle, Exercise, Attitudes, Relationship, and Nutrition) Program for Weight Management.<sup><a href=#bibr15-aph-1R501 role=doc-biblioref data-xml-rid=bibr15-aph-1R501 id=body-ref-bibr15-aph-1R501-1 href-manipulated=true>15</a></sup> However, adherence to LEARN was not assessed. Furthermore, all patients were advised to increase daily physical activity, reduce caloric intake by 500-kcal/day, and increase water consumption.<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-5 href-manipulated=true>12</a>–<a href=#bibr15-aph-1R501 role=doc-biblioref data-xml-rid=bibr15-aph-1R501 id=body-ref-bibr15-aph-1R501-2 href-manipulated=true>15</a></sup> If participants discontinued treatment for any reason, they were encouraged to remain in the study and complete monthly assessments.</div><div role=paragraph>The EQUIP and CONQUER studies consisted of a 2-week screening period, 4-week postrandomization titration period, and a 52-week treatment period. The aptly-named SEQUEL study was a 52-week extension of CONQUER.<sup><a href=#bibr5-aph-1R501 role=doc-biblioref data-xml-rid=bibr5-aph-1R501 id=body-ref-bibr5-aph-1R501-6 href-manipulated=true>5</a></sup> In all 3 studies, the primary end points were percent weight loss from baseline and percentage of subjects achieving at least 5% weight loss from baseline to study completion; secondary end points varied.</div><section id=sec-13-1><h3>OBESITY WITHOUT COMORBIDITIES</h3><div role=paragraph>The EQUIP study evaluated low-dose and high-dose PHEN/TPM compared with placebo for a total treatment duration of 56 weeks (4-week titration phase; 52-week maintenance phase).<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-6 href-manipulated=true>12</a></sup> Study participants were 18–70 years of age with a BMI of 35 kg/m<sup>2</sup> or more and controlled triglycerides, blood pressure, and fasting plasma glucose. Study inclusion criteria and results are detailed in <a href=#table1-aph-1R501>Table 2</a>. Exclusion criteria were extensive and included the following: weight gain or loss greater than 5 kg within the past 3 months; history of eating disorders, previous bariatric surgery, glaucoma, and nephrolithiasis; thyroid dysfunction; chronic systemic glucocorticoid therapy; bipolar disorder or psychosis history, more than 1 lifetime episode of major depression, current depression of moderate or greater severity, presence or history of suicidal behavior or ideation with some intent to act, or antidepressant use that had not been stable for at least 3 months; stroke, myocardial infarction, life-threatening arrhythmia, or coronary revascularization within the past 6 months; unstable angina, congestive heart failure, or known or suspected clinically significant valvular heart disease; cholelithiasis within the past 6 months; use of any investigational medication or device within the past month.<sup><a href=#bibr5-aph-1R501 role=doc-biblioref data-xml-rid=bibr5-aph-1R501 id=body-ref-bibr5-aph-1R501-7 href-manipulated=true>5</a>,<a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-7 href-manipulated=true>12</a></sup> Baseline characteristics for patients enrolled in EQUIP are presented in <a href=#table1-aph-1R501>Table 3</a>.</div><div role=paragraph>Overall, the placebo-subtracted percent weight loss was significant in both the low-dose and high-dose PHEN/TPM groups (p &lt; 0.0001 for both comparisons with placebo). Participants receiving high-dose PHEN/TPM, low-dose PHEN/TPM, and placebo lost 10.9%, 5.1%, and 1.6% of body weight, respectively. The placebo-subtracted percentage of individuals with at least 5% weight loss and 10% weight loss was 49.4% and 39.8% for high-dose and 27.6% and 11.4% for low-dose PHEN/TPM, respectively.<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-8 href-manipulated=true>12</a></sup> Low-dose PHEN/TPM compared with placebo resulted in significant reductions in waist circumference, systolic blood pressure (SBP), and total cholesterol to high-density lipoprotein cholesterol (HDL-C) ratio.<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-9 href-manipulated=true>12</a></sup> Furthermore, compared with low-dose, high-dose PHEN/TPM resulted in significant reductions in waist circumference measurements, diastolic blood pressure (DBP) (<a href=#table1-aph-1R501>Table 2</a>), reduced total cholesterol to HDL-C ratio, and reduced percent triglycerides, as well as increased HDL-C.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-7 href-manipulated=true>9</a></sup></div><div class=figure-wrap><figure id=table1-aph-1R501 class=table><figcaption><span class=heading>Table 1</span>. Clinical Pharmacokinetics of Phentermine/Topiramate<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-8 href-manipulated=true>9</a></sup></figcaption><div class=table-wrap><table><thead><tr><th data-xml-align=left>Parameter<th data-xml-align=left>Phentermine<th data-xml-align=left>Topiramate<tbody><tr><td data-xml-align=left colspan=3>Absorption<a href=#table-fn2-aph-1R501 role=doc-noteref><sup>a</sup></a><tr><td data-xml-align=left> C<sub>max</sub>, ng/mL<td data-xml-align=left>49.1<td data-xml-align=left>1020<tr><td data-xml-align=left> time to C<sub>max</sub>, hours<td data-xml-align=left>6<td data-xml-align=left>9<tr><td data-xml-align=left> AUC<sub>0-t</sub>, ng•h/mL<td data-xml-align=left>1990<td data-xml-align=left>61600<tr><td data-xml-align=left colspan=3>Distribution<a href=#table-fn3-aph-1R501 role=doc-noteref><sup>b</sup></a><tr><td data-xml-align=left> V<sub>d</sub>, L<td data-xml-align=left>348<td data-xml-align=left>50.8 (central); 13.1 (peripheral)<tr><td data-xml-align=left> plasma protein binding, %<td data-xml-align=left>17.5<td data-xml-align=left>15–41<a href=#table-fn4-aph-1R501 role=doc-noteref><sup>c</sup></a><tr><td data-xml-align=left>Metabolism<a href=#table-fn3-aph-1R501 role=doc-noteref><sup>b</sup></a><td data-xml-align=left>Minor, primarily via CYP3A4<td data-xml-align=left>Not extensively metabolized<tr><td data-xml-align=left colspan=3>Excretion<a href=#table-fn3-aph-1R501 role=doc-noteref><sup>b</sup></a><tr><td data-xml-align=left> clearance, L/h<td data-xml-align=left>8.79<td data-xml-align=left>1.17<tr><td data-xml-align=left> half-life, hours<td data-xml-align=left>20<td data-xml-align=left>65<tr><td data-xml-align=left> elimination, % (renal)<td data-xml-align=left>70–80<td data-xml-align=left>70<tr><td data-xml-align=left colspan=3>Impairment<a href=#table-fn2-aph-1R501 role=doc-noteref><sup>a</sup></a><tr><td data-xml-align=left> hepatic<td>&nbsp;<td>&nbsp;<tr><td data-xml-align=left> mild (Child-Pugh score 5–6)<td data-xml-align=left>AUC ↑ 37%<td data-xml-align=left>No effect on AUC<tr><td data-xml-align=left> moderate (Child-Pugh score 7–9)<td data-xml-align=left>AUC ↑ 60%<td data-xml-align=left>No effect on AUC<tr><td data-xml-align=left>renal<td>&nbsp;<td>&nbsp;<tr><td data-xml-align=left> mild (CrCL 50–79 mL/min)<td data-xml-align=left>AUC ↑ 22%<td data-xml-align=left>AUC ↑ 25%<tr><td data-xml-align=left> moderate (CrCL 30–49 mL/min)<td data-xml-align=left>AUC ↑ 45%<td data-xml-align=left>AUC ↑ 85%<tr><td data-xml-align=left> severe (CrCL &lt;30 mL/min)<td data-xml-align=left>AUC ↑ 91%<td data-xml-align=left>AUC ↑ 126%</table></div><div class=notes><div role=doc-footnote><div id=table-fn1-aph-1R501 role=paragraph>AUC<sub>0-t</sub> = area under the concentration time curve, zero to the last time with measurable concentration; C<sub>max</sub> = maximum concentration; CrCl = creatinine clearance; V<sub>d</sub> = volume of distribution.</div></div><div role=doc-footnote data-has=label><div class=label>a</div><div id=table-fn2-aph-1R501 role=paragraph>Data obtained following a single 15/92-mg dose of phentermine/topiramate.</div></div><div role=doc-footnote data-has=label><div class=label>b</div><div id=table-fn3-aph-1R501 role=paragraph>Data obtained from individual dosing of phentermine and topiramate.</div></div><div role=doc-footnote data-has=label><div class=label>c</div><div id=table-fn4-aph-1R501 role=paragraph>The fraction bound decreases as blood topiramate concentrations increase from 0.5 to 250 μg/mL.</div></div></div></figure><a href=#table1-aph-1R501 class="open-in-viewer btn btn-dark figure-pop-btn" data-index=0><i aria-hidden=true class=icon-open_in_new></i><span>Open in viewer</span></a></div><div role=paragraph>Study limitations included a high dropout rate (40.1 %) and overrepresentation of female white participants, reducing study generalizability. However, the dropout rate in EQUIP is generally consistent with dropout rates in other pharmacotherapy trials for obesity (∼30–50%). Of the 59.9% of participants who completed the study, only 53.7% took the drug for the full treatment course. Using the intention-to-treat last-observation-carried-forward (ITT-LOCF) analysis for missing data and failing to obtain final weight measurements for 40.1% of study participants may introduce bias when comparing randomized groups since the LOCF is based on an unrealistic assumption that weight will not change after the last measurement.<sup><a href=#bibr16-aph-1R501 role=doc-biblioref data-xml-rid=bibr16-aph-1R501 id=body-ref-bibr16-aph-1R501 href-manipulated=true>16</a></sup> However, most weight loss occurs early and is often regained with time, particularly with agents that suppress appetite, such as phentermine and possibly topiramate. The most common reasons for discontinuation were loss to follow-up, withdrawal of consent, or adverse events. Discontinuations due to adverse events were more common in active treatment groups, with a higher frequency occurring with high-dose PHEN/TPM (see “Adverse Effects”).</div></section><section id=sec-13-2><h3>OVERWEIGHT OR OBESITY WITH WEIGHT-RELATED COMORBIDITIES</h3><div role=paragraph>The CONQUER study and its 52-week extension study, SEQUEL, evaluated the safety and efficacy of mid-dose (7.5/46 mg) and high-dose (15/92 mg) PHEN/TPM compared with placebo in individuals with 2 or more weight-related comorbidities (eg, hypertension, dyslipidemia, type 2 diabetes, prediabetes, abdominal obesity). Unlike the EQUIP study, eligible patients had a BMI of 27 kg/m<sup>2</sup> or more and 45 kg/m<sup>2</sup> or less. However, in CONQUER, there was no designated lower limit on BMI for participants with type 2 diabetes at baseline.<sup><a href=#bibr2-aph-1R501 role=doc-biblioref data-xml-rid=bibr2-aph-1R501 id=body-ref-bibr2-aph-1R501-2 href-manipulated=true>2</a>,<a href=#bibr11-aph-1R501 role=doc-biblioref data-xml-rid=bibr11-aph-1R501 id=body-ref-bibr11-aph-1R501-2 href-manipulated=true>11</a>,<a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-10 href-manipulated=true>12</a></sup> Study inclusion criteria and results are detailed in <a href=#table1-aph-1R501>Table 2</a>. Exclusion criteria were similar to those in the EQUIP study with the exception of the following: use of phentermine or topiramate for weight loss or any other indication within 3 months prior to the study; type 1 diabetes or antidiabetic medications other than metformin; SBP greater than 160 mm Hg; DBP greater than 100 mm Hg or antihypertensive medication use that had not been stable for the preceding month; history of malignancy within 5 years; obesity of known genetic or endocrine origin; use of very-low-calorie diet or participation in a formal weight loss program in the 3 months prior to the study; smoking cessation within previous 3 months or plans to quit during the study period; history of drug/alcohol abuse within the preceding year; women who were pregnant, breastfeeding, or planning to conceive during the trial period. Prior to randomization, potential subjects were excluded for plasma bicarbonate level outside the normal range, aspartate aminotransferase and alanine aminotransferase greater than 2.5 times the upper limit of normal (ULN), fasting blood glucose greater than 240 mg/dL, serum triglycerides greater than 400 mg/dL, creatinine clearance less than 60 mL/min, thyroid stimulating hormone 1.5 times the ULN, or clinically significant abnormalities.<sup><a href=#bibr13-aph-1R501 role=doc-biblioref data-xml-rid=bibr13-aph-1R501 id=body-ref-bibr13-aph-1R501-2 href-manipulated=true>13</a></sup> At the end of the CONQUER study, participants were automatically excluded from SEQUEL if they had a BMI of 22 kg/m<sup>2</sup> or less, had discontinued the study drug more than 4 weeks after 56 weeks of treatment, or had participated in another formal weight loss program during the interim between CONQUER completion and SEQUEL initiation.<sup><a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-4 href-manipulated=true>14</a></sup></div><div role=paragraph>At the completion of CONQUER (56 weeks of therapy), the placebo-subtracted weight loss was significantly greater at both mid-dose and high-dose PHEN/TPM compared with placebo (p &lt; 0.0001 for both comparisons to placebo).<sup><a href=#bibr13-aph-1R501 role=doc-biblioref data-xml-rid=bibr13-aph-1R501 id=body-ref-bibr13-aph-1R501-3 href-manipulated=true>13</a></sup> The corresponding odds ratios for achieving at least 5% weight loss in the mid-dose and high-dose groups relative to placebo were 6.3 (95% CI 4.9–8.0; p &lt; 0.0001) and 9.0 (95% CI 7.3–11.1; p &lt; 0.0001), respectively. For patients completing the SEQUEL study, mean placebo-subtracted weight loss from baseline (week 0 of CONQUER) to 108 weeks was also significantly greater at both doses compared with placebo (p &lt; 0.0001 for both comparisons with placebo).<sup><a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-5 href-manipulated=true>14</a></sup> In CONQUER, the corresponding odds ratios for achieving at least 10% weight loss in the mid-dose and high-dose PHEN/TPM groups compared with placebo were 7.6 (95% CI 5.6–10.2) and 11.7 (95% CI 8.9–15.4), respectively.<sup><a href=#bibr13-aph-1R501 role=doc-biblioref data-xml-rid=bibr13-aph-1R501 id=body-ref-bibr13-aph-1R501-4 href-manipulated=true>13</a></sup> Furthermore, after 108 weeks of treatment (completion of SEQUEL), high-dose PHEN/TPM resulted in a significantly greater percentage weight loss compared with mid-dose in severely obese subjects (BMI ≥40 kg/m<sup>2</sup> and &lt;45 kg/m<sup>2</sup>) at baseline (p = 0.0016 for the comparison between doses).<sup><a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-6 href-manipulated=true>14</a></sup> Both doses of PHEN/TPM also resulted in significant reductions in SBP, waist circumference measurement, total cholesterol, triglycerides, fasting plasma glucose, and improved insulin concentrations compared with placebo. In patients without type 2 diabetes at baseline, progression to type 2 diabetes was reduced by 54% and 76%, respectively, in subjects receiving mid-dose and high-dose PHEN/TPM compared with placebo.<sup><a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-7 href-manipulated=true>14</a></sup> For patients with prediabetes at baseline, the risk of progression to diabetes was reduced with both doses of PHEN/TPM compared with placebo, but only the comparison of high-dose PHEN/TPM with placebo was statistically significant, with a relative risk versus placebo of 0.47 (95% CI 0.25–0.88).<sup><a href=#bibr13-aph-1R501 role=doc-biblioref data-xml-rid=bibr13-aph-1R501 id=body-ref-bibr13-aph-1R501-5 href-manipulated=true>13</a></sup> Furthermore, PHEN/TPM reduced the use of antidiabetic, antihypertensive, and lipid-lowering medications compared with placebo. These results remained essentially unchanged at 108 weeks in the SEQUEL extension study.</div><div role=paragraph>Study limitations included a lack of end point data for 31% of the study sample, restriction of the upper limit of BMI, a generally homogenous study population with mostly women (70%) and white (86%) participants, and lack of active comparator groups.<sup><a href=#bibr11-aph-1R501 role=doc-biblioref data-xml-rid=bibr11-aph-1R501 id=body-ref-bibr11-aph-1R501-3 href-manipulated=true>11</a>,<a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-11 href-manipulated=true>12</a></sup> Like EQUIP, limited heterogeneity of the study population affects the generalizability of findings. Additionally, although the CONQUER and SEQUEL study findings showed a reduction in concomitant use of drugs for comorbid conditions, patients with type 2 diabetes did not have advanced disease, again limiting the generalizability of the findings. Furthermore, not all CONQUER subjects were eligible for enrollment in SEQUEL because of limitations in enrollment based on study center; only participants from high-enrolling centers were given the option (36 of 93 centers in CONQUER). Since patients were allowed an option for continuation, a bias for inclusion of subjects with positive treatment outcomes may have been introduced. Furthermore, for unknown reasons, a higher percentage of subjects in the high-dose arm were lost to follow-up, resulting in an underestimation of reasons for drop-out including potential adverse events or lack of efficacy. Finally, some patients treated with metformin were likely included in the studies; however, neither study addressed the impact of metformin on additional weight loss when compared with PHEN/TPM.</div><div class=figure-wrap><figure id=table2-aph-1R501 class=table><figcaption><span class=heading>Table 2</span>. Efficacy of Phentermine/Topiramate in Clinical Trials</figcaption><div class=table-wrap><table><thead><tr><th data-xml-align=left>Study<th data-xml-align=left>Design<th data-xml-align=left>Inclusion Criteria<th data-xml-align=left>Treatment<th data-xml-align=left>Primary Efficacy Outcome<th data-xml-align=left>Secondary Efficacy Outcome<a href=#table-fn6-aph-1R501 role=doc-noteref><sup>a</sup></a><tbody><tr><td data-xml-align=left>OB-302 EQUIP<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-12 href-manipulated=true>12</a></sup> 56 weeks N = 1267<td data-xml-align=left>R, DB, PG, MC Phase 3<br>2:1:1 allocation ratio<td data-xml-align=left>Age 18–70 years; BMI ≥35 kg/m<sup>2</sup><br>Triglycerides ≤200 mg/dL, untreated or no more than 1 lipid-lowering medication<br>BP ≤140/90 mm Hg, untreated or no more than 2 antihypertensive medications<br>Fasting serum glucose level ≤110 mg/dL<td data-xml-align=left>Placebo (n = 514)<br>PHEN/TPM CR 3.75/23 mg (n = 241)<br>PHEN/TPM CR 15/92 mg (n = 512)<td data-xml-align=left>Placebo-subtracted weight loss at 56 weeks (%): 3.75/23 mg = 3.5 15/92 mg = 9.3<br>Pts. with at least 5% weight loss at 56 weeks (%): 3.75/23 mg = 44.9 15/92 mg = 66.7<br>Placebo = 17.3<td data-xml-align=left>WC (% change), mean: 3.75/23 mg = −5.6 (p = 0.0006) 15/92 mg = −10.9 (p &lt; 0.0001 vs placebo and 3.75/23 mg)<br>SBP (% change), mean: 3.75/23 mg = −1.8 (p = 0.0019 vs placebo) 15/92 mg = −2.9 (p &lt; 0.0001 vs placebo; p = 0.2176 vs 3.75/23 mg)<br>DBP (% change), mean: 3.75/23 mg = −0.1 (p = 0.4267 vs placebo) 15/92 mg = −1.5 (p = 0.0002 vs placebo; p = 0.0269 vs 3.75/23 mg)<br>TG (% change), mean: 3.75/23 mg = 5.2 (p = 0.2639 vs placebo) 15/92 mg = −5.2 (p &lt; 0.0001 vs placebo; p = 0.0027 vs 3.75/23 mg)<br>Total cholesterol/HDL-C ratio (% change), mean: 3.75/23 mg = −0.22 (p = 0.0148 vs placebo) 15/92 mg = −0.35 (p &lt; 0.0001 vs placebo; p = 0.023 vs 3.75/23 mg)<br>HDL-C (% change), mean: 3.75/23 mg = 0.5 (p = 0.7057 vs placebo) 15/92 mg = 3.5 (p &lt; 0.0001 vs placebo; p = 0.0008 vs 3.75/23 mg)<tr><td data-xml-align=left>OB-303 CONQUER<sup><a href=#bibr13-aph-1R501 role=doc-biblioref data-xml-rid=bibr13-aph-1R501 id=body-ref-bibr13-aph-1R501-6 href-manipulated=true>13</a></sup> 56 weeks N = 2487<td data-xml-align=left>R, DB, PG (3-arm), MC Phase 3<br>2:1:2 allocation ratio<td data-xml-align=left>Age 18–70 years; BMI ≥27 (no lower limit for pts. with T2DM), ≤45 kg/m<sup>2</sup> and &gt;2 of the following at baseline: hypertension with SBP 140–160 mm Hg (130–160 mm Hg with DM), or DBP 90–100 mm Hg (85–100 mm Hg with DM), or taking ≥2 antihypertensive drugs to achieve control BP &lt;140/90 mm Hg<br>Hypertriglyceridemia with TG ≥200 mg/dL and ≤400 mg/dL or treated with ≥2 drugs to achieve TG &lt;200 mg/dL<br>Metabolic disorders with ≥1 of the following: fasting blood glucose level &gt;100 mg/dL, glucose level &gt;140 mg/dL at 2-hour OGTT, T2DM managed with lifestyle modifications or metformin monotherapy WC ≥102 cm for men or ≥88 cm for women<td data-xml-align=left>Placebo (n = 994)<br>PHEN/TPM CR 7.5/46 mg (n = 498)<br>PHEN/TPM CR 15/92 mg (n = 995)<td data-xml-align=left>Placebo-subtracted weight loss at 56 weeks (%): 7.5/46 mg = 6.6 15/92 mg = 8.6<br>Pts. with ≥5% weight loss at 56 weeks: 7.5/46 mg = 62.1 15/92 mg = 70.0<br>Placebo = 21.0<td data-xml-align=left>Weight loss (kg), mean: 7.5/46 mg = −8.1 (p &lt; 0.0001 vs placebo) 15/92 mg = −10.2 (p &lt; 0.0001 vs placebo)<br>WC change (cm), mean: 7.5/46 mg = −7.6 (p &lt; 0.0001 vs placebo) 15/92 mg = −9.2 (p &lt; 0.0001 vs placebo)<br>SBP change (mm Hg), mean: 7.5/46 mg −4.7 (p = 0.0008 vs placebo) 15/92 mg = −5.6 (p &lt; 0.0001 vs placebo)<br>Total cholesterol change (%), mean: 7.5/46 mg = −4.9 (p = 0.0345 vs placebo) 15/92 mg = −6.3 (p &lt; 0.0001 vs placebo)<br>TG change (%), mean: 7.5/46 mg = −8.6 (p &lt; 0.0001 vs placebo) 15/92 mg = −10.6 (p &lt; 0.0001 vs placebo)<br>FPG change (mmol/L), mean: 7.5/46 mg = −0.01 (p = 0.0047 vs placebo) 15/92 mg = −0.07 (p &lt; 0.0001 vs placebo)<br>Fasting insulin change (pmol/L), mean: 7.5/46 mg = −24 (p = 0.0004 vs placebo) 15/92 mg = −27.6 (p &lt; 0.0001 vs placebo)<tr><td data-xml-align=left>OB-303 Extension Trial, OB-305 SEQUEL<sup><a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-8 href-manipulated=true>14</a></sup> Weeks 56–108 N = 676<td data-xml-align=left>R, DB, PG, (3 arm), MC Phase 3<br>2:1:2 allocation ratio<td data-xml-align=left>CONQUER inclusion/exclusion criteria: BMI ≥27 kg/m<sup>2</sup> and ≤45 kg/m<sup>2</sup> and &gt;2 weight-related comorbidities; pts. were excluded from extension if BMI ≤22 kg/m<sup>2</sup>, if study drug had been discontinued for &gt;4 weeks after CONQUER study end, and if they had participated in another formal weight-loss program in the interim<td data-xml-align=left>PTS. continued randomly assigned treatments from CONQUER<br>Placebo (n = 227)<br>PHEN/TPM CR 7.5/46 mg (n = 153)<br>PHEN/TPM CR 15/92 mg (n = 295)<td data-xml-align=left>Placebo-subtracted weight loss, week 108 (%): 7.5/46 mg = 7.5 15/92 mg = 8.7<br>Pts. with ≥5% weight loss from baseline to week 108: 7.5/46 mg = 75.2 15/92 mg = 79.3<br>Placebo = 30.0<td data-xml-align=left>Weight loss change (%), mean: 7.5/46 mg = −9.3 15/92 mg = −10.5 (p &lt; 0.0001 for both doses vs placebo)<br>WC change (cm), mean: 7.5/46 mg = −9.8 15/92 mg = −10.6 (p &lt; 0.0001 for both doses vs placebo)<br>FPG change (mg/dL), mean: 7.5/46 mg = 0.1 (p = 0.0872 vs placebo) 15/92 mg = −1.2 (p = 0.0048 vs placebo)<br>Fasting insulin change (<i>m</i>lU/mL), mean: 7.5/46 mg = −5.3 (p = 0.0051 vs placebo) 15/92 mg = −5.2 (p = 0.0012 vs placebo)</table></div><div class=notes><div role=doc-footnote><div id=table-fn5-aph-1R501 role=paragraph>BMI = body mass index; BP = blood pressure; CR = controlled release; DB = double-blind; DBP = diastolic blood pressure; FPG = fasting plasma glucose; MC = multicenter; OGTT = oral glucose tolerance test; PG = parallel-group; PHEN/TPM = phentemine/topiramate; R = randomized; SBP = systolic blood pressure; TG = triglycerides; T2DM = type 2 diabetes mellitus; WC = waist circumference.</div></div><div role=doc-footnote data-has=label><div class=label>a</div><div id=table-fn6-aph-1R501 role=paragraph>Selected secondary outcomes that were significantly different between phentermine/topiramate doses or between either phentermine/topiramate dose and placebo.</div></div></div></figure><a href=#table2-aph-1R501 class="open-in-viewer btn btn-dark figure-pop-btn" data-index=0><i aria-hidden=true class=icon-open_in_new></i><span>Open in viewer</span></a></div></section></section><section id=sec-14><h2>Dosing Recommendations</h2><div role=paragraph>FDA-approved dosage forms for PHEN/TPM include 3.75/23 mg (low dose), 7.5/46 mg (mid dose), 11.25/69 mg (three-quarter dose), and 15/92 mg (high dose), but the low-dose and three-quarter dose PHEN/TPM are for titration purposes only.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-9 href-manipulated=true>9</a></sup> PHEN/TPM is given as a single daily dose in the morning, with or without food. To prevent insomnia, evening doses should be avoided.</div><div role=paragraph>The recommended starting dose is PHEN/TPM 3.75/23 mg daily for 14 days, subsequently increasing to a recommended 7.5/46-mg daily dose. Dosing should not exceed 7.5/46 mg daily in patients with moderate or severe renal impairment (estimated CrCl &lt;50 mL/min) or moderate or severe hepatic impairment (Child-Pugh score ≥7).</div><div role=paragraph>For patients not achieving clinically significant weight loss of at least 3% after 12 weeks, PHEN/TPM may be increased to 11.25/69 mg for 14 days, followed by 15/92 mg daily if needed. If, after 12 weeks of taking PHEN/TPM 15/92 mg daily, 5% weight loss is not achieved, PHEN/TPM should be discontinued gradually by taking a dose every other day for 1 week to minimize the possibility of precipitating seizures from rapid topiramate withdrawal.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-10 href-manipulated=true>9</a></sup> The mechanism of precipitant seizures is unclear.</div></section><section id=sec-15><h2>Adverse Effects</h2><div role=paragraph>In general, PHEN/TPM was well tolerated in Phase 3 clinical trials, with the most commonly reported adverse effects being dry mouth, dizziness, constipation, insomnia, dysgeusia, and paresthesia (<a href=#table1-aph-1R501>Table 4</a>).<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-13 href-manipulated=true>12</a>–<a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-9 href-manipulated=true>14</a></sup> Rates of discontinuation due to adverse events were greater with high-dose PHEN/TPM and appear to be dose-related. The most common reasons for discontinuation were blurred vision, headache, and irritability.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-11 href-manipulated=true>9</a></sup></div><div role=paragraph>In monotherapy weight loss studies, topiramate has been associated with dose-dependent neuropsychiatric adverse events, mainly memory and mood events such as depression. Consequently, during clinical trials for PHEN/TPM, depressive symptoms were assessed using the Patient Health Questionnaire 9 (PHQ-9), and suicide ideation and behavior were assessed using the clinician-administered Columbia Suicide Severity Rating Scale (C-SSRS). Across all 3 trials, depressive symptoms tended to improve over time and no significant increase in suicide risks was identified.<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-14 href-manipulated=true>12</a>–<a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-10 href-manipulated=true>14</a></sup></div><div role=paragraph>Like other carbonic anhydrase inhibitors, topiramate can decrease serum concentrations of bicarbonate and potassium, increasing the risk of hypokalemia and nephrolithiasis.<sup><a href=#bibr13-aph-1R501 role=doc-biblioref data-xml-rid=bibr13-aph-1R501 id=body-ref-bibr13-aph-1R501-7 href-manipulated=true>13</a></sup> In the CONQUER trial, 3 serious adverse events of nephrolithiasis occurred in participants treated with high-dose PHEN/TPM.<sup><a href=#bibr13-aph-1R501 role=doc-biblioref data-xml-rid=bibr13-aph-1R501 id=body-ref-bibr13-aph-1R501-8 href-manipulated=true>13</a></sup> To monitor for hypokalemia and reduce the risk for nephrolithiasis, a blood chemistry profile should be collected at baseline before initiating PHEN/TPM and periodically thereafter.</div><div class=figure-wrap><figure id=table3-aph-1R501 class=table><figcaption><span class=heading>Table 3</span>. Baseline Characteristics for Phase 3 Clinical Trials</figcaption><div class=table-wrap><table><thead><tr><th data-xml-align=left>Characteristic<th data-xml-align=left>EQUIP (OB-302)<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-15 href-manipulated=true>12</a></sup><th data-xml-align=left>CONQUER (OB-303)<sup><a href=#bibr13-aph-1R501 role=doc-biblioref data-xml-rid=bibr13-aph-1R501 id=body-ref-bibr13-aph-1R501-9 href-manipulated=true>13</a></sup><th data-xml-align=left>SEQUEL (OB-305)<sup><a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-11 href-manipulated=true>14</a></sup><tbody><tr><td data-xml-align=left>Age (years), mean (SD)<td data-xml-align=left>42.7 (11.6)<td data-xml-align=left>51.1 (10.4)<td data-xml-align=left>52 (10.3)<tr><td data-xml-align=left>Female, %<td data-xml-align=left>2.8<td data-xml-align=left>70<td data-xml-align=left>66.7<tr><td data-xml-align=left>Race, %<td>&nbsp;<td>&nbsp;<td>&nbsp;<tr><td data-xml-align=left> white<td data-xml-align=left>9.9<td data-xml-align=left>86<td data-xml-align=left>85.8<tr><td data-xml-align=left> African American<td data-xml-align=left>17.7<td data-xml-align=left>12<td data-xml-align=left>12.7<tr><td data-xml-align=left>BMI (kg/m<sup>2</sup>), mean (range)<td data-xml-align=left>42 (35.0–78.7)<td data-xml-align=left>36.6 (32–41)<td data-xml-align=left>36.1 (31.4–40.8)<tr><td data-xml-align=left>Other factors<td data-xml-align=left>Personal Health Questionnaire-9 score, mean 2.8<td data-xml-align=left>Comorbidities:<br>hypertension<a href=#table-fn8-aph-1R501 role=doc-noteref><sup>a</sup></a>: 52.4%<br>hypertriglyceridemia<a href=#table-fn9-aph-1R501 role=doc-noteref><sup>b</sup></a>: 36.1%<br>impaired glucose tolerance or impaired fasting glucose (including T2DM): 68%<br>T2DM<a href=#table-fn10-aph-1R501 role=doc-noteref><sup>c</sup></a>: 15.8%<br>abdominal obesity<a href=#table-fn11-aph-1R501 role=doc-noteref><sup>d</sup></a>: 98.3%<br>≥Comorbidities: 51.3%<td data-xml-align=left>Comorbidities:<br>hypertension<a href=#table-fn8-aph-1R501 role=doc-noteref><sup>a</sup></a>: 50.5%<br>hypertriglyceridemia<a href=#table-fn9-aph-1R501 role=doc-noteref><sup>b</sup></a>: 34.1%<br>T2DM<a href=#table-fn10-aph-1R501 role=doc-noteref><sup>c</sup></a>: 21.5%<br>metabolic syndrome: 66.8%</table></div><div class=notes><div role=doc-footnote><div id=table-fn7-aph-1R501 role=paragraph>BMI = body mass index; T2DM = type 2 diabetes mellitus.</div></div><div role=doc-footnote data-has=label><div class=label>a</div><div id=table-fn8-aph-1R501 role=paragraph>Defined as systolic blood pressure 140–160 mm Hg or diastolic blood pressure 90–100 mm Hg, or controlled (&lt;140/90 mm Hg) with 2 or more antihypertensive drugs.</div></div><div role=doc-footnote data-has=label><div class=label>b</div><div id=table-fn9-aph-1R501 role=paragraph>Defined as fasting triglycerides greater than 200–400 mg/dL or receiving treatment with 2 or more lipid-lowering agents.</div></div><div role=doc-footnote data-has=label><div class=label>c</div><div id=table-fn10-aph-1R501 role=paragraph>Defined as fasting blood glucoses &gt;100 mg/dL, blood glucoses greater than 140 mg/dL 2 hours after an oral glucose tolerance test, or diagnosed T2DM managed with lifestyle changes or metformin monotherapy. For SEQUEL, T2DM was defined as fasting blood glucoses ≥126 mg/dL or 2-hour blood glucoses ≥200 mg/dL after oral-glucose-tolerance tests.</div></div><div role=doc-footnote data-has=label><div class=label>d</div><div id=table-fn11-aph-1R501 role=paragraph>Defined as waist circumference of at least 102 cm for men and at least 88 cm for women.</div></div></div></figure><a href=#table3-aph-1R501 class="open-in-viewer btn btn-dark figure-pop-btn" data-index=0><i aria-hidden=true class=icon-open_in_new></i><span>Open in viewer</span></a></div><div class=figure-wrap><figure id=table4-aph-1R501 class=table><figcaption><span class=heading>Table 4</span>. Adverse Events with a Frequency of 5% or More in Any PHEN/TPM Group</figcaption><div class=table-wrap><table><thead><tr><td>&nbsp;<th data-xml-align=center colspan=2><span>EQUIP<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-16 href-manipulated=true>12</a></sup></span><th data-xml-align=center colspan=2><span>CONQUER<sup><a href=#bibr13-aph-1R501 role=doc-biblioref data-xml-rid=bibr13-aph-1R501 id=body-ref-bibr13-aph-1R501-10 href-manipulated=true>13</a></sup></span><th data-xml-align=center colspan=2><span>SEQUEL<sup><a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-12 href-manipulated=true>14</a></sup></span><tr><th data-xml-align=left>Event<th data-xml-align=center>PHEN/TPM CR 3.75/23 (n = 240)<th data-xml-align=center>PHEN/TPM CR 15/92 (n = 511)<th data-xml-align=center>PHEN/TPM CR 7.5/46 (n = 153)<th data-xml-align=center>PHEN/TPM CR 15/92 (n = 295)<th data-xml-align=center>PHEN/TPM CR 7.5/46 (n = 153)<th data-xml-align=center>PHEN/TPM CR 15/92 (n = 295)<tbody><tr><td data-xml-align=left colspan=7>General, n (%)<tr><td data-xml-align=left> paresthesia<td data-xml-align=center>10 (4.2)<td data-xml-align=center>96 (18.8)<td data-xml-align=center>21 (13.7)<td data-xml-align=center>62 (21.0)<td data-xml-align=center>1 (0.7)<td data-xml-align=center>10 (3.4)<tr><td data-xml-align=left> dry mouth<td data-xml-align=center>16 (6.7)<td data-xml-align=center>87 (17.0)<td data-xml-align=center>21 (13.7)<td data-xml-align=center>59 (20.0)<td data-xml-align=center>1 (0.7)<td data-xml-align=center>4 (1.4)<tr><td data-xml-align=left> constipation<td data-xml-align=center>19 (7.9)<td data-xml-align=center>72 (14.1)<td data-xml-align=center>25 (16.3)<td data-xml-align=center>62 (21.0)<td data-xml-align=center>11 (7.2)<td data-xml-align=center>12 (4.1)<tr><td data-xml-align=left> upper respiratory tract infection<td data-xml-align=center>38 (15.8)<td data-xml-align=center>63 (12.3)<td data-xml-align=center>23 (15.0)<td data-xml-align=center>55 (18.6)<td data-xml-align=center>26 (17.0)<td data-xml-align=center>45 (15.3)<tr><td data-xml-align=left> headache<td data-xml-align=center>25 (10.4)<td data-xml-align=center>61 (11.9)<td data-xml-align=center>8 (5.2)<td data-xml-align=center>28 (9.5)<td data-xml-align=center>4 (2.6)<td data-xml-align=center>12 (4.1)<tr><td data-xml-align=left> dysgeusia<td data-xml-align=center>3 (1.3)<td data-xml-align=center>43 (8.4)<td data-xml-align=center>18 (11.8)<td data-xml-align=center>39 (13.2)<td data-xml-align=center>1 (0.7)<td data-xml-align=center>3 (1.0)<tr><td data-xml-align=left colspan=7>Psychiatric, n (%)<tr><td data-xml-align=left> depression<td data-xml-align=center>8 (3.3)<td data-xml-align=center>24 (4.7)<td data-xml-align=center>14 (3)<td data-xml-align=center>39 (4)<td data-xml-align=center>(3.9)<td data-xml-align=center>(8.1)<tr><td data-xml-align=left> anxiety<td data-xml-align=center>7 (2.9)<td data-xml-align=center>19 (3.7)<td data-xml-align=center>9 (2)<td data-xml-align=center>41 (4)<td data-xml-align=center>(6.5)<td data-xml-align=center>(9.5)<tr><td data-xml-align=left colspan=7>Cognitive, n (%)<tr><td data-xml-align=left> attention disturbance<td data-xml-align=center>1 (0.4)<td data-xml-align=center>18 (3.5)<td data-xml-align=center>10 (2)<td data-xml-align=center>35 (4)<td>&nbsp;<td>&nbsp;</table></div><div class=notes><div role=doc-footnote><div id=table-fn12-aph-1R501 role=paragraph>CR = controlled release; PHEN/TPM = phentermine/topiramate.</div></div></div></figure><a href=#table4-aph-1R501 class="open-in-viewer btn btn-dark figure-pop-btn" data-index=0><i aria-hidden=true class=icon-open_in_new></i><span>Open in viewer</span></a></div><div role=paragraph>Because the area under the curve of PHEN/TPM can be increased by mild hepatic and renal impairment, careful monitoring of hepatic and renal function is warranted. If PHEN/TPM is used in persons with mild or worse than mild hepatic or renal function, careful monitoring of adverse events is needed.</div><div role=paragraph>In addition to blood chemistry profiles, regular measurement of resting heart rate during treatment with PHEN/TPM is recommended.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-12 href-manipulated=true>9</a></sup> The phentermine component of high-dose PHEN/TPM increased resting heart rate by 1.2 beats/min in the EQUIP study compared with placebo (p = 0.0830) and by 1.7 beats/min in the CONQUER and SEQUEL studies (p &lt; 0.0001 vs placebo).<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-17 href-manipulated=true>12</a>–<a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-13 href-manipulated=true>14</a></sup> The clinical significance of increased heart rate is unknown, especially in patients with chronic cardiac conditions. Regardless, patients should be educated to inform health care providers if they experience heart palpitations while resting.</div><div role=paragraph>Other safety considerations for PHEN/TPM include misuse, abuse, and overdose potential, given phentermine's structural similarity to amphetamine.<sup><a href=#bibr5-aph-1R501 role=doc-biblioref data-xml-rid=bibr5-aph-1R501 id=body-ref-bibr5-aph-1R501-8 href-manipulated=true>5</a>,<a href=#bibr7-aph-1R501 role=doc-biblioref data-xml-rid=bibr7-aph-1R501 id=body-ref-bibr7-aph-1R501-4 href-manipulated=true>7</a></sup> PHEN/TPM is a Schedule IV drug under the FDA Controlled Substances Act, meaning abuse of the drug may lead to limited physical dependence or psychological dependence.</div><div role=paragraph>PHEN/TPM is contraindicated in patients with glaucoma or hyperthyroidism, as well as during pregnancy and during or within 14 days following monoamine oxidase inhibitor use.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-13 href-manipulated=true>9</a></sup> Due to an increased risk for cleft lip and cleft palate during the first trimester of pregnancy, the FDA recently classified PHEN/TPM in pregnancy category X.<sup><a href=#bibr10-aph-1R501 role=doc-biblioref data-xml-rid=bibr10-aph-1R501 id=body-ref-bibr10-aph-1R501-3 href-manipulated=true>10</a></sup> In each Phase 3 trial, 2 forms of birth control were required for women of childbearing age. Even with strict study requirements, 15 pregnancies were reported in women exposed to PHEN/TPM in the EQUIP study and 2 in the SEQUEL study.<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-18 href-manipulated=true>12</a>–<a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-14 href-manipulated=true>14</a></sup> Of these pregnancies, there were 3 spontaneous abortions, 3 elective abortions, and 9 healthy live births. Congenital malformations were not observed.</div><div role=paragraph>A Risk Evaluation and Mitigation Strategy (REMS) is in place for PHEN/TPM to discuss appropriate contraception and pregnancy test requirements, as well as to educate women on immediate discontinuation and reporting should pregnancy occur.<sup><a href=#bibr5-aph-1R501 role=doc-biblioref data-xml-rid=bibr5-aph-1R501 id=body-ref-bibr5-aph-1R501-9 href-manipulated=true>5</a></sup> A pregnancy test is required at baseline before starting PHEN/TPM and monthly thereafter for all females of childbearing age, defined as those who have not had a hysterectomy, bilateral oophorectomy, or medically documented spontaneous ovarian failure, and have not completed menopause.<sup><a href=#bibr9-aph-1R501 role=doc-biblioref data-xml-rid=bibr9-aph-1R501 id=body-ref-bibr9-aph-1R501-14 href-manipulated=true>9</a>,<a href=#bibr17-aph-1R501 role=doc-biblioref data-xml-rid=bibr17-aph-1R501 id=body-ref-bibr17-aph-1R501 href-manipulated=true>17</a></sup> Menopause should be confirmed clinically by a health care provider. More information about prescribing requirements, REMS training, and PHEN/TPM prescribing requirements is available at <a href=http://www.qsymia.com/hcp/>www.qsymia.com/hcp/</a>.</div></section><section id=sec-16><h2>Formulary Considerations</h2><div role=paragraph>To date, no clinical trials have directly compared PHEN/TPM with other weight-loss medications. Consequently, any comparison of pharmacotherapy-induced weight loss across trials has inherent limitations, most notably differences in trial design, length, and patient populations. With these limitations in mind, some general comparisons can be made between PHEN/TPM and other weight-loss agents.</div><div role=paragraph>When compared with other long-term weight-loss options, PHEN/TPM has generally resulted in similar or superior weight reductions after 1 year of therapy. Specifically, orlistat 120 mg 3 times daily for 1 year resulted in a 9.6% weight loss compared with 5.6% with placebo (p &lt; 0.001), for a placebo-subtracted weight loss of 4%. The proportion of patients achieving 5% or more weight loss was also greater with orlistat (73%) compared with placebo (45%; p &lt; 0.001).<sup><a href=#bibr18-aph-1R501 role=doc-biblioref data-xml-rid=bibr18-aph-1R501 id=body-ref-bibr18-aph-1R501 href-manipulated=true>18</a></sup> Lorcaserin 10 mg twice daily for 1 year resulted in 5.8% (±7.8%) weight loss compared with 2.2% (±3.9%) with placebo (p &lt; 0.001), for a placebo-subtracted weight loss of approximately 3.6%, on average. The proportion of patients achieving 5% or more weight loss with lorcaserin and placebo was 48% and 20%, respectively (p &lt; 0.001).<sup><a href=#bibr19-aph-1R501 role=doc-biblioref data-xml-rid=bibr19-aph-1R501 id=body-ref-bibr19-aph-1R501-1 href-manipulated=true>19</a></sup> In comparison with orlistat and lorcaserin, the percent placebo-subtracted weight loss achieved with PHEN/TPM may be modestly superior after 1 year of treatment at approximately 9% for high-dose and approximately 7% for mid-dose. Notably, baseline weight was generally similar among these trials (mean baseline weight approximately 100–103 kg), except for the EQUIP study (mean baseline weight approximately 115 kg). Furthermore, across Phase 3 clinical trials, the percentages of participants who achieved 5% or more weight loss with PHEN/TPM were 69%, 62%, and 27.6% for high-dose, mid-dose, and low-dose, respectively.<sup><a href=#bibr12-aph-1R501 role=doc-biblioref data-xml-rid=bibr12-aph-1R501 id=body-ref-bibr12-aph-1R501-19 href-manipulated=true>12</a>–<a href=#bibr14-aph-1R501 role=doc-biblioref data-xml-rid=bibr14-aph-1R501 id=body-ref-bibr14-aph-1R501-15 href-manipulated=true>14</a></sup> PHEN/TPM may also be associated with fewer adverse effects compared with lorcaserin.<sup><a href=#bibr19-aph-1R501 role=doc-biblioref data-xml-rid=bibr19-aph-1R501 id=body-ref-bibr19-aph-1R501-2 href-manipulated=true>19</a>,<a href=#bibr20-aph-1R501 role=doc-biblioref data-xml-rid=bibr20-aph-1R501 id=body-ref-bibr20-aph-1R501 href-manipulated=true>20</a></sup></div><div role=paragraph>The average wholesale price (AWP) per unit for PHEN/TPM varies from $4.80 for 3.75/23-mg capsules and $7.35 for 15/92-mg capsules.<sup><a href=#bibr21-aph-1R501 role=doc-biblioref data-xml-rid=bibr21-aph-1R501 id=body-ref-bibr21-aph-1R501 href-manipulated=true>21</a></sup> By comparison, Adipex-P (phentermine) AWP per unit is approximately $2.00 to $2.50, and the AWP per unit of regular-release topiramate at doses of 25–100 mg varies between approximately $2.00 and $7.00, depending on package size. PHEN/TPM contains extended-release topiramate, which is not available as monotherapy. The AWP per unit of orlistat is $5.40 for 120-mg capsules and AWP information for lorcaserin is currently unavailable.</div></section><section id=sec-17><h2>Summary</h2><div role=paragraph>PHEN/TPM should be avoided or carefully initiated and monitored in patient populations excluded in clinical trials until further postmarketing safety data become available. Furthermore, caution should be exercised when prescribing PHEN/TPM for the elderly or for patients with mild to moderate hepatic or renal impairment. PHEN/TPM has not been studied in patients on insulin or sulfonylureas. Consequently, as patients lose weight, antidiabetic and antihypertensive regimens may need to be adjusted to prevent potential hypoglycemia or hypotension.</div><div role=paragraph>Future studies evaluating the efficacy and safety of PHEN/TPM in the elderly and in men, as well as in patients with significant depression, cardiac, or cerebrovascular disease are needed. Head-to-head trials comparing long-term pharmacologic interventions (ie, lorcaserin, PHEN/TPM, orlistat) and surgical interventions (eg, lap banding, bariatric surgery) may further guide practitioners.</div></section><section id=conflict class=core-conflict><h2>Competing Interests</h2><div role=paragraph><b>Conflict of interest</b>: Authors reported none</div></section></div></section><section id=backmatter data-extent=backmatter><div class=core-container><section id=bibliography role=doc-bibliography><h2>References</h2><div role=list><div role="doc-biblioentry listitem"><div id=bibr1-aph-1R501 class=citations><div class=citation><div class=citation-content>1 Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. <em>JAMA</em> 2012; 307: 491–7.</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr1-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href=https://doi.org/10.1001/jama.2012.39>Crossref</a></div><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/22253363>PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000299728000030">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Prevalence+of+obesity+and+trends+in+the+distribution+of+body+mass+index+among+US+adults%2C+1999%E2%80%932010&amp;author=KM+Flegal&amp;author=MD+Carroll&amp;author=BK+Kit&amp;author=CL+Ogden&amp;publication_year=2012&amp;journal=JAMA&amp;pages=491-7&amp;doi=10.1001%2Fjama.2012.39&amp;pmid=22253363">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2012.39&amp;rft_id=info%3Apmid%2F22253363&amp;rft.atitle=Prevalence+of+obesity+and+trends+in+the+distribution+of+body+mass+index+among+US+adults%2C+1999%E2%80%932010&amp;rft.aufirst=KM&amp;rft.aulast=Flegal&amp;rft.jtitle=JAMA&amp;rft.title=JAMA&amp;rft.date=2012&amp;rft.volume=307&amp;rft.spage=491&amp;rft.epage=7" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr1-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr2-aph-1R501 class=citations><div class=citation><div class=citation-content>2 Centers for Disease Control and Prevention. <em>Obesity and overweight for professionals: childhood data</em>. <a href=http://www.cdc.gov/obesity/data/childhood.html>www.cdc.gov/obesity/data/childhood.html</a> (accessed 2012 Jul 21).</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr2-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href="https://scholar.google.com/scholar_lookup?title=Obesity+and+overweight+for+professionals%3A+childhood+data">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft.title=Obesity+and+overweight+for+professionals%3A+childhood+data" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr2-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr3-aph-1R501 class=citations><div class=citation><div class=citation-content>3 National Heart, Lung, and Blood Institute (NHLBI). <em>Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults</em>, 1998. <a href=http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf>www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf</a> (accessed 2012 Aug 20).</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr3-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href="https://scholar.google.com/scholar_lookup?title=Clinical+guidelines+on+the+identification%2C+evaluation%2C+and+treatment+of+overweight+and+obesity+in+adults&amp;publication_year=1998">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft.title=Clinical+guidelines+on+the+identification%2C+evaluation%2C+and+treatment+of+overweight+and+obesity+in+adults&amp;rft.date=1998" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr3-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr4-aph-1R501 class=citations><div class=citation><div class=citation-content>4 Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. <em>JAMA</em> 2010; 303: 235–41.</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr4-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href=https://doi.org/10.1001/jama.2009.2014>Crossref</a></div><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/20071471>PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000273690600019">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Prevalence+and+trends+in+obesity+among+US+adults%2C+1999%E2%80%932008&amp;author=KM+Flegal&amp;author=MD+Carroll&amp;author=CL+Ogden&amp;author=LR+Curtin&amp;publication_year=2010&amp;journal=JAMA&amp;pages=235-41&amp;doi=10.1001%2Fjama.2009.2014&amp;pmid=20071471">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2009.2014&amp;rft_id=info%3Apmid%2F20071471&amp;rft.atitle=Prevalence+and+trends+in+obesity+among+US+adults%2C+1999%E2%80%932008&amp;rft.aufirst=KM&amp;rft.aulast=Flegal&amp;rft.jtitle=JAMA&amp;rft.title=JAMA&amp;rft.date=2010&amp;rft.volume=303&amp;rft.spage=235&amp;rft.epage=41" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr4-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr5-aph-1R501 class=citations><div class=citation><div class=citation-content>5 Qnexa New Drug Application. <em>Department of Health and Human Services: 2010</em>. <a href=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM292317.pdf>www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM292317.pdf</a> (accessed 2012 Jul 10).</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr5-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href="https://scholar.google.com/scholar_lookup?title=Department+of+Health+and+Human+Services%3A+2010">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft.title=Department+of+Health+and+Human+Services%3A+2010" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr5-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr6-aph-1R501 class=citations><div class=citation><div class=citation-content>6 Food and Drug Administration. <em>FDA drug safety communication: completed safety review of Xenical/Alli (orlistat) and severe liver injury</em>. <a href=http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm213038.htm>www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm213038.htm</a> (accessed 2012 Jul 20).</div><div class=external-links><div class=to-citation__wrapper><a class="to-citation btn-outline-secondary" href=#body-ref-bibr6-aph-1R501><span>Go to Reference</span></a></div><div><a href="https://scholar.google.com/scholar_lookup?title=FDA+drug+safety+communication%3A+completed+safety+review+of+Xenical%2FAlli+%28orlistat%29+and+severe+liver+injury">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft.title=FDA+drug+safety+communication%3A+completed+safety+review+of+Xenical%2FAlli+%28orlistat%29+and+severe+liver+injury" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> </div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr7-aph-1R501 class=citations><div class=citation><div class=citation-content>7 <em>Product information. Adipex-p (phentermine)</em>. Sellersville, PA: TEVA Pharmaceuticals, July 2005.</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr7-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href="https://scholar.google.com/scholar_lookup?title=Product+information.+Adipex-p+%28phentermine%29&amp;publication_year=2005">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft.btitle=Product+information.+Adipex-p+%28phentermine%29&amp;rft.title=Product+information.+Adipex-p+%28phentermine%29&amp;rft.date=2005" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr7-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr8-aph-1R501 class=citations><div class=citation><div class=citation-content>8 Langlois KJ, Forbes JA, Bell GW, et al. A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity. <em>Curr Ther Res</em> 1974; 16: 289–96.</div><div class=external-links><div class=to-citation__wrapper><a class="to-citation btn-outline-secondary" href=#body-ref-bibr8-aph-1R501><span>Go to Reference</span></a></div><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/4208343>PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=A+double-blind+clinical+evaluation+of+the+safety+and+efficacy+of+phentermine+hydrochloride+%28Fastin%29+in+the+treatment+of+exogenous+obesity&amp;author=KJ+Langlois&amp;author=JA+Forbes&amp;author=GW+Bell&amp;publication_year=1974&amp;journal=Curr+Ther+Res&amp;pages=289-96&amp;pmid=4208343">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft_id=info%3Apmid%2F4208343&amp;rft.atitle=A+double-blind+clinical+evaluation+of+the+safety+and+efficacy+of+phentermine+hydrochloride+%28Fastin%29+in+the+treatment+of+exogenous+obesity&amp;rft.aufirst=KJ&amp;rft.aulast=Langlois&amp;rft.jtitle=Curr+Ther+Res&amp;rft.title=Curr+Ther+Res&amp;rft.date=1974&amp;rft.volume=16&amp;rft.spage=289&amp;rft.epage=96" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> </div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr9-aph-1R501 class=citations><div class=citation><div class=citation-content>9 <em>Product information. Qsymia (phentermine/topiramate)</em>. Winchester, KY: VIVUS Inc., July 2012.</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr9-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href="https://scholar.google.com/scholar_lookup?title=Product+information.+Qsymia+%28phentermine%2Ftopiramate%29&amp;publication_year=2012">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft.btitle=Product+information.+Qsymia+%28phentermine%2Ftopiramate%29&amp;rft.title=Product+information.+Qsymia+%28phentermine%2Ftopiramate%29&amp;rft.date=2012" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr9-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr10-aph-1R501 class=citations><div class=citation><div class=citation-content>10 <em>Product information. Topamax (topiramate)</em>. Titusville, NJ: Janssen Pharmaceuticals, January 2009.</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr10-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href="https://scholar.google.com/scholar_lookup?title=Product+information.+Topamax+%28topiramate%29&amp;publication_year=2009">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft.btitle=Product+information.+Topamax+%28topiramate%29&amp;rft.title=Product+information.+Topamax+%28topiramate%29&amp;rft.date=2009" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr10-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr11-aph-1R501 class=citations><div class=citation><div class=citation-content>11 Ben-Menachem E, Axelsen M, Hohanson EH, Stagge A, Smith U. Predictors of weight loss in adults with topiramate-treated epilepsy. <em>Obes Res</em> 2003; 11: 556–62.</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr11-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href=https://doi.org/10.1038/oby.2003.78>Crossref</a></div><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/12690085>PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Predictors+of+weight+loss+in+adults+with+topiramate-treated+epilepsy&amp;author=E+Ben-Menachem&amp;author=M+Axelsen&amp;author=EH+Hohanson&amp;author=A+Stagge&amp;author=U+Smith&amp;publication_year=2003&amp;journal=Obes+Res&amp;pages=556-62&amp;doi=10.1038%2Foby.2003.78&amp;pmid=12690085">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft_id=info%3Adoi%2F10.1038%2Foby.2003.78&amp;rft_id=info%3Apmid%2F12690085&amp;rft.atitle=Predictors+of+weight+loss+in+adults+with+topiramate-treated+epilepsy&amp;rft.aufirst=E&amp;rft.aulast=Ben-Menachem&amp;rft.jtitle=Obes+Res&amp;rft.title=Obes+Res&amp;rft.date=2003&amp;rft.volume=11&amp;rft.spage=556&amp;rft.epage=62" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr11-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr12-aph-1R501 class=citations><div class=citation><div class=citation-content>12 Allison D, Gadde K, Garvey WT, et al. Controlled release phentermine/topiramate in severely obese adults: a randomized, controlled trial (EQUIP). <em>Obesity</em> 2011; 20: 330–42.</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr12-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href=https://doi.org/10.1038/oby.2011.330>Crossref</a></div><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/22051941>PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Controlled+release+phentermine%2Ftopiramate+in+severely+obese+adults%3A+a+randomized%2C+controlled+trial+%28EQUIP%29&amp;author=D+Allison&amp;author=K+Gadde&amp;author=WT+Garvey&amp;publication_year=2011&amp;journal=Obesity&amp;pages=330-42&amp;doi=10.1038%2Foby.2011.330&amp;pmid=22051941">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft_id=info%3Adoi%2F10.1038%2Foby.2011.330&amp;rft_id=info%3Apmid%2F22051941&amp;rft.atitle=Controlled+release+phentermine%2Ftopiramate+in+severely+obese+adults%3A+a+randomized%2C+controlled+trial+%28EQUIP%29&amp;rft.aufirst=D&amp;rft.aulast=Allison&amp;rft.jtitle=Obesity&amp;rft.title=Obesity&amp;rft.date=2011&amp;rft.volume=20&amp;rft.spage=330&amp;rft.epage=42" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr12-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr13-aph-1R501 class=citations><div class=citation><div class=citation-content>13 Gadde K, Allison D, Ryan D, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial. <em>Lancet</em> 2011; 377: 1341–52.</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr13-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href=https://doi.org/10.1016/S0140-6736(11)60205-5>Crossref</a></div><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/21481449>PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000289962900035">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Effects+of+low-dose%2C+controlled-release%2C+phentermine+plus+topiramate+combination+on+weight+and+associated+comorbidities+in+overweight+and+obese+adults+%28CONQUER%29%3A+a+randomized%2C+placebo-controlled%2C+phase+3+trial&amp;author=K+Gadde&amp;author=D+Allison&amp;author=D+Ryan&amp;publication_year=2011&amp;journal=Lancet&amp;pages=1341-52&amp;doi=10.1016%2FS0140-6736%2811%2960205-5&amp;pmid=21481449">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2811%2960205-5&amp;rft_id=info%3Apmid%2F21481449&amp;rft.atitle=Effects+of+low-dose%2C+controlled-release%2C+phentermine+plus+topiramate+combination+on+weight+and+associated+comorbidities+in+overweight+and+obese+adults+%28CONQUER%29%3A+a+randomized%2C+placebo-controlled%2C+phase+3+trial&amp;rft.aufirst=K&amp;rft.aulast=Gadde&amp;rft.jtitle=Lancet&amp;rft.title=Lancet&amp;rft.date=2011&amp;rft.volume=377&amp;rft.spage=1341&amp;rft.epage=52" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr13-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr14-aph-1R501 class=citations><div class=citation><div class=citation-content>14 Garvey T, Ryan D, Look M, et al. Two-year sustained weight loss and metabolic benefits with controlled release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. <em>Am J Clin Nutr</em> 2012; 95: 297–308.</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr14-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href=https://doi.org/10.3945/ajcn.111.024927>Crossref</a></div><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/22158731>PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Two-year+sustained+weight+loss+and+metabolic+benefits+with+controlled+release+phentermine%2Ftopiramate+in+obese+and+overweight+adults+%28SEQUEL%29%3A+a+randomized%2C+placebo-controlled%2C+phase+3+extension+study&amp;author=T+Garvey&amp;author=D+Ryan&amp;author=M+Look&amp;publication_year=2012&amp;journal=Am+J+Clin+Nutr&amp;pages=297-308&amp;doi=10.3945%2Fajcn.111.024927&amp;pmid=22158731">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft_id=info%3Adoi%2F10.3945%2Fajcn.111.024927&amp;rft_id=info%3Apmid%2F22158731&amp;rft.atitle=Two-year+sustained+weight+loss+and+metabolic+benefits+with+controlled+release+phentermine%2Ftopiramate+in+obese+and+overweight+adults+%28SEQUEL%29%3A+a+randomized%2C+placebo-controlled%2C+phase+3+extension+study&amp;rft.aufirst=T&amp;rft.aulast=Garvey&amp;rft.jtitle=Am+J+Clin+Nutr&amp;rft.title=Am+J+Clin+Nutr&amp;rft.date=2012&amp;rft.volume=95&amp;rft.spage=297&amp;rft.epage=308" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr14-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr15-aph-1R501 class=citations><div class=citation><div class=citation-content>15 Brownell KD. <em>The LEARN program for weight management</em>. 10th ed. Dallas, TX: American Health Publishing Company, 2004.</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr15-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href="https://scholar.google.com/scholar_lookup?title=The+LEARN+program+for+weight+management&amp;author=KD+Brownell&amp;publication_year=2004">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft.aufirst=KD&amp;rft.aulast=Brownell&amp;rft.btitle=The+LEARN+program+for+weight+management&amp;rft.title=The+LEARN+program+for+weight+management&amp;rft.date=2004" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr15-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr16-aph-1R501 class=citations><div class=citation><div class=citation-content>16 Simons-Morton DG, Obarzanek E, Cutler JA. Obesity research—limitations of methods, measurements, and medications. <em>JAMA</em> 2006; 295: 826–8.</div><div class=external-links><div class=to-citation__wrapper><a class="to-citation btn-outline-secondary" href=#body-ref-bibr16-aph-1R501><span>Go to Reference</span></a></div><div><a href=https://doi.org/10.1001/jama.295.7.826>Crossref</a></div><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/16478906>PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Obesity+research%E2%80%94limitations+of+methods%2C+measurements%2C+and+medications&amp;author=DG+Simons-Morton&amp;author=E+Obarzanek&amp;author=JA+Cutler&amp;publication_year=2006&amp;journal=JAMA&amp;pages=826-8&amp;doi=10.1001%2Fjama.295.7.826&amp;pmid=16478906">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.295.7.826&amp;rft_id=info%3Apmid%2F16478906&amp;rft.atitle=Obesity+research%E2%80%94limitations+of+methods%2C+measurements%2C+and+medications&amp;rft.aufirst=DG&amp;rft.aulast=Simons-Morton&amp;rft.jtitle=JAMA&amp;rft.title=JAMA&amp;rft.date=2006&amp;rft.volume=295&amp;rft.spage=826&amp;rft.epage=8" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> </div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr17-aph-1R501 class=citations><div class=citation><div class=citation-content>17 <em>Product information. Qsymia (phentermine/topiramate CR)</em>. <a href=http://www.qsymia.com/hcp/>www.qsymia.com/hcp/</a> (accessed 2012 Sept 21).</div><div class=external-links><div class=to-citation__wrapper><a class="to-citation btn-outline-secondary" href=#body-ref-bibr17-aph-1R501><span>Go to Reference</span></a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Product+information.+Qsymia+%28phentermine%2Ftopiramate+CR%29">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft.title=Product+information.+Qsymia+%28phentermine%2Ftopiramate+CR%29" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> </div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr18-aph-1R501 class=citations><div class=citation><div class=citation-content>18 Torgerson JS, Hauptman J, Boldrin MN, et al. Xenical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. <em>Diabetes Care</em> 2004; 27: 155–61.</div><div class=external-links><div class=to-citation__wrapper><a class="to-citation btn-outline-secondary" href=#body-ref-bibr18-aph-1R501><span>Go to Reference</span></a></div><div><a href=https://doi.org/10.2337/diacare.27.1.155>Crossref</a></div><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/14693982>PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000187632200027">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Xenical+in+the+prevention+of+diabetes+in+obese+subjects+%28XENDOS%29+study%3A+a+randomized+study+of+orlistat+as+an+adjunct+to+lifestyle+changes+for+the+prevention+of+type+2+diabetes+in+obese+patients&amp;author=JS+Torgerson&amp;author=J+Hauptman&amp;author=MN+Boldrin&amp;publication_year=2004&amp;journal=Diabetes+Care&amp;pages=155-61&amp;doi=10.2337%2Fdiacare.27.1.155&amp;pmid=14693982">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft_id=info%3Adoi%2F10.2337%2Fdiacare.27.1.155&amp;rft_id=info%3Apmid%2F14693982&amp;rft.atitle=Xenical+in+the+prevention+of+diabetes+in+obese+subjects+%28XENDOS%29+study%3A+a+randomized+study+of+orlistat+as+an+adjunct+to+lifestyle+changes+for+the+prevention+of+type+2+diabetes+in+obese+patients&amp;rft.aufirst=JS&amp;rft.aulast=Torgerson&amp;rft.jtitle=Diabetes+Care&amp;rft.title=Diabetes+Care&amp;rft.date=2004&amp;rft.volume=27&amp;rft.spage=155&amp;rft.epage=61" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> </div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr19-aph-1R501 class=citations><div class=citation><div class=citation-content>19 Smith SR, Weissman NJ, Anderson CM, et al. Multi-center, placebo-controlled trial of lorcaserin for weight management. <em>N Engl J Med</em> 2010; 363: 245–56.</div><div class=external-links><div class=to-citation__wrapper><button aria-controls=to-citation__accordion-bibr19-aph-1R501 aria-expanded=false aria-haspopup=true aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden=true class=icon-plus></i><span data-expand-title="Hide references" data-collapsed-title="Show references" class=accordion__toggle__title></span></button></div><div><a href=https://doi.org/10.1056/NEJMoa0909809>Crossref</a></div><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/20647200>PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Multi-center%2C+placebo-controlled+trial+of+lorcaserin+for+weight+management&amp;author=SR+Smith&amp;author=NJ+Weissman&amp;author=CM+Anderson&amp;publication_year=2010&amp;journal=N+Engl+J+Med&amp;pages=245-56&amp;doi=10.1056%2FNEJMoa0909809&amp;pmid=20647200">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa0909809&amp;rft_id=info%3Apmid%2F20647200&amp;rft.atitle=Multi-center%2C+placebo-controlled+trial+of+lorcaserin+for+weight+management&amp;rft.aufirst=SR&amp;rft.aulast=Smith&amp;rft.jtitle=N+Engl+J+Med&amp;rft.title=N+Engl+J+Med&amp;rft.date=2010&amp;rft.volume=363&amp;rft.spage=245&amp;rft.epage=56" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> <div role=menu aria-label=links class=to-citation__accordion id=to-citation__accordion-bibr19-aph-1R501 style=display:none></div></div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr20-aph-1R501 class=citations><div class=citation><div class=citation-content>20 Hurrne KM, Berlie HD. Lorcaserin: an investigational serotonin 2C agonist for weight loss. <em>Am J Health Syst Pharm</em> 2011; 68: 2029–37.</div><div class=external-links><div class=to-citation__wrapper><a class="to-citation btn-outline-secondary" href=#body-ref-bibr20-aph-1R501><span>Go to Reference</span></a></div><div><a href=https://doi.org/10.2146/ajhp100638>Crossref</a></div><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/22011982>PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Lorcaserin%3A+an+investigational+serotonin+2C+agonist+for+weight+loss&amp;author=KM+Hurrne&amp;author=HD+Berlie&amp;publication_year=2011&amp;journal=Am+J+Health+Syst+Pharm&amp;pages=2029-37&amp;doi=10.2146%2Fajhp100638&amp;pmid=22011982">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft_id=info%3Adoi%2F10.2146%2Fajhp100638&amp;rft_id=info%3Apmid%2F22011982&amp;rft.atitle=Lorcaserin%3A+an+investigational+serotonin+2C+agonist+for+weight+loss&amp;rft.aufirst=KM&amp;rft.aulast=Hurrne&amp;rft.jtitle=Am+J+Health+Syst+Pharm&amp;rft.title=Am+J+Health+Syst+Pharm&amp;rft.date=2011&amp;rft.volume=68&amp;rft.spage=2029&amp;rft.epage=37" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> </div></div></div></div><div role="doc-biblioentry listitem"><div id=bibr21-aph-1R501 class=citations><div class=citation><div class=citation-content>21 <em>Micromedex Healthcare Series</em>. Greenwood Village, CO: Thomson Reuters (Healthcare) Inc. (accessed 2012 Sept 25).</div><div class=external-links><div class=to-citation__wrapper><a class="to-citation btn-outline-secondary" href=#body-ref-bibr21-aph-1R501><span>Go to Reference</span></a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Micromedex+Healthcare+Series">Google Scholar</a></div><div> <a href="https://ufl-flvc.primo.exlibrisgroup.com/openurl/01FALSC_UFL/01FALSC_UFL:UFL?url_ver=Z39.88-2004&amp;rft.btitle=Micromedex+Healthcare+Series&amp;rft.title=Micromedex+Healthcare+Series" title=OpenURL><img alt="Open URL" src='data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="90" height="20"><rect fill-opacity="0"/></svg>' < img style="background-blend-mode:normal!important;background-clip:content-box!important;background-position:50% 50%!important;background-color:rgba(0,0,0,0)!important;background-image:var(--sf-img-22)!important;background-size:100% 100%!important;background-origin:content-box!important;background-repeat:no-repeat!important"></a></div> </div></div></div></div></div></section></div></section><div data-extent=backmatter class=contentAfter><div class=core-container></div></div></article><div data-extent=article-wrapper><div class=core-container></div><div class=after-credits><div class=core-container><a href=https://journals.sagepub.com/doi/full/10.1345/aph.1R501><span>View full text</span></a><a href="https://journals.sagepub.com/doi/pdf/10.1345/aph.1R501?download=true"><span>Download PDF</span></a></div></div></div><div role=navigation title="Sticky Navigation" class=st-header><div class=st-header__content><div class="st-header__item st-header__menu sf-hidden"></div><div class="st-header__current st-header__item"><div class=st-header__label>Now Reading:</div><div class=st-header__title></div></div><div class="st-header__favorite st-header__item sf-hidden"></div><div class="st-header__alerts st-header__item sf-hidden"></div><div class="st-header__share st-header__item"><div title data-toggle=tooltip class="share-dropblock dropdown" data-original-title="Share options"><a id=sticky-header-dropBlock role=button data-toggle=dropdown aria-haspopup=true aria-expanded=false class=dropdown-toggle tabindex=0><span class=sr-only>Share</span><i aria-hidden=true class=icon-share></i></a><div aria-labelledby=sticky-header-dropBlock class="dropdown__menu sf-hidden"></div></div></div><div class="st-header__nav st-header__item"><nav class=content-navigation><a href=https://journals.sagepub.com/doi/10.1345/aph.1R496 title="Risk Factors for Venous Thromboembolism in Patients with Chronic Liver Disease" class=content-navigation__prev><div aria-hidden=true class=content-navigation__hint><div class=content-navigation__hint__content><h6>PREVIOUS ARTICLE</h6><div>Risk Factors for Venous Thromboembolism in Patients with Chronic Liver Disease</div></div></div><i aria-hidden=true class=icon-arrow-long-left></i><span class=sf-hidden>Previous</span></a><a href=https://journals.sagepub.com/doi/10.1345/aph.1R333 title="Pharmacogenetics of Risperidone: A Systematic Review of the Clinical Effects of CYP2D6 Polymorphisms" class=content-navigation__next><div aria-hidden=true class=content-navigation__hint><div class=content-navigation__hint__content><h6>NEXT ARTICLE</h6><div>Pharmacogenetics of Risperidone: A Systematic Review of the Clinical Effects of CYP2D6 Polymorphisms</div></div></div><span class=sf-hidden>Next</span><i aria-hidden=true class=icon-arrow-long-right></i></a></nav></div></div><div class=st-header__track><div id=progress-tracker class=st-header__tracker></div></div></div><template id=mobile_sticky_template class=sf-hidden><div class="sticky-menu"><nav title="Sticky Menu Navigation"><a href="#" title="Article Contents" class="sticky-menu__sections"><i aria-hidden="true" class="icon-list"></i></a><span id="navigationReplacer"></span></nav></div></template><template id=figure_nav_template class=sf-hidden><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-open_in_new"></i><span>Open in viewer</span></a></template><template id=fv_panel_template data-sharesocial="Share on social media" class=sf-hidden><div class="fv__panel js--hidden"><div class="fv__panel__title"></div><div class="fv__panel__text"><div class="fv__panel__contentTitle"></div><div class="fv__panel__contentText"></div></div></div></template>
<template id=fv_directory_template data-overlay="View figure" class=sf-hidden><div class="fv__directory"><div class="fv__header"><nav class="tab__nav"></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"></div></div></template><template id=fv_directory_tabItem_template data-figures=Figures data-others=Others data-tables=Tables class=sf-hidden><button role="tab" data-toggle="tab" class="tab__nav__item"></button></template>
<template id=fv_lightbox_template data-sr-back="Go to figure location within the article" data-sr-closealt=Close data-sr-download="Toggle download panel" data-sr-info="Toggle information panel" data-sr-panel="Close panel" data-sr-share="Toggle share panel" data-sr-zoom=Zoom data-text-close="Back to article" data-text-nav-figures="All figures" data-text-nav-others="All others" data-text-nav-tables="All tables" data-text-viewall="View all material" data-title-back="Back to article" data-title-closealt=Close data-title-download=Download data-title-info=Info data-title-share=Share data-title-zoom=Zoom class=sf-hidden></template>
<template id=fv_toolbar_template class=sf-hidden><div class="fv__toolbar__info"><p class="fv__toolbar__contentText"></p><strong class="fv__toolbar__contentTitle uppercase"></strong></div></template><template id=toCitationLink data-citation=Reference data-footnote=Footnote class=sf-hidden><div class="to-citation__wrapper"><a class="to-citation btn-outline-secondary"><span>Go to</span></a></div></template><template id=toCitationButton data-citation=Reference data-footnote=Footnote class=sf-hidden><div class="to-citation__wrapper"><button class="to-citation btn-outline-secondary"><span>Go to</span></button></div></template><template id=toCitationAccordion data-collapse-citation="Hide references" data-expand-citation="Show references" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes" class=sf-hidden><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-haspopup="true" aria-label="Toggle citations menu" class="to-citation__toggle btn-outline-secondary"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion"><ul></ul></div></div></template><template id=toCitationAccordionItem class=sf-hidden><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id=citations_truncate_template class=sf-hidden><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id=collateral_texts_template data-references=References data-figure="Go to Figure" data-media="Go to Video" data-more=More data-original="Go to original" data-table="Go to Table" data-inviewer="Open in Viewer" data-allinviewer="Open all in viewer" class=sf-hidden><span>Request permissions</span><i aria-hidden="true" class="icon-external-link"></i></template><template id=collapsible_authors_template class=sf-hidden><button aria-expanded="false" data-expandable="all" data-label-expand="Show all" data-label-collapse="Hide all" class="collateral-contributors-control"><i aria-hidden="true" class="icon-view"></i><span>Show all</span></button></template>
<template id=collapsible_tables_collapse_template class=sf-hidden><div class="collapsible-figure-btn__wrapper expanded"><button class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id=collapsible_tables_expand_template class=sf-hidden><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="aria-expanded" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template>
<template id=collapsible_figures_template class=sf-hidden><button aria-expanded="false" data-expandable="all" data-label-expand="Show all" data-label-collapse="Hide all" class="collateral-media-control"><i aria-hidden="true" class="icon-view"></i><span>Show all</span></button></template><template id=sections_navbar_button_template class=sf-hidden><button title="Toggle sections navigation" class="sections-navbar__trigger"><i aria-hidden="true" class="icon-list"></i></button></template><template id=authorsAffiliationsLink class=sf-hidden><a href="#tab-contributors" class="to-authors-affiliations">View all authors and affiliations</a></template>
</main>
<section class=more-sage-products__container><div class=container><div class=row><div class=col><div role=region aria-labelledby=cp-footer-label class=more-sage-products><h2 id=cp-footer-label class=more-sage-products__title>Also from SAGE Publishing</h2><ul data-id=cross-product-footer class=more-sage-products__list><li class=more-sage-products__list__item><a href="https://library.cqpress.com/index.php?utm_source=cross-product-footer&amp;utm_medium=cross-product" target=_blank rel=noopener data-id=cross-product-footer-cq-library class="more-sage-products__link cqlibrary"><span class=product-name>CQ Library</span> American political resources<span class=offscreen>opens in new tab</span></a><li class=more-sage-products__list__item><a href="https://www.data-planet.com/?utm_source=cross-product-footer&amp;utm_medium=cross-product" target=_blank rel=noopener data-id=cross-product-footer-data-planet class="more-sage-products__link dataplanet"><span class=product-name>Data Planet</span> A universe of data<span class=offscreen>opens in new tab</span></a><li class=more-sage-products__list__item><a href="https://www.leanlibrary.com/?utm_source=cross-product-footer&amp;utm_medium=cross-product" target=_blank rel=noopener data-id=cross-product-footer-lean-library class="more-sage-products__link leanlibrary"><span class=product-name>Lean Library</span> Increase the visibility of your library<span class=offscreen>opens in new tab</span></a><li class=more-sage-products__list__item><a href="https://sk.sagepub.com/cases?utm_source=cross-product-footer&amp;utm_medium=cross-product" target=_blank rel=noopener data-id=cross-product-footer-sage-business-cases class="more-sage-products__link sagebusinesscases"><span class=product-name>SAGE Business Cases</span> Real-world cases at your fingertips<span class=offscreen>opens in new tab</span></a><li class=more-sage-products__list__item><a href="https://classroom.sagepub.com/?utm_source=cross-product-footer&amp;utm_medium=cross-product" target=_blank rel=noopener data-id=cross-product-footer-sage-campus class="more-sage-products__link sagecampus"><span class=product-name>SAGE Campus</span> Online skills and methods courses<span class=offscreen>opens in new tab</span></a><li class=more-sage-products__list__item><a href="https://sk.sagepub.com/?utm_source=cross-product-footer&amp;utm_medium=cross-product" target=_blank rel=noopener data-id=cross-product-footer-sage-knowledge class="more-sage-products__link sageknowledge"><span class=product-name>SAGE Knowledge</span> The ultimate social science library<span class=offscreen>opens in new tab</span></a><li class=more-sage-products__list__item><a href="https://methods.sagepub.com/?utm_source=cross-product-footer&amp;utm_medium=cross-product" target=_blank rel=noopener data-id=cross-product-footer-sage-research-methods class="more-sage-products__link sageresearchmethods"><span class=product-name>SAGE Research Methods</span> The ultimate methods library<span class=offscreen>opens in new tab</span></a><li class=more-sage-products__list__item><a href="https://sk.sagepub.com/video?utm_source=cross-product-footer&amp;utm_medium=cross-product" target=_blank rel=noopener data-id=cross-product-footer-sage-video class="more-sage-products__link sagevideo"><span class=product-name>SAGE Video</span> Streaming video collections<span class=offscreen>opens in new tab</span></a></ul></div></div></div></div></section>
<footer role=contentinfo class=footer><div data-show-after=400 class="back-to-top back-to-top--align-right"><button data-snap=footer__top class="back-to-top__action position-relative p-0 m-0 border-0 d-flex flex-column align-items-center justify-content-center"><svg viewBox="0 0 36 36" class=position-relative><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" class=back-to-top__action__ring-bg></path><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" stroke-dasharray="0, 100" class=back-to-top__action__ring></path></svg><span class="back-to-top__action-icon position-absolute d-flex"><i aria-hidden=true class=icon-arrow_up></i></span><span class=sr-only>Back to top</span></button></div><div class=container><div class="row footer__row__one"><div class="col-12 col-sm-4"><div class=footer__heading><img src="data:image/svg+xml;base64,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" class=footer__icon><h2 class=footer__title>About</h2></div><div class=footer__nav><ul class=rlist><li><a href=https://sagepub.com/journals target=_blank rel=noopener><span>About SAGE Journals</span></a><li><a href=https://journals.sagepub.com/page/help/accessibility><span>Accessibility guide</span></a><li><a href=https://www.sagepub.com/journals/historical-content target=_blank rel=noopener><span>Historical content</span></a><li><a href=https://sagepub.com/journals-permissions target=_blank rel=noopener><span>Permissions</span></a><li><a href=https://journals.sagepub.com/page/policies/terms-of-use><span>Terms of use</span></a><li class=top-gap><a href=https://journals.sagepub.com/disciplines data-id=global-footer-discipline-hubs-link><span>SAGE discipline hubs</span></a><li><a href=https://journals.sagepub.com/opportunities/microsites data-id=global-footer-microsites-link><span>SAGE microsites</span></a></ul></div></div><div class="col-12 col-sm-4"> <div class=footer__heading><img src="data:image/svg+xml;base64,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" class=footer__icon><h2 class=footer__title>Information for</h2></div><div class=footer__nav><ul class=rlist><li><a href="https://sagepub.com/journal-author-gateway?utm_source=journals.sagepub.com&amp;utm_medium=referral&amp;utm_campaign=journalauthorgateway&amp;utm_content=footer&amp;_gl=1*10o6ad2*_ga*MjA4MDA2MTMyNy4xNjE0MjUxMjMz*_ga_60R758KFDG*MTYyMjEwMzg3MC45MC4wLjE2MjIxMDQwNTAuMA.." data-id=global-footer-authors-link target=_blank rel=noopener><span>Authors</span></a><li><a href=https://sagepub.com/journal-editor-gateway data-id=global-footer-editors-link target=_blank rel=noopener><span>Editors</span></a><li><a href=https://journalssolutions.sagepub.com/support/solutions data-id=global-footer-librarians-link target=_blank rel=noopener><span>Librarians</span></a><li><a href=https://sagepub.com/advertising-and-promotion data-id=global-footer-advertisers-link target=_blank rel=noopener><span>Promoters / Advertisers</span></a><li><a href=https://journalssolutions.sagepub.com/support/solutions/7000038586 data-id=global-footer-researchers-link target=_blank rel=noopener><span>Researchers</span></a><li><a href="https://sagepub.com/journal-reviewer-gateway?utm_source=journals.sagepub.com&amp;utm_medium=referral&amp;utm_campaign=journalreviewergateway&amp;utm_content=footer&amp;_gl=1*1vgao1k*_ga*MjA4MDA2MTMyNy4xNjE0MjUxMjMz*_ga_60R758KFDG*MTYyMjEwMzg3MC45MC4xLjE2MjIxMDYyMjMuMA.." data-id=global-footer-reviewers-link target=_blank rel=noopener><span>Reviewers</span></a><li><a href=https://journals.sagepub.com/page/resources/societies data-id=global-footer-societies-link><span>Societies</span></a><li><a href=https://journalssolutions.sagepub.com/support/solutions data-id=global-footer-faq-link target=_blank rel=noopener><span>Frequently asked questions</span></a></ul></div></div><div class="col-12 col-sm-4">
<div class=footer__heading>
<img src=data:image/svg+xml;base64,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 class=footer__icon>
<h2 class=footer__title>
Annals of Pharmacotherapy
</h2>
</div>
<div class=footer__nav>
<ul class=rlist>
<li>
<span>ISSN: 1060-0280</span>
</li>
<li>
<span>Online ISSN: 1542-6270</span>
</li>
</ul>
</div>
</div></div><div class="row footer__row__two"><div class=col><div class=footer__nav><ul class="rlist--inline separator"><li><a href=https://group.sagepub.com/about target=_blank rel=noopener><span>About SAGE Publishing</span></a><li><a href=https://journalssolutions.sagepub.com/support/home target=_blank rel=noopener><span>Contact us</span></a><li><a><span>CCPA - Do not sell my personal information</span></a><li><a href=https://sagepub.com/ccpa target=_blank rel=noopener><span>CCPA</span></a><li><a href=https://sagepub.com/privacy-policy target=_blank rel=noopener><span>Privacy Policy</span></a></ul></div><div class=footer__copyright>
<div class=footer__copyright>
<p>
Copyright © 2022
by SAGE Publications
</p>
</div>
</div></div></div></div></footer>
<div class=pb-ad><div id=div-gpt-ad-123456789-4 style=display:none data-google-query-id=CO_l1d_czvsCFSoJigMd06ADXw></div>
</div>
<div class=pb-ad>
<img id=ad-blocker-test-image src=data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7 alt>
</div>
</div>
<div data-widget-def=UX3share data-widget-id=3c185187-c18e-4a08-b415-d077335b785e class="d-none sf-hidden">
</div>
</div>
</div><div id=no-ad-blocker-present style=display:none></div>
<div style=visibility:hidden;height:1px;width:1px;position:absolute;top:-9999px;z-index:100000 id=_atssh></div><div class=core-collateral style=display:none><div id=core-collateral-info role=tabpanel data-core-tabs=core-collateral-info tabindex=-1 class=sf-hidden><section id=tab-information aria-labelledby=information role=tabpanel tabindex=0 class=sf-hidden><section class="core-self-citation sf-hidden"><div class="core-journal-presentation sf-hidden">
<div class="cover-image sf-hidden"><div class="cover-image__image sf-hidden"><noscript><img src="/na101/home/literatum/publisher/sage/journals/content/aopd/2023/aopd_57_1/aopd_57_1/20221027/aopd_57_1.largecover.png"></noscript></div></div>
</div></section></section></div><div id=core-collateral-metrics role=tabpanel data-core-tabs=core-collateral-metrics tabindex=-1 class=sf-hidden><div class="section--wrapper sf-hidden"><section class=sf-hidden>
<div data-pb-dropzone=conditional class=sf-hidden>
<div style="margin:0 auto;width:fit-content" class=sf-hidden>
</div>
</div>
</section></div></div></div><div class="fv figureViewer sf-hidden"></div><div id=crossmark-widget style=display:none></div>
<div style=display:none;visibility:hidden>
</div>